Publikationen

2021

• Acharya P , Chouhan K., Weiskirchen S., Weiskirchen R. (2021): Cellular Mechanisms of Liver Fibrosis. frontiers in Pharmacology, 12, [5.330]
• Fromme M. , Schneider C. V., Pereira V., Hamesch K., Pons M., Reichert M. C., Benini F., Ellis P., Thorhauge K. T., Mandorfer M., Burbaum B., Woditsch V., Chorostowska-Wynimko J., Verbeek J., Nevens F., Genesca J., Miravitlles M., Nuñez A., Schaefer B., Zoller H., Janciauskiene S., Abreu N., Jasmins L., Gaspar R., Liberal R., Macedo G., Mahadeva R., Gomes C., Schneider K. M., Trauner M., Krag A., Gooptu B., Thorburn D., Marshall A., Hurst J. R., Lomas D. A., Lammert F., Gaisa N. T., Clark V., Griffiths W., Trautwein C., Turner A. M., McElvaney N. G., Strnad P. (2021): Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency. GUT 2021, gutjnl-2020-323729, [19.819]
• Heinrichs D. , Brandt E. F., Fischer P., Köhncke J., Wirtz T. H., Guldiken N., Djudjaj S., Boor P., Kroy D., Weiskirchen R., Bucala R., Wasmuth H. E., Strnad P., Trautwein C., Bernhagen J., Berres M.-L. (2021): Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations. Cells, in press, [5.656]
• Krause J. , Grabsch H. I., Kloor M., Jendrusch M., Echle A., Buelow R. D., Boor P., Luedde T., Brinker T. J., Trautwein C., Pearson A. T., Quirke P., Jenniskens J., Offermans K., van den Brandt P. A., Kather J. N. (2021): Deep learning detects genetic alterations in cancer histology generated by adversarial networks. Journal of Pathology, 254(1), 70-79, [5.979]
• Kuscuoglu D. , Bewersdorf L., Wenzel K., Gross A., Kobazi Ensari G., Luo Y., Kilic K., Hittatiya K., Golob-Schwarzl N., Leube R. W., Preisinger C., George J., Metwally M., Eslam M., Lampertico P., Petta S., Mangia A., Berg T., Boonstra A., Brouwer W. P., Abate M. L., Loglio A., Sutton A., Nahon P., Schaefer B., Zoller H., Aigner E., Trautwein C., Haybaeck J., Strnad P. (2021): Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2. Journal of Pathology, 254(1), 80-91, [5.979]
• Wirtz T. H. , Reuken P. A., Jansen C., Fischer P., Bergmann I., Backhaus C., Emontzpohl C., Reißing J., Brandt E. F., Koenen T. M., Schneider K. M., Schierwagen R., Brol M. J., Chang J., Zimmermann H. W., Köse-Vogel N., Eggermann T., Kurth I., Stoppe C., Bucala R., Bernhagen J., Praktiknjo M., Stallmach A., Trautwein C., Trebicka J., Bruns T., Berres M.-L. (2021): Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis. JHEP Reports, in press,

2020

• Atkinson S. , R., Grove J. I., Liebig S., Astbury S., Vergis N., Goldin R., Quaglia A., Bantel H., Guha I. N., Thursz M. R., Newcombe P., Strnad P., Aithal G. P. (2020): In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic and Theragnostic Biomarkers. American Journal of Gastroenterology, 115(11), 1857-1868, [10.171]
• Azzam M. , El Safy S., Abdelgelil S. A., Weiskirchen R., Asimakopoulou A., de Lorenzi F., Lammers T., Mansour S., Tammam S. (2020): Targeting activated hepatic stellate cells using collagen-binding chitosan nanoparticles for siRNA delivery to fibrotic livers. Pharmaceutics, 12(6), 590, [4.773]
• Baues M. , Klinkhammer B. M., Ehling J., Gremse F., van Zandvoort M. A. M. J., Reutelingsperger C. P. M., Daniel C., Amann K., Bábíčková J., Kiessling F., Floege J., Lammers T., Boor P. (2020): A collagen-binding protein enables molecular imaging of kidney fibrosis in vivo. Kidney International, 97(3), 609-614, [8.306]
• Boehner A. , Viehmann S., Kurts C. (2020): Unraveling the complexity of the renal mononuclear phagocytic system by cell lineage tracing. J Am Soc Nephrol, Epub 2020, [8.547]
• Borkham-Kamphorst E. , Haas U., Van de Leur E., Trevanich A., Weiskirchen R. (2020): Chronic carbon tetra chloride applications induced hepatocyte apoptosis in Lipocaline 2 null mice through endoplasmic reticulum stress and unfolded protein response. International Journal of Molecular Sciences, 21(15), 5230, [4.183]
• Breitkopf D. M. , Jankowski V., Ohl K., Hermann J., Hermert D., Tenbrock K., Liu X., Martin I. V., Wang J., Groll F., Gröne E., Floege J., Ostendorf T., Rauen T., Raffetseder U. (2020): TheYB-q: Notch-3 axis modulates immune cell responses and organ damage in systemic tupus erythematosus. Kidney International, 97(2), 289-303, [8.306]
• Cubero F. J. , Mohamed M. R., Woitok M. M., Zhao G., Hatting M., Nevzorova Y. A., Chen C., Haybaeck J., de Bruin A., Avila M. A., Boekschoten m. V., Davis R. J., Trautwein C. (2020): Loss of JNK1/2 function in liver epithelial cells triggers biliary hyperprolif eration resembling cholangiocarcinoma. Hepatol Commun., 4(6), 834-851, [0.800]
• Drescher H. K. , Bartsch L. M., Weiskirchen S., Weiskirchen R. (2020): Intrahepatic TH17/Treg cells in homeostasis and disease - it's all about balance. Front Pharmacol, 11, 588436, [3.845]
• Drescher H. K. , Schippers A., Rosenhain S., Gremse F., Bongiovanni L., de Bruin A., Eswaran S., Gallage S. U., Pfister D., Szydlowska M., Heikenwalder M., Weiskirchen S., Wagner N., Trautwein C., Weiskirchen R., Kroy D. C. (2020): L-Selectin/CD62L is a Key Driver of non-alcoholic Steatohepatitis in Mouse and Men. Cells, 9(5), 1106, [5.656]
• Echle A. , Grabsch H. I., Quirke P., van den Brandt P. A., West N. P., Hutchins G. G. A., Heij L. R., Tan X., Richman S. D., Krause J., Alwers E., Jenniskens J., Offermans K., Gray R., Brenner H., Chang-Claude J., Trautwein C., Pearson A. T., Boor P., Luedde T., Gaisa N. T., Hoffmeister M., Kather J. N. (2020): Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning. Gastroenterology, 159, 1406-1416,
• Hermert D. , Martin I. V., Reiss L. K., Liu X., Breitkopf D. M., Reimer K. C., Alidousty C., Rauen T., Floege J., Ostendorf T., Weiskirchen R., Raffetseder U. (2020): The nucleic acid binding protein YB-1-controlled expression of CXCL-1 modulates kidney damage in liver fibrosis. Kidney International, 97(4), 741-752, [8.306]
• Hübbers A. , Hennings J., Lambertz D., Haas U., Trautwein C., Nevzorova Y. A., Sonntag R., Liedtke C. (2020): Pharmacological Inhibition of Cyclin dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic stellate cells in vitro. International Journal of Molecular Science, 21(9), 3267, [4.183]
• Jobin K. , Stumpf N. E., Schwab S., Eichler M., Neubert P., Rauh M., Adamowski M., Babyak O., Hinze D., Sivalingam S., Weisheit C., Hochheiser K., Schmidt S., Meissner M., Garbi N., Abdullah Z., Wenzel U., Hölzel M., Jantsch J., Kurts C. (2020): A high-salt diet compromises antibacterial neutrophil responses through hormonal perturbation. Science Translat Med, 12(536), eaay3850, [17.161]
• Kim P. , Zhang C. C., Thoröe-Boveleth S., Weiskirchen S., Gaisa N. T., Buhl E. M., Stremmel W., Merle U., Weiskirchen R. (2020): Accurate Measurement of Copper Overload in an Experimental Model of Wilson Disease by Laser Ablation Inductively Coupled Plamsa Mass Spectrometry. Biomedicines, 8(9), 356, [3.600]
• Klinkhammer B. M. , Djudjaj S., Kunter U., Palsson R., Edvardsson V. O., Wiech T., Thorsteinsdottir M., Hardarson S., Foresto-Neto O., Mulay S. R., Moeller M. J., Jahnen-Dechent W., Floege J., Anders H.J., Boor P. (2020): Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy. Journal of American Society of Nephrology, 31(4), 799-816, [8.491]
• Krebs C. , Schlitzer A., Kurts C. (2020): Drawing a single cell landscape of the human kidney in (pseudo)space and time. Kidney Int, 97(5), 842-844, [8.429]
• Kuppe C. , Ibrahim M. M., Kranz J., Zhang X., Ziegler S., Perales-Patón J., Jansen J., Reimer K. C., Smith J. R., Dobie R., Wilson-Kanamori J. R., Halder M., Xu Y., Kabgani N., Kaesler N., Klaus M., Gernhold L., Puelles V. G., Huber T. B., Boor P., Menzel S., Hoogenboezem R. M., Bindels E. M. J., Steffens J., Floege J., Schneider R. K., Saez-Rodriguez J., Henderson N. C., Kramann R. (2020): Decoding myofibroblast origins in human kidney fibrosis. nature, 589, 281–286,
• Kurts C. , Ginhoux F., Panzer U. (2020): Kidney dendritic cells: Basic biology and role in health and disease. Nat Rev Nephrol, 16(7), 391-407, [19.684]
• Loosen S. H. , Schulze-Hagen M., Püngel T., Bündgens L., Wirtz T., Kather J. N., Vucur M., Paffenholz P., Demir M., Bruners P., Kuhl C., Trautwein C., Tacke F., Luedde T., Koch A., Roderburg C. (2020): Skeletal muscle composition predicts outcome in criticalliy ill patients. Critical Care Explorations, 2(8),
• Paffenholz P. (2020): Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey. Emerging Microbes & Infectons, 9(1), 1590-1599,
• Rigau M. , Ostrouska S., Fulford T. S., Johnson D. N., Woods K., Ruan Z., McWilliam H. E., Hudson C., Tutuka C., Wheatley A. K., Kent S. J., Villadangos J. A., Pal B., Kurts C., Simmonds J., Pelzing M., Hammet A., Verhagen A. M., Vairo G., Maraskovsky E., Panousis C., Gherardin N. A., Cebon J., Godfrey D. I., Behren A., Uldrich A. P. (2020): Butyrophilin 2A1 mediates phosphoantigen reactivity by γδ T cells. Science 2020, in press,
• Rosenbaum M. , Gewies A., Pechloff K., Heuser C., Engleitner T., Gehring T., Krappmann D., Krebs S., Kriegsmann M., Weichert W., Rad R., Kurts C., Ruland J. (2020): Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Nat Commun Epub May 28, 10(1), 2352, [11.878]
• Schneider C.V. , Hamesch K., Gross A., Mandorfer M., Moeller L. S., Pereira V., Pons M., Kuca P., Reichert M. C., Benini F., Burbaum B., Voss J., Gutberlet M., Woditsch V., Lindhauer C., Fromme M., Kümpers J., Bewersdorf L., Schaefer B., Eslam M., Bals R., Janciauskiene S., Carvão J., Neureiter D., Zhou B., Wöran K., Bantel H., Geier A., Dirrichs T., Stickel F., Teumer A., Verbeek J., Nevens F., Govaere O., Krawczyk M., Roskams T., Haybaeck J., Lurje G., Chorostowska-Wynimko J., Genesca J., Reiberger T., Lammert F., Krag A., George J., Anstee Q. M., Trauner M., Datz C., Gaisa N. T., Denk H., Trautwein C., Aigner E., Strnad P. (2020): Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers. Gastroenterology, 159, 534-548,
• Schneider K. M. , Elfers C., Ghallab A., Schneider C. V., Galvez E. J. C., Mohs A., Gui W., Candels L. S., Wirtz T. H., Zuehlke S., Spiteller M., Myllys M., Roulet A., Ouzerdine A., Lelouvier B., Kilic K., Liao L., Nier A., Latz E., Bergheim I., Thaiss C. A., Hengstler J. G., Strowig T., Trautwein C. (2020): Intestinal dysbiosis amplifies acetaminophen induced acute liver injury. Cell Mol Gastroenterol Hepatol, S2352-345X(20), 30181-8, [6.850]
• Weiskirchen S. , Weiper K., Tolba R. H., Weiskirchen R. (2020): All you can feed: Some comments on Production of mouse diets used in Biomedical Research with special emphasis on non-alcoholic fatty liver disease research. Nutrients, 12(1), 163,
• Woitok M. M. , Zoubek M. E., Doleschel Dr., Bartneck M., Mohamed M. R., Kießling F., Lederle W., Trautwein C., Cubero F. J. (2020): Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease. Cell Death Dis, 11(5), 343,

2019

• Abraldes J. G. , Trebicka J., Chalasani N., D'Amico G., Rockey D. C., Shah V. H., Bosch J., Garcia-Tsao G. (2019): Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension. Hepatology, 69(3), 1287-1299, [14.079]
• Alvarez-Silva C. , Schierwagen R., Pohlmann A., Magdaleno F., Uschner F. E., Ryan P., Vehreschild M. J. G. T., Claria J., Latz E., Lelouvier B., Arumugam M., Trebicka J. (2019): Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis. Front Immunol, 10, 69, [4.716]
• Asimakopoulou A. , Vucur M., Luedde T., Weiss T.S., Schneiders S., Kalampoka S., Weiskirchen R. (2019): Perilipin 5 and Lipocalin 2 expression in hepatocellular carcinoma. Cancers, 11(3), 385, [6.162]
• Asphaug L. , Thiele M., Krag A., Melberg H. O.; GALAXY consortium (2019): Cost-effectiveness of non-invasive screening for alcohol-related liver fibrosis. Hepatology, 2019, [14.079]
• Bartneck M. , Schrammen P. L., Möckel D., Govaere O., Liepelt A., Krenkel O., Ergen C., McCain M. V., Eulberg D., Luedde T., Trautwein C., Kiessling F., Reeves H., Lammers T., Tacke F. (2019): The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers. Cell Mol Gastroenterol Hepatol, 7(2), 371-390, [6.850]
• Borkham-Kamphorst E. , Van de Leur E., Haas U., Weiskirchen R. (2019): Liver parenchymal cells lacking Lipocalin 2 (LCN2) are prone to endoplasmic reticulum stress and unfolded protein response. Cell Signal, 55, 90-99, [3.388]
• Breitkopf D. M. , Jankowski V., Ohl K., Hermann J., Hermert D., Tenbrock K., Liu X., Martin I. V., Wang J., Groll F., Gröne E., Floege J., Ostendorf T., Rauen T., Raffetseder U. (2019): The YB-1:Notch-3 axis modulates immune cell responses and organ damage in systemic lupus erythematosus. Kidney Int, in press, [8.306]
• Brol M. J. , Rösch F., Schierwagen R., Magdaleno F., Uschner F. E., Manekeller S., Queck A., Schwarzkopf K., Odenthal M., Drebber U., Thiele M., Lingohr P., Plamper A., Kristiansen G., Lotersztajn S., Krag A., Klein S., Rheinwalt K. P., Trebicka J. (2019): Combination of CCl with alcoholic and metabolic injuries mimics human liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 317(2), G182-G194, [3.468]
• Casey S. , Schierwagen R., Mak K. Y., Klein S., Uschner F., Jansen C., Praktiknjo M., Meyer C., Thomas D., Herath C., Jones R., Trebicka J., Angus P. (2019): Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation. J Clin Med, 8(4), E419, [5.583]
• Christ A. , Latz E. (2019): The Western lifestyle has lasting effects on metaflammation. Nature Reviews immunology, 19, 267-268, [44.019]
• Christ A. , Lauterbach M., Latz E. (2019): Western Diet and the Immune System: An Inflammatory Connection. Immunity, 51(5), 794-811, [21.522]
• Clària J. , Moreau R., Fenaille F., Amorós A., Junot C., Gronbaek H., Coenraad M. J., Pruvost A., Ghettas A., Chu-Van E., López-Vicario C., Oettl K., Caraceni P., Alessandria C., Trebicka J., Pavesi M., Deulofeu C., Albillos A., Gustot T., Welzel T. M., Fernández J., Stauber R. E., Saliba F., Butin N., Colsch B., Moreno C., Durand F., Nevens F., Bañares R., Benten D., Ginès P., Gerbes A., Jalan R., Angeli P., Bernardi M., Arroyo V.; CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif) (2019): Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis. Hepatology, 69(4), 1686-1701, [14.079]
• Cossarizza A. , Chang H. D., Radbruch A., Acs A., Adam D., Adam-Klages S., Agace W. W., Aghaeepour N., Akdis M., Allez M., Almeida L. N., Alvisi G., Anderson G., Andrä I., Annunziato F., Anselmo A., Bacher P., Baldari C. T., Bari S., Barnaba V., Barros-Martins J., Battistini L., Bauer W., Baumgart S., Baumgarth N., Baumjohann D., Baying B., Bebawy M., Becher B., Beisker W., Benes V., Beyaert R., Blanco A., Boardman D. A., Bogdan C., Borger J. G., Borsellino G., Boulais P. E., Bradford J. A., Brenner D., Brinkman R. R., Brooks A. E. S., Busch D. H., Büscher M., Bushnell T. P., Calzetti F., Cameron G., Cammarata I., Cao X., Cardell S. L., Casola S., Cassatella M. A., Cavani A., Celada A., Chatenoud L., Chattopadhyay P. K., Chow S., Christakou E., Čičin-Šain L., Clerici M., Colombo F. S., Cook L., Cooke A., Cooper A. M., Corbett A. J., Cosma A., Cosmi L., Coulie P. G., Cumano A., Cvetkovic L., Dang V. D., Dang-Heine C., Davey M. S., Davies D., De Biasi S., Del Zotto G., Dela Cruz G. V., Delacher M., Della Bella S., Dellabona P., Deniz G., Dessing M., Di Santo J. P., Diefenbach A., Dieli F., Dolf A., Dörner T., Dress R. J., Dudziak D., Dustin M., Dutertre C. A., Ebner F., Eckle S. B. G., Edinger M., Eede P., Ehrhardt G. R. A., Eich M., Engel P., Engelhardt B., Erdei A., Esser C., Everts B., Evrard M., Falk C. S., Fehniger T. A., Felipo-Benavent M., Ferry H., Feuerer M., Filby A., Filkor K., Fillatreau S., Follo M., Förster I., Foster J., Foulds G. A., Frehse B., Frenette P. S., Frischbutter S., Fritzsche W., Galbraith D. W., Gangaev A., Garbi N., Gaudilliere B., Gazzinelli R. T., Geginat J., Gerner W., Gherardin N. A., Ghoreschi K., Gibellini L., Ginhoux F., Goda K., Godfrey D. I., Goettlinger C., González-Navajas J. M., Goodyear C. S., Gori A., Grogan J. L., Grummitt D., Grützkau A., Haftmann C., Hahn J., Hammad H., Hämmerling G., Hansmann L., Hansson G., Harpur C. M., Hartmann S., Hauser A., Hauser A. E., Haviland D. L., Hedley D., Hernández D. C., Herrera G., Herrmann M., Hess C., Höfer T., Hoffmann P., Hogquist K., Holland T., Höllt T., Holmdahl R., Hombrink P., Houston J. P., Hoyer B. F., Huang B., Huang F. P., Huber J. E., Huehn J., Hundemer M., Hunter C. A., Hwang W. Y. K., Iannone A., Ingelfinger F., Ivison S. M., Jäck H. M., Jani P. K., Jávega B., Jonjic S., Kaiser T., Kalina T., Kamradt T., Kaufmann S. H. E., Keller B., Ketelaars S. L. C., Khalilnezhad A., Khan S., Kisielow J., Klenerman P., Knopf J., Koay H. F., Kobow K., Kolls J. K., Kong W. T., Kopf M., Korn T., Kriegsmann K., Kristyanto H., Kroneis T., Krueger A., Kühne J., Kukat C., Kunkel D., Kunze-Schumacher H., Kurosaki T., Kurts C., Kvistborg P., Kwok I., Landry J., Lantz O., Lanuti P., LaRosa F., Lehuen A., LeibundGut-Landmann S., Leipold M. D., Leung L. T., Levings M. K., Lino A. C., Liotta F., Litwin V., Liu Y., Ljunggren H. G., Lohoff M., Lombardi G., Lopez L., López-Botet M., Lovett-Racke A. E., Lubberts E., Luche H., Ludewig B., Lugli E., Lunemann S., Maecker H. T., Maggi L., Maguire O., Mair F., Mair K. H., Mantovani A., Manz R. A., Marshall A. J., Martínez-Romero A., Martrus G., Marventano I., Maslinski W., Matarese G., Mattioli A. V., Maueröder C., Mazzoni A., McCluskey J., McGrath M., McGuire H. M., McInnes I. B., Mei H. E., Melchers F., Melzer S., Mielenz D., Miller S. D., Mills K. H. G., Minderman H., Mjösberg J., Moore J., Moran B., Moretta L., Mosmann T. R., Müller S., Multhoff G., Muñoz L. E., Münz C., Nakayama T., Nasi M., Neumann K., Ng L. G., Niedobitek A., Nourshargh S., Núñez G., O'Connor J. E., Ochel A., Oja A., Ordonez D., Orfao A., Orlowski-Oliver E., Ouyang W., Oxenius A., Palankar R., Panse I., Pattanapanyasat K., Paulsen M., Pavlinic D., Penter L., Peterson P., Peth C., Petriz J., Piancone F., Pickl W. F., Piconese S., Pinti M., Pockley A. G., Podolska M. J., Poon Z., Pracht K., Prinz I., Pucillo C. E. M., Quataert S. A., Quatrini L., Quinn K. M., Radbruch H., Radstake T. R. J., Rahmig S., Rahn H. P., Rajwa B., Ravichandran G., Raz Y., Rebhahn J. A., Recktenwald D., Reimer D., Reis E., Sousa C., Remmerswaal E. B. M., Richter L., Rico L. G., Riddell A., Rieger A. M., Robinson J. P., Romagnani C., Rubartelli A., Ruland J., Saalmüller A., Saeys Y., Saito T., Sakaguchi S., Sala-de-Oyanguren F., Samstag Y., Sanderson S., Sandrock I., Santoni A., Sanz R. B., Saresella M., Sautes-Fridman C., Sawitzki B., Schadt L., Scheffold A., Scherer H. U., Schiemann M., Schildberg F. A., Schimisky E., Schlitzer A., Schlosser J., Schmid S., Schmitt S., Schober K., Schraivogel D., Schuh W., Schüler T., Schulte R., Schulz A. R., Schulz S. R., Scottá C., Scott-Algara D., Sester D. P., Shankey T. V., Silva-Santos B., Simon A. K., Sitnik K. M., Sozzani S., Speiser D. E., Spidlen J., Stahlberg A., Stall A. M., Stanley N., Stark R., Stehle C., Steinmetz T., Stockinger H., Takahama Y., Takeda K., Tan L., Tárnok A., Tiegs G., Toldi G., Tornack J., Traggiai E., Trebak M., Tree T. I. M., Trotter J., Trowsdale J., Tsoumakidou M., Ulrich H., Urbanczyk S., van de Veen W., van den Broek M., van der Pol E., van Gassen S., van Isterdael G., van Lier R. A. W., Veldhoen M., Vento-Asturias S., Vieira P., Voehringer D., Volk H. D., von Borstel A., von Volkmann K., Waisman A., Walker R. V., Wallace P. K., Wang S. A., Wang X. M., Ward M. D., Ward-Hartstonge K. A., Warnatz K., Warnes G., Warth S., Waskow C., Watson J. V., Watzl C., Wegener L., Weisenburger T., Wiedemann A., Wienands J., Wilharm A., Wilkinson R. J., Willimsky G., Wing J. B., Winkelmann R., Winkler T. H., Wirz O. F., Wong A., Wurst P., Yang J. H. M., Yang J., Yazdanbakhsh M., Yu L., Yue A., Zhang H., Zhao Y., Ziegler S. M., Zielinski C., Zimmermann J., Zychlinsky A. (2019): Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol, Oct;49(10), 1457-1973, [4.695]
• Cubero F. J. , Peng J., Liao L., Su H., Zhao G., Zoubek M. E., Macías-Rodríguez R., Ruiz-Margain A., Reißing J., Zimmermann H. W., Gassler N., Luedde T., Liedtke C., Hatting M., Trautwein C. (2019): Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis. Journal of Hepatology, 69(6), 1326-1334, [10.590]
• Cubero F. J. , Woitok M. M., Zoubek M. E., de Bruin A., Hatting M., Trautwein C. (2019): Disruption of the FasL/FasR axis protects against inflammation-derived tumorigenesis in chronic liver disease. Cell Death & Disease, 10, 115, [5.959]
• Cullaro G. , Sharma R., Trebicka J., Cardenas A., Verna E. C. (2019): ”.” [5.583] (2019): Precipitants of Acute-On-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes. Liver Transpl, [5.583]
• De Gottardi A. , Rautou P. E., Schouten J., Rubbia-Brandt L., Leebeek F., Trebicka J., Murad S. D., Vilgrain V., Hernandez-Gea V., Nery F., Plessier A., Berzigotti A., Bioulac-Sage P., Primignani M., Semela D., Elkrief L., Bedossa P., Valla D., Garcia-Pagan J. C., VALDIG group (2019): Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol, 4(5), 399-411, [12.865]
• Dold L. , Nielsen M. J., Praktiknjo M., Schwarze-Zander C., Boesecke C., Schierwagen R., Mohr R., Wasmuth J. C., Jansen C., Bischoff J., Rockstroh J. K., Karsdal M. A., Spengler U., Trebicka J., Leeming D. J. (2019): Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART. PLoS One, 14(7), e0219526, [2.776]
• Drescher H. K. , Brandt E. F., Fischer P., Dreschers S., Schwendener R. A., Kowalska M. A., Canbay A., Wasmuth H. E., Weiskirchen R., Trautwein C., Berres M. L., Kroy D. C., Sahin H. (2019): “.” 10, 326, [3.201] (2019): Platelet Factor 4 Attenuates Experimental Acute Liver Injury in Mice. Front Physiol, 10, 326, [3.201]
• Drescher H. K. , Weiskirchen R., Fülöp A., Hopf C., Gonzáles de San Roman E., Huesgen P.F., de Bruin A., Christ A., Tolba R., Trautwein C., Kroy D.C. (2019): The influence of different fat sources on steatohepatitis and fibrosis development in the Western diet mouse model of non-alcoholic steatohepatitis (NASH). Front Physiol, 10, 770, [3.394]
• Drescher H. K. , Weiskirchen S., Weiskirchen R. (2019): Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Cells, 8, 845, [5.656]
• Dutton Sackett S. , Otto T., Mohs A., Sander L. E., Strauch S., Streetz K.L., Kroy D. C., Trautwein C. (2019): Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis. The FASEB Journal, 33(5), [5.498]
• Elkrief L. , Ferrusquia-Acosta J., Payancé A., Moga L., Tellez L., Praktiknjo M., Procopet B., Farcau O., De Lédinghen V., Yuldashev R., Tabchouri N., Barbier L., Dumortier J., Menahem B., Magaz M., Hernández-Gea V., Albillos A., Trebicka J., Spahr L., De Gottardi A., Plessier A., Valla D., Rubbia-Brandt L., Toso C., Bureau C., Garcia-Pagan J. C., Rautou P. E., for VALDIG, an EASL consortium (2019): Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study. Hepatology, 70(3), 911-924, [14.079]
• Enders M. , Franken L., Philipp M. S., Kessler N., Baumgart A. K., Eichler M., Wirtz E., Garbi N., Kurts C. (2019): Splenic red pulp macrophages cross-prime early effector CTL that provide rapid defense against viral infections. J Immunol, 204(1), 87-100, [4.718]
• Fabry G. , Doorschodt B. M., Grzanna T., Boor P., Elliott A., Stollenwerk A., Tolba R. H., Rossaint R., Bleilevens C. (2019): Cold Preflush of Porcine Kidney Grafts Prior to Normothermic Machine Perfusion Aggravates Ischemia Reperfusion Injury. Sci Rep, 9, 13897, [4.011]
• Faron A. , Pieper C. C., Schmeel F. C., Sprinkart A. M., Kuetting D. L. R., Fimmers R., Trebicka J., Schild H. H., Meyer C., Thomas D., Luetkens J. A. (2019): Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases. Eur Radiol, 29(9), 4709-4717, [4.027]
• Fernández J , Prado V, Trebicka J, Amoros A, Gustot T, Wiest R, Deulofeu C, Garcia E, Acevedo J, Fuhrmann V, Durand F, Sánchez C, Papp M, Caraceni P, Vargas V, Bañares R, Piano S, Janicko M, Albillos A, Alessandria C, Soriano G, Welzel TM, Laleman W, Gerbes A, De Gottardi A, Merli M, Coenraad M, Saliba F, Pavesi M, Jalan R, Ginès P, Angeli P, Arroyo V; European Foundation for the Study of Chronic Liver Failure (EF-Clif) (2019): Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol, 70(3), 398-411, [18.946]
• Fernández J. , Angeli P., Trebicka J., Merli M., Gustot T., Alessandria C., Aagaard N. K., de Gottardi A., Welzel T. M., Gerbes A., Soriano G., Vargas V., Albillos A., Salerno F., Durand F., Bañares R., Stauber R., Prado V., Arteaga M., Hernández-Tejero M., Aziz F., Morando F., Jansen C., Lattanzi B., Moreno C., Campion D., Gronbaek H., Garcia R., Sánchez C., García E., Amorós A., Pavesi M., Clària J., Moreau R., Arroyo V. (2019): Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. Clin Gastroenterol Hepatol, [7.958]
• Fernández J. , Clària J., Amorós A., Aguilar F., Castro M., Casulleras M., Acevedo J., Duran-Güell M., Nuñez L., Costa M., Torres M., Horrillo R., Ruiz-Del-Árbol L., Villanueva C., Prado V., Arteaga M., Trebicka J., Angeli P., Merli M., Alessandria C., Aagaard N. K., Soriano G., Durand F., Gerbes A., Gustot T., Welzel T. M., Salerno F., Bañares R., Vargas V., Albillos A., Silva A., Morales-Ruiz M., García-Pagán J. C., Pavesi M., Jalan R., Bernardi M., Moreau R., Páez A., Arroyo V. (2019): Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. Gastroenterology, 157(1), 149-162, [20.773]
• Gadermayr M. , Gupta L., Appel V., Boor P., Klinkhammer B. M., Merhof D. (2019): Generative Adversarial Networks for Facilitating Stain-Independent Supervised & Unsupervised Segmentation: A Study on Kidney Histology. IEEE Trans Med Imaging (TMI), 38, 2293-2302, [7.816]
• Gerbes A. L. , Labenz J., Appenrodt B., Dollinger M., Gundling F., Gülberg V., Holstege A., Lynen-Jansen P., Steib C. J., Trebicka J., Wiest R., Zipprich A., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), Deutsche Gesellschaft für Innere Medizin e. V. (DGIM), Deutsche Gesellschaft für Infektiologie e. V. (DGI), Deutsche Gesellschaft für Pathologie e. V./Bundesverband deutscher Pathologen e. V. (DGP/BDP), Deutsche Röntgengesellschaft e. V. (DRG), Deutsche Gesellschaft für Interventionelle Radiologie und minimal-invasive Therapie (DeGIR), Deutsche Gesellschaft für Nephrologie (DGFN), Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM), Deutsche Gesellschaft für Neurologie e. V. (DGN), Deutsche Gesellschaft für Ernährungsmedizin e. V. (DGEM), Lebertransplantierte Deutschland e. V., Collaborators (2019): Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS). Zeitschrift für Gastroenterologie, 57(5), 611-680, [1.612]
• Gonzalez-Carmona M. A. , Bolch M., Jansen C., Vogt A., Sampels M., Mohr R. U., van Beekum K., Mahn R., Praktiknjo M., Nattermann J., Trebicka J., Branchi V., Matthaei H., Manekeller S., Kalff J. C., Strassburg C. P., Weismüller T. J. (2019): Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma. Aliment Pharmacol Ther, 49(4), 437-447, [7.357]
• Graefe C. , Eichhorn L., Wurst P., Kleiner J., Heine A., Panetas I., Abdulla Z., Hoeft A., Frede S., Kurts C., Endl E., Weisheit C. K. (2019): Optimized Ki-67 staining in murine cells: a tool to determine cell proliferation. Mol Biol Rep, 2019 46(4), 4631-4643, [2.107]
• Guillot A. , Tacke F. (2019): Liver Macrophages: Old Dogmas and New Insights. Hepatol Commun., 3 (6), 730-743, [0.800]
• Guldiken N. , Hamesch K., Schuller S. M., Aly M., Lindhauer C., Schneider C. V., Fromme M., Trautwein C., Strnad P. (2019): Mild Iron Overload is not a major driver of liver fibrogenesis in individuals homozygous for the Alpha-1 Antitrypsin Pi*Z Variant. Cells, 8(11), 1415, [5.656]
• Gussen H. , Hohlstein P., Bartneck M., Warzecha K. T., Buendgens L., Luedde T., Trautwein C., Koch A., Tacke F. (2019): Neutrophils are a main source of circulating suPAR predicting outcome in critical illness. J Intensive Care, 7, 26, [3.510]
• Hamesch K. , Mandorfer M., Pereira V. M., Moeller L. S., Pons M., Dolman G. E., Reichert M. C., Heimes C. V., Woditsch V., Voss J., Lindhauer C., Fromme M., Spivak I., Guldiken N., Zhou B., Arslanow A., Schaefer B., Zoller H., Aigner E., Reiberger T., Wetzel M., Siegmund B., Simões C., Gaspar R., Maia L., Costa D., Bento-Miranda M., van Helden J., Yagmur E., Bzdok D., Stolk J., Gleiber W., Knipel V., Windisch W., Mahadeva R., Bals R., Koczulla R., Barrecheguren M., Miravitlles M., Janciauskiene S., Stickel F., Lammert F., Liberal R., Genesca J., Griffiths W. J., Trauner M., Krag A., Trautwein C., Strnad P., European Alpha1-Liver Study Group (2019): Liver Fibrosis and Metabolic Alterations in Adults with Alpha1 Antitrypsin Deficiency Caused by the Pi*ZZ Mutation. Gastroenterology, 157, 705-719, [20.773]
• Hansel C. , Erschfeld S., Baues M., Lammers T., Weiskirchen R., Trautwein C., Kroy D. C., Drescher H. K. (2019): The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis. frontiers in Pharmacology, [3.845]
• Hansel C. , Erschfeld S., Baues M., Lammers T., Weiskirchen R., Trautwein C., Kroy D.C., Drescher H.K. (2019): The inhibitory T cell receptors PD1 and 2B4 are differentially regulated on CD4 and CD8 T cells in a mouse model of non-alcoholic steatohepatitis. Front Pharmacol, 10, 244, [3.845]
• He J. , Li T., Próchnicki T., Horvath G., Latz E., Takeoka S. (2019): Membrane Fusogenic Lysine Type Lipid Assemblies Possess Enhanced NLRP3 Inflammasome Activation Potency. Biochemistry and Biophysics Reports, 18, 100623, [1.650]
• Hermert D. , Martin I.V., Reiss L.K., Breitkopf D.M., Rauen T., Floege J., Ostendorf T., Weiskirchen R., Raffetseder U. (2019): YB-1-controlled CXCL-1 expression decides on kidney damage in liver fibrosis. Kidney Int, [8.395]
• Hernández-Gea V. , Procopet B., Giráldez Á., Amitrano L., Villanueva C., Thabut D., Ibañez-Samaniego L., Silva-Junior G., Martinez J., Genescà J., Bureau C., Trebicka J., Llop E., Laleman W., Palazon J. M., Castellote J., Rodrigues S., Gluud L. L., Noronha Ferreira C., Barcelo R., Cañete N., Rodríguez M., Ferlitsch A., Mundi J. L., Gronbaek H., Hernández-Guerra M., Sassatelli R., Dell'Era A., Senzolo M., Abraldes J. G., Romero-Gómez M., Zipprich A., Casas M., Masnou H., Primignani M., Krag A., Nevens F., Calleja J. L., Jansen C., Robic M. A., Conejo I., Catalina M. V., Albillos A., Rudler M., Alvarado E., Guardascione M. A., Tantau M., Bosch J., Torres F., Garcia-Pagán J. C., International Variceal Bleeding Observational Study Group and Baveno Cooperation (2019): Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study. Hepatology, 69(1), 282-293, [14.079]
• Heymann F. , von Trotha K.-T., Preisinger C., Lynen-Jansen P., Roeth A. A., Geiger M., Geisler L. J., Frank A. K., Conze J., Luedde T., Trautwein C., Binnebösel M., Neumann U. P., Tacke F. (2019): Polypropylene mesh implantation for hernia repair causes myeloid cell-driven persistent inflammation. JCI insight, [6.014]
• Hohlstein P. , Gussen H., Bartneck M., Warzecha K. T., Roderburg C., Buendgens L., Trautwein C., Koch A., Tacke F. (2019): Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis. Journal of Clinical Medicine, [5.688]
• Iwasaki J. , Afify M., Bleilevens C., Klinge U., Weiskirchen R., Steitz J., Vogt M., Yagi S., Nagai K., Uemoto S., Tolba R.H. (2019): The impact of a nitric oxide synthase inhibitor (L-NAME) on ischemia-reperfusion injury of cholestatic livers by Pringle Maneuver and liver resection after bile duct ligation in rats. Int J Mol Sci, 20, 2114, [4.183]
• Jansen C , Chatterjee DA, Thomsen KL, Al-Kassou B, Sawhney R, Jones H, Gallego-Leon A, Lehmann J, Pohlmann A., Nickenig G., Strassburg C. P., Andrié R., Jalan R., Linhart M., Trebicka J., Mookerjee R. P. (2019): Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality. Aliment Pharmacol Ther, 50(5), 568-579, [7.357]
• Jansen C. , Schröder A., Schueler R., Lehmann J., Praktiknjo M., Uschner F. E., Schierwagen R., Thomas D., Monteiro S., Nickenig G., Strassburg C. P., Meyer C., Arroyo V., Hammerstingl C., Trebicka J. (2019): Left Ventricular Longitudinal Contractility Predicts Acute-on-Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt. Hepatol Commun, 3(3), 340-347, [0.800]
• Jansen C. , Trebicka J. (2019): Editorial: diastolic dysfunction seems not to be decisive for survival after transjugular intrahepatic portosystemic stent-shunt. Aliment Pharmacol Ther, 49(8), 1101-1102, [7.357]
• Jordan S. , Tung N., Casanova-Acebes M., Chang C., Cantoni C., Zhang D., Wirtz T. H., Naik S., Rose S. A., Brocker C. N., Gainullina A., Hornburg D., Horng S., Maier B. B., Cravedi P., LeRoith D., Gonzalez F. J., Meissner F., Ochando J., Rahman A., Chipuk J. E., Artyomov M. N., Frenette P. S., Piccio L., Berres M. L., Gallagher E. J., Merad M. (2019): Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell, 178(5), 1102-1114, [36.216]
• Kather J. N. , Pearson A. T., Halama N., Jäger D., Krause J., Loosen S. H., Marx A., Boor P., Tacke F., Neumann U. P., Grabsch H. I., Yoshikawa T., Brenner H. B., Chang-Claude J., Hoffmeister M., Trautwein C., Luedde T. (2019): Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med, 25, 1054-1056, [30.641]
• Kelly J. , Minoda Y., Meredith T., Cameron G., Philipp M. S., Pellicci D. G., Corbett A. J., Kurts C., Gray D. H., Godfrey D. I., Kannourakis G., Berzins S. P. (2019): Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers. Immunol Cell Biol., 97(8), 689-699, [3.947]
• Klein L. M. , Chang J., Gu W., Manekeller S., Jansen C., Lingohr P., Praktiknjo M., Kalf J. C., Schulz M., Spengler U., Strassburg C., Cardenas A., Arroyo V., Trebicka J. (2019): The development and outcome of acute-on-chronic liver failure after surgical interventions. Liver Transpl, [5.583]
• Klein S. , Frohn F., Magdaleno F., Reker-Smit C., Schierwagen R., Schierwagen I., Uschner F. E., Fürst D. O., Djudjaj S., Boor P., Poelstra K., Beljaars L., Trebicka J. (2019): Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats with increased renal perfusion. Sci Rep, 9, 2256, [4.011]
• Klein S. , Kleine C. E., Pieper A., Granzow M., Gautsch S., Himmit M., Kahrmann K., Schierwagen R., Uschner F. E., Magdaleno F., Naoum M. E., Kristiansen G., Walther T., Bader M., Sauerbruch T., Trebicka J. (2019): TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor. Sci Rep, 9, (1), 11598, [4.011]
• Koppe C. , Reisinger F., Wehr K., Vucur M., Trautwein C., Tacke F., Heikenwalder M., Luedde T. (2019): An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration. Cancers, 11(7), 999, [6.162]
• Krenkel O. , Hundertmark J., Ritz T.P., Weiskirchen R., Tacke F. (2019): Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis. Cells, 8, 503, [5.656]
• Krishnan S. M. , Ling Y. H., Huuskes B. M., Ferens D. M., Saini N., Chan C. T., Diep H., Kett M. M., Samuel C. S., Kemp-Harper B. K., Robertson A. A. B, Cooper M. A., Peter K., Latz E., Mansell A. S., Sobey C. G., Drummond G. R., Vinh A. (2019): Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovascular Research, 115(4), 776-787, [7.014]
• Kuppe C. , Gröne H.-J., Ostendorf T, van Kuppevelt T. H., Boor P., Floege J., Smeets B., Moeller M. J. (2019): Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis. Kidney International, [8.306]
• Kuppe C. , Leuchtle K., Wagner A., Kabgani N., Saritas T., Puelles V. G., Smeets B., Hakroush S., van der Vlag J., Buhl E. M., Boor P., Schiffer M., Gröne H. J., Fogo A., Floege J., Moeller M. J. (2019): Novel parietal epithelial cell subpopulations in FSGS and the origin of the glomerular tip lesion. Kidney Int, 96, 80-93, [8.306]
• Kurts C. , Meyer-Schwesinger C. (2019): Protecting the kidney against autoimmunity and inflammation. Nat Rev Nephrol, Feb;15(2), 66-68, [19.684]
• Langhans B. , Nischalke H. D., Krämer B., Dold L., Lutz P., Mohr R., Vogt A., Toma M., Eis-Hübinger A. M., Nattermann J., Strassburg C. P., Gonzalez-Carmona M. A., Spengler U. (2019): Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma. Cancer Immunol Immunother, 68(12), 2055-2066, [4.900]
• Laurentius T. , Raffetseder U., Fellner C., Kob R., Nourbakhsh M., Floege J., Bertsch T., Bollheimer L. C., Ostendorf T. (2019): High-fat diet-induced obesity causes an inflammatory microenvironment in the kidneys of aging Long-Evans rats. J Inflamm (Lond), 16, 14 eCollection, [2.662]
• Lehmann J. , Praktiknjo M., Nielsen M. J., Schierwagen R., Meyer C., Thomas D., Violi F., Strassburg C. P., Bendtsen F., Møller S., Krag A., Karsdal M. A., Leeming D. J., Trebicka J. (2019): Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis. Liver Int, 39(5), 885-893, [5.542]
• Li T. , Zehner M., He J., Próchnicki T., Horvath G., Latz E., Burgdorf S., Takeoka S. (2019): NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells. International Journal of Nanomedicine, 14, 3503-3516, [4.471]
• Liao L. , Schneider K. M., Galvez E. J. C., Frissen M., Marschall H.-U., Su H., Hatting M., Wahlström A., Haybaeck J., Puchas P., Mohs A., Peng J., Bergheim I., Nier A., Hennings J., Reißing J., Zimmermann H. W., Longerich T., Strowig T., Liedtke, C., Cubero F. J., Trautwein C. (2019): Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosring cholangitis. Gut, 68, 1477-1492, [17.160]
• Loosen S. H. , Hoening P., Puethe N., Luedde M., Spehlmann M., Ulmer T. F., Cardenas D. V., Roy S., Tacke F., Trautwein C., Neumann U. P., Luedde T., Roderburg C. (2019): Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma. Sci Rep., 9(1), 1489, [4.011]
• Loosen S. H. , Lurje G., Wiltberger G., Vucur M., Koch A., Kather J. N., Paffenholz P., Tacke F., Ulmer F. T., Trautwein C. (2019): Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma. PLoS ONE, 14 (1), e0210944, [2.776]
• Loosen S. H. , Tacke F., Püthe N., Binneboesel M., Wiltberger G., Alizai P. H., Kather J. N., Paffenholz P., Ritz T., Koch A., Bergmann F., Trautwein C., Longerich T., Roderburg C., Neumann U. P., Luedde T. (2019): High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma. Carcinogenesis, 40(8), 947–955, [4.004]
• Loosen S.H. , Koch A., Tacke F., Roderburg C., Luedde T. (2019): The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis. Int J Mol Sci, 20(19), 4820, [4.183]
• Loosen S.H. , Schulze-Hagen M., Bruners P., Tacke F., Trautwein C., Kuhl C., Luedde T., Roderburg C. (2019): Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies. Cancers, 11(10), 1503, [6.162]
• Luetkens J. A. , Klein S., Träber F., Block W., Schmeel F. C., Sprinkart A. M., Kuetting D. L. R., Uschner F. E., Schierwagen R., Thomas D., Trebicka J., Kukuk G.M. (2019): Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model. Eur Radiol Exp, 3(1), 22, [4.027]
• Lutz P. , Jeffery H. C., Jones N., Birtwistle J., Kramer B., Nattermann J., Spengler U., Strassburg C. P., Adams D. H., Oo Y. H. (2019): NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune Response. Front Immunol, 10, 1838, [4.716]
• Mahli A. , Seitz T., Beckröge T., Freese K., Thasler W.E., Benkert M., Dietrich P., Weiskirchen R., Bosserhoff A., Hellerbrand C. (2019): Bone morphogenetic protein-8B expression is induced in steatotic hepatocytes and promotes hepatic steatosis and inflammation in vitro. Cells, 8, 457, [5.656]
• Mahli A. , Seitz T., Fresse K., Frank J., Weiskirchen R., Abdel-Tawab M., Behnam D., Hellerbrand C. (2019): Therapeutic application of micellar solubilized xanthohumol in a Western-type diet-induced mouse model of obesity, diabetes and non-alcoholic fatty liver disease. Cells, 8, 359, [5.656]
• Malin J. J. , Boesecke C., Schwarze-Zander C., Wasmuth J. C., Schlabe S., Trebicka J., Spengler U., Llibre J. M., Jou T., Vasylyev M., Clotet B., Rockstroh J. K. (2019): Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection. HIV Med, 20(3), 230-236, [3.734]
• Martin-Higueras C. , Ludwig-Portugall I., Hoppe B., Kurts C. (2019): Targeting kidney inflammation as a new therapy for Primary Hyperoxaluria?. Nephrol Dial Transpl, 34(6), 908-914, [4.198]
• Meurer S.K. , Wimmer A.E., van de Leur E., Weiskirchen R. (2019): Endoglin trafficking/exosomal targeting in liver cells depends on N-glycosylation. Cells, 8, 997, [5.656]
• Mohs A. , Kuttkat N., Otto T., Youssef S. A., De Bruin A., Trautwein C. (2019): MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis. Carcinogenesis, [4.004]
• Mossanen J. C. , Kohlhepp M., Wehr A., Krenkel O., Liepelt A., Roeth A. A., Möckel D., Heymann F., Lammers T., Gassler N., Hermann J., Jankowski J., Neumann U. P., Luedde T., Trautwein C., Tacke F. (2019): CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence. Gastroenterology, 156(6), 1877-1889, [20.773]
• Mulay S. R. , Honarpisheh M. M., Foresto-Neto O., Shi C., Desai J., Zhao Z. B., Marschner J. A., Popper B., Buhl E. M., Boor P., Linkermann A., Liapis H., Bilyy R., Herrmann M., Romagnani P., Belevich I., Jokitalo E., Becker J. U., Anders H. J. (2019): Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI. Am Soc Nephrol., 30, 1857-1869, [8.547]
• Neubert P. , Weichselbaum A., Reitinger C., Schatz V., Schröder A., Ferdinand J. R., Simon M., Bär A. L., Brochhausen C., Gerlach R. G., Tomiuk S., Hammer K., Wagner S., van Zandbergen G., Binger K. J., Müller D. N., Kitada K., Clatworthy M. R., Kurts C., Titze J., Abdullah Z., Jantsch J. (2019): HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting. Autophagy, 15(11), 1899-1916, [11.059]
• Pinheiro D. , Dias I., Silva K. R., Stumbo A. C., Thole A., Cortez E., de Carvalho L., Weiskirchen R., Carvalho S. (2019): Mechanisms underlying cell therapy in liver fibrosis: an overview. Cells, in press, [5.656]
• Poluzzi C. , Nastase M. V., Zeng-Brouwers J., Roedig H., Hsieh L. T. H., Michaelis J. B., Abderrahman N. B., Buhl E. M., Rezende F., Manavski Y., Bleich A., Boor P., Brandes R. P., Pfeilschifter J., Stelzer E. H. K., Münch C., Dikic I., Brandts C., Iozzo R. V., Wygrecka M. Schaefer L. (2019): Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis: Impact on renal ischemia/reperfusion injury. Kidney Int, 95, 540-562, [8.429]
• Pose E. , Napoleone L., Amin A., Campion D., Jimenez C., Piano S., Roux O., Uschner F. E., de Wit K., Zaccherini G., Alessandria C., Angeli P., Bernardi M., Beuers U., Caraceni P., Durand F., Mookerjee R. P., Trebicka J., Vargas V., Andrade R. J., Carol M., Pich J., Ferrero J., Domenech G., Llopis M., Torres F., Kamath P. S., Abraldes J. G., Solà E., Ginès P. (2019): Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPESAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Gastroenterol Hepatol, [12.865]
• Pose E. , Trebicka J., Mookerjee R. P., Angeli P., Ginès P. (2019): Statins: Old drugs as new therapy for liver diseases?. J Hepatol, 70(1), 194-202, [18.946]
• Praktiknjo M. , Clees C., Pigliacelli A., Fischer S., Jansen C., Lehmann J., Pohlmann A., Lattanzi B., Krabbe V. K., Strassburg C. P., Arroyo V., Merli M., Meyer C., Trebicka J. (2019): Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Clin Transl Gastroenterol, 10(4), e00025, [4.621]
• Praktiknjo M. , Djayadi N., Mohr R., Schierwagen R., Bischoff J., Dold L., Pohlmann A., Schwarze-Zander C., Wasmuth J. C., Boesecke C., Rockstroh J. K., Trebicka J. (2019): Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIVinfected patients. Liver Int, 39(8), 1514-1520, [5.542]
• Puelles V. G. , Fleck D., Ortz L., Papadouri S., Strieder T., Boehner A., van der Wolde J. W., Vogt M., Saritas T., Kuppe C., Fuss A., Menzel S., Klinkhammer B. M., Müller-Newen G., Heymann F., Decker L., Braun F., Kretz O., Huber T. B., Susaki E. A., Ueda H. R., Boor P., Floege J., Kramann R., Kurts C., Bertram J. F., Spehr M., Nikolic-Paterson D. J., Moeller M. J. (2019): 3D analysis of rapidly progressive glomerulonephritis using optical tissue clearing. Kidney Int, 96, 505-516, [8.306]
• Queck A. , Carnevale R., Uschner F. E., Schierwagen R., Klein S., Jansen C., Meyer C., Praktiknjo M., Thomas D., Strassburg C., Zeuzem S., Violi F., Trebicka J. (2019): Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS. Gut, [17.160]
• Queck A. , Thomas D., Jansen C., Schreiber Y., Rüschenbaum S., Praktiknjo M., Schwarzkopf K. M., Mücke M. M., Schierwagen R., Uschner F. E., Meyer C., Clària J., Zeuzem S., Geisslinger G., Trebicka J., Lange C. M. (2019): Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis. PLoS One, 14(10), e0222840, [2.776]
• Rao T. N. , Hansen N., Hilfiker J., Rai S., Majewska J. M., Leković D., Gezer D., Andina N., Galli S., Cassel T., Geier F., Delezie J., Nienhold R., Hao-Shen H., Beisel C., Di Palma S., Dimeloe S., Trebicka J., Wolf D., Gassmann M., Fan T. W., Lane A. N., Handschin C., Dirnhofer S., Kröger N., Hess C., Radimerski T., Koschmieder S., Čokić V. P., Skoda R. C. (2019): JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms. Blood, 134(21), 1832-1846, [16.562]
• Reinicke A. T. , Raczkowski F., Mühlig M., Schmucker P., Lischke T., Reichelt J., Schneider E., Zielinski S., Sachs M., Jurack E., Tolosa E., Kurts C., Mittrücker H. W., Meyer-Schwesinger C. (2019): Deubiquitinating Enzyme UCH-L1 Promotes Dendritic Cell Antigen Cross-Presentation by Favoring Recycling of MHC Class I Molecules. J Immunol., 2019 Oct 1;203(7), 1730-1742, [4.718]
• Roderfeld M. , Padem S., Lichtenberger J., Quack T., Weiskirchen R., Longerich T., Schramm G., Churin Y., Irungbam K., Tschuschner A., Windhorst A., Grevelding C.G., Roeb E. (2019): Schistosoma mansoni egg secreted antigens activate HCC-associated transcription factors c-Jun and STAT3 in hamster and human hepatocytes. Hepatology, 69, in press, [14.079]
• Roedig H. , Damiescu R., Zeng-Brouwers J., Kutija I., Trebicka J., Wygrecka M., Schaefer L. (2019): Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development. Semin Cancer Biol, [10.198]
• Rosenbaum M. , Gewies A., Pechloff K., Heuser C., Engleitner T., Gehring T., Krappmann D., Krebs S., Kriegsmann M., Weichert W., Rad R., Kurts C., Ruland J. (2019): Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Nat Commun, Epub May 28; 10(1), 2352, [11.878]
• Roy S. , Hooiveld G. J., Seehawer M., Caruso S., Heinzmann F., Schneider A. T., Frank A. K., Vargas Cardenas D., Sonntag R., Luedde M., Trautwein C., Stein I., Pikarsky E., Loosen S., Tacke F., Ringelhan M., Avsaroglu S. K.,Goga A., Buendia M.-A., Vucur M., Heikenwalder M., Zucman-Rossi J., Zender L., Roderburg C., Luedde T. (2019): microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis. Gastroenterology, 155(6), 1951–1966, [20.773]
• Saez-Rodriguez J. , Rinschen M.M., Floege J., Kramann R. (2019): Big Science and Big Data in Nephrology. Kidney International, 95(6), 1326-1337, [8.306]
• Schneider K. M. , Mohs A., Kilic K., Candels L. S., Elfers C., Bennek E., Schneider L. B., Heymann F., Gassler N., Penders J., Trautwein C. (2019): Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis. International Journal of Molecular Sciences, 20(2), 308, [4.183]
• Sharkawy R. E. , Bayoumi A., Metwally M., Mangia A., Berg T., Romero-Gomez M., Abate M. L., Irving W. L., Sheridan D., Dore G. J., Spengler U., Lampertico P., Bugianesi E., Weltman M., Mollison L., Cheng W., Riordan S., Santoro R., Gallego-Durán R., Fischer J., Nattermann J., D'Ambrosio R., McLeod D., Powell E., Latchoumanin O., Thabet K., Najim M. A. M., Douglas M. W., Liddle C., Qiao L., George J., Eslam M.; International Liver Disease Genetics Consortium (ILDGC) (2019): A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Sci Rep., 9(1), 1439, [4.011]
• Spivak I. , Arora J., Meinzer C., Durkalski-Mauldin V., Lee W. M., Trautwein C., Fontana R. J., Strnad P. (2019): Low Serum Hepicidin is associated with reuced short-term survival in adults with acute liver failure. Hepatology, 59(5), 2136-2149, [14.079]
• Stickel F. , Lutz P., Buch S., Nischalke H. D., Silva I., Rausch V., Fischer J., Weiss K. H., Gotthardt D., Rosendahl J., Marot A., Elamly M., Krawczyk M., Casper M., Lammert F., Buckley T. W., McQuillin A., Spengler U., Eyer F., Vogel A., Marhenke S., von Felden J., Wege H., Sharma R,. Atkinson S., Franke A., Nehring S., Moser V., Schafmayer C., Spahr L., Lackner C., Stauber R. E., Canbay A., Link A., Valenti L., Grove J. I., Aithal G. P., Marquardt J. U., Fateen W., Zopf S., Dufour J. F., Trebicka J., Datz C., Deltenre P., Mueller S., Berg T., Hampe J., Morgan M. Y. (2019): Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers. Hepatology, [14.079]
• Stratmann K. , Fitting D., Zeuzem S., Bojunga J., Trebicka J., Friedrich-Rust M., Dultz G. (2019): Establishing an indwelling peritoneal catheter as a standard procedure for hospitalized patients with ascites: Retrospective data on feasibility, effectiveness and safety. United European Gastroenterol J, 7(5), 673-681, [3.477]
• Stremmel W. , Merle U., Weiskirchen R. (2019): Clinical features of Wilson disease. Annals Transl Med, 7(2), 61, [3.689]
• Stremmel W. , Staffer S. G., Weiskirchen R. (2019): Phosphatidylcholine passes by paracellular transport to the apical side of the polarized biliary tumor cell line Mz-ChA-1. Int J Mol Sci, 20, 4034, [4.183]
• Strnad P. , Buch S., Hamesch K., Fischer J., Rosendahl J., Schmelz R., Brueckner S., Brosch M., Heimes C. V., Woditsch V., Scholten D., Nischalke H. D., Janciauskiene S., Mandorfer M., Trauner M., Way M. J., McQuillin A., Reichert M. C., Krawczyk M., Casper M., Lammert F., Braun F., von Schönfels W., Hinz S., Burmeister G., Hellerbrand C., Teufel A., Feldman A., Schattenberg J. M., Bantel H., Pathil A., Demir M., Kluwe J., Boettler T., Ridinger M., Wodarz N., Soyka M., Rietschel M., Kiefer F., Weber T., Marhenke S., Vogel A., Hinrichsen H., Canbay A., Schlattjan M., Sosnowsky K., Sarrazin C., von Felden J., Geier A., Deltenre P., Sipos B., Schafmayer C., Nothnagel M., Aigner E., Datz C., Stickel F., Morgan M. Y., Hampe J., Berg T., Trautwein C. (2019): Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Gut, 68, 1099-1107, [17.160]
• Sun Q. , Baues M., Klinkhammer B. M., Ehling J., Djudjaj S., Drude N. I., Daniel C., Amann K., Kramann R., Kim H., Saez-Rodriguez J., Weiskirchen R., Onthank D. C., Botnar R. M., Kiessling F., Floege J., Lammers T., Boor P. (2019): Elastin imaging enables non-invasive staging and treatment monitoring of kidney fibrosis. Sci Transl Med, 11, 486, [17.161]
• Tacke F. , Spehlmann M.E., Vucur M., Benz F., Luedde M., Cardenas D.V., Roy S., Loosen S, Hippe H.J., Frey N., Trautwein C., Koch A., Roderburg C., Luedde T. (2019): miR-155 predicts lpongterm mortality in critically ill patiens younger than 65 years. Mediators Inflamm, [3.549]
• Tajti F. , Kuppe C., Antoranz a., Ibrahim M. M., Kim H., Ceccarelli F., Holland C. H., Olauson H., Flege J., Alexopoulos L. G., Kramann R., Saez-Rodriguez J. (2019): A functional landscape of chronic kidney disease entities from public transcriptomic data. Kidney International Reports, [2.260]
• Tangudu N. K. , Buth N., Strnad P., Cirstea I. C., Spasić M.V. (2019): Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions. Pharmaceuticals (Basel), 12, E70, [3.800]
• Tomás-Loba A. , Manieri E., González-Terán B., Mora A., Leiva-Vega L., Santamans A. M., Romero-Becerra R., Rodríguez E., Pintor-Chocano A., Feixas F., López J. A., Caballero B., Trakala M., Blanco Ó., Torres J. L., Hernández-Cosido L., Montalvo-Romeral V., Matesanz N., Roche-Molina M., Bernal J. A., Mischo H., León M., Caballero A., Miranda-Saavedra D., Ruiz-Cabello J., Nevzorova Y. A., Cubero F. J., Bravo J., Vázquez J., Malumbres M., Marcos M., Osuna S., Sabio G. (2019): p38γ is essential for cell cycle progression and liver tumorigenesis. Nature, 568(7753), 557-560, [43.070]
• Torner M. , Mangal A., Scharnagl H., Jansen C., Praktiknjo M., Queck A., Gu W., Schierwagen R., Lehmann J., Uschner F. E., Graf C., Strassburg C. P., Fernandez J., Stojakovic T., Woitas R., Trebicka J. (2019): Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS. Liver Int, [5.542]
• Trebicka J. , Amoros A., Pitarch C., Titos E., Alcaraz-Quiles J., Schierwagen R., Deulofeu C., Fernandez-Gomez J., Piano S., Caraceni P., Oettl K., Sola E., Laleman W., McNaughtan J., Mookerjee R. P., Coenraad M. J., Welzel T., Steib C., Garcia R., Gustot T., Rodriguez Gandia M. A., Bañares R., Albillos A., Zeuzem S., Vargas V., Saliba F., Nevens F., Alessandria C., de Gottardi A., Zoller H., Ginès P., Sauerbruch T., Gerbes A., Stauber R. E., Bernardi M., Angeli P., Pavesi M., Moreau R., Clària J., Jalan R., Arroyo V. (2019): Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis. Front Immunol, 10, 476, [4.716]
• Trebicka J. , Bastgen D., Byrtus J., Praktiknjo M., Terstiegen S., Meyer C., Thomas D., Fimmers R., Treitl M., Euringer W., Sauerbruch T., Rössle M. (2019): Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival. Clin Gastroenterol Hepatol, 17(13), 2793-2799, [7.958]
• van Roeyen C. R. C. , Martin I. V., Drescher A., Schuett K. A., Hermert D., Raffetseder U., Otten S., Buhl E. M., Braun G., Kuppe C., Liehn E., Boor P., Weiskirchen R., Eriksson U., Gross O., Eitner F., Floege J., Ostendorf T. (2019): Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension. Kidney Int, 95, 1103-1119, [8.000]
• Weiskirchen R. , Stremmel W. (2019): Wilson disease: current knowledge, challenges and perspectives. Preface to the Focused Issue “Wilson’s disease: from genetics to management of disease (Eds. Ralf Weiskirchen & Wolfgang Stremmel). Annals Transl Med, 7(2), 55, [3.689]
• Weiskirchen R. , Tacke F. (2019): Relevance of autophagy in parenchymal and non-parenchymal liver cells for health and disease. Cells, 8, 16, [5.656]
• Weiskirchen R. , Tacke F. (2019): Hepatic fibrogenesis. Encyclopedia of Gastroenterology, 2nd Edition, Elsevier, New York, [0.200]
• Weiskirchen R. , Tacke F. (2019): Hepatic Fibrogenesis. Reference Module in Biomedical Sciences, , 1-7, [0.200]
• Weiskirchen R. , Tacke F. (2019): Pathophysiologie: Immunologie.“ Nichtalkoholische Fettleber. (Eds. Andreas Geier, Ali Canbay & Frank Lammert). Springer Verlag, im Druck, [0.200]
• Weiskirchen R. , Weiskirchen S., Kim P., Winkler R. (2019): Software solutions for evaluation and visualization of laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI) data: a short overview. J Cheminform, 11, 16, [4.154]
• Weiskirchen R. , Weiskirchen S., Tacke F. (2019): Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Aspects Med, 65, 2-15, [10.238]
• Weiskirchen S. , Kim P., Weiskirchen R. (2019): Determination of copper poisoning in Wilson’s disease using laser ablation inductively coupled plasma spectrometry. Annals Transl Med, 7(2), 72, [3.689]
• Weiskirchen S. , Kim P., Weiskirchen R. (2019): Laser ablation inductively coupled plasma spectrometry: metal imaging in experimental and clinical Wilson Disease. Inorganics, 7, 54, [1.900]
• Wirtz T. H. , Brandt E. F., Berres M. L. (2019): Liver DCs in health and disease. International Review of Cell & Molecular biology (IRCMB), 348, 263-299, [3.788]
• Wirtz T. H. , Fischer P., Backhaus C., Bergmann I., Brandt E. F., Heinrichs D., Koenen M. T., Schneider K. M., Eggermann T., Kurth I., Stoppe C., Bernhagen J., Bruns T., Fischer J., Berg T., Trautwein C., Berres M.-L. 1 (2019): Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis. Internation Journal of Molecular Sciences, 20(15), 3753, [3.687]
• Yagmur E. , Bast E., Mühlfeld A. S., Koch A., Weiskirchen R., Tacke F., Neulen J. (2019): High prevalence of sticky platelet syndrome in patients with infertility and pregnancy loss. J Clin Med, 8, 1328, [5.583]
• Yagmur E. , Buergerhausen D., Koek G. H., Weiskirchen R., Trautwein C., Koch A., Tacke F. (2019): Elevated CTRP1 plasma concentration is associated with sepsis and pre-existing type 2 diabetes mellitus in critically ill patients. J Clin Med, 8, 661, [5.583]
• Yagmur E. , Otto S., Koek G. H., Weiskirchen R., Trautwein C., Koch A., Tacke F. (2019): Decreased CTRP3 plasma concentrations are associated wtih sepsis and predict mortality in critically ill patients. Diagnostics, 9, 63, [2.489]
• Zoubek M. E. , Woitok M. M., Sydor S., Nelson L. J., Bechmann L. P., Lucena M. I., Andrade R. J.,Bast A., Koek G.H., Trautwein C., Cubero F. J. (2019): Protective role of c‐Jun N‐terminal kinase‐2 (JNK2) in ibuprofen‐induced acute liver injury. Journal of Pathology, 247, 110-122, [6.253]

2018

• Ahadzadeh E. , Rosendahl A., Czesla D., Steffens P., Prüßner L., Meyer-Schwesinger C., Wanner N., Paust H. J., Huber T. B., Stahl R. A., Wiech T., Kurts C., Seniuk A., Ehmke H., Wenzel U. O. (2018): The chemokine receptor CX3CR1 reduces renal injury in mice with angiotensin II induced hypertension. Am J Physiol Renal Physiol, Sep, [3.611]
• Alsamman, M. , Sterzer, V., Meurer, S. K., Sahin, H., Schaeper, U., Kuscuoglu, D., Strnad, P., Weiskirchen, R., Trautwein, C., Scholten, D. (2018): Endoglin in human liver disease and murine models of liver fibrosis – a protective factor against liver fibrosis. Liver International, 38, 858-867, [4.470]
• Anadol E. , Lust K., Boesecke C., Schwarze-Zander C., Mohr R., Wasmuth J. C., Rockstroh J. K., Trebicka J. (2018): Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients. PLoS One, 13(1), e0191118, [2.776]
• Audebert C. , Peeters G., Segers P., Laleman W., Monbaliu D., Korf H., Trebicka J., Vignon-Clementel I. E., Debbaut C. (2018): Closed-Loop Lumped Parameter Modeling of Hemodynamics During Cirrhogenesis in Rats. IEEE Trans Biomed Eng, 65(10), 2311-2322, [4.491]
• Beiert T. , Knappe V., Tiyerili V., Stöckigt F., Effelsberg V., Linhart M., Steinmetz M., Klein S., Schierwagen R., Trebicka J., Roell W., Nickenig G., Schrickel J. W., Andrié R. P. (2018): Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties. Int J Cardiol, 250, 21-28, [4.034]
• Borkham-Kamphorst E. , Steffen B. T., van de Leur E., Haas U., Weiskirchen R. (2018): Portal myofibroblasts are sensitive to CCN-mediated endoplasmic reticulum stress-related apoptosis with potential to attenuate biliary fibrogenesis. Cell Signal, 51, 72-85, [3.388]
• Borkham-Kamphorst, E. , Van de Leur, E., Buhl, E. M., Meurer, S. K., Weiskirchen, R. (2018): N-glycosylation of Lipocalin 2 is not required for secretion or exosome targeting.. Front. Pharmacol., 9:426,
• Breitbach M. , Kimura K., Luis T. C., Fuegemann C. J.; Woll P. S., Hesse M.; Facchini R., Rieck S., Jobin K., Reinhardt J., Ohneda O., Wenzel D., Geisen C., Kurts C., Kastenmuller W., Holzel M., Jacobsen S. E. W., Sten E. W., Fleischmann B. K. (2018): In Vivo Labeling by CD73 Marks Multipotent Stromal Cells and Highlights Endothelial Heterogeneity in the Bone Marrow Niche. Cell Stem Cell, 22(2), 262-7, [21.464]
• Buchtler S. , Grill A., Hofmarksrichter S., Stöckert P., Schiechl-Brachner G., Rodriguez Gomez M., Neumayer S., Schmidbauer K., Talke Y., Klinkhammer B. M., Boor P., Medvinsky A., Renner K., Castrop H., Mack M. (2018): Cellular Origin and Functional Relevance of Collagen I Production in the Kidney. J Am Soc Nephrol, 29(7), 1859-1873, [8.547]
• Christ A. , Günther P., Lauterbach M. A. R., Duewell P., Biswas D., Pelka K., Scholz C. J., Oosting M., Haendler K., Baßler K., Klee K., Schulte-Schrepping J., Ulas T., Moorlag S. J. C. F. M., Kumar V., Park M. H., Joosten L. A. B., Groh L. A., Riksen N. P., Espevik T., Schlitzer A., Li Y., Fitzgerald M. L., Netea M. G., Schultze J. L., Latz E. (2018): Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell, 172 (1-2), 162-175, [32.304]
• Cubero F. J. , Peng J., Liao L., Su H., Zhao G., Zoubek M. E., Macias-Rodriguez R., Ruiz-Margain A., Reissing J., Zimmermann H. W., Gassler N., Luedde T., Liedtke C., Hatting M., Trautwein C. (2018): Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis. J Hepatol, 69, 1326-1334, [18.946]
• De Nardo D. , Balka K. R., Gloria Y. C., Rao‖ V. R., Latz E., Masters S. L. (2018): Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling. Journal of Biological Chemistry, 293, 15195-15207, [5.328]
• Ehedego H. , Mohs A., Jansen B., Hiththetiya K., Sicinski P., Liedtke C., Trautwein C. (2018): Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury. Oncogene, 37, 3329-3339, [6.854]
• Eymael J. , Sharma S., Loeven M. A., Wetzels J. F., Mooren F., Florquin S., Deegens J. K., Willemsen B. K., Sharma V., van Kuppevelt T. H., Bakker M. A., Ostendorf T., Moeller M. J., Dijkman H. B., Smeets B., van der Vlag J. (2018): CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis. Kidney Int, 93, 626-642, [8.429]
• Franklin B. S. , Latz E., Schmidt F. I. (2018): The intra- and extracellular functions of ASC specks. Immunological Reviews, 281(1), 74-87, [11.292]
• Franklin B. S. , Mangan M. S., Latz E. (2018): Crystal Formation in Inflammation. Annual Reviews of Immunology, 34, 173-202, [21.429]
• Gadermayr M. , Dombrowski A.-K., Klinkhammer B. M., Boor P., Merhof D. (2018): CNN Cascades for Segmenting Sparse Objects in Gigapixel Whole Slide Images. Comput Med Imaging Graph, 71, 40-48, [3.298]
• Gauthier A. , Fisch A., Seuwen K., Baumgarten B., Ruffner H., Aebi A., Rausch M., Bartneck M., Weiskirchen R., Tacke F., Storm G., Lammers T., Ludwig M.-G. (2018): Glucocorticoid-loaded liposomes induce a pro-resolution phenotype in human primary macrophages to support chronic wound healing. Biomaterials, 178, 481-495, [10.273]
• Gauthier, A. , Fisch, A., Seuwen, K., Baumgarten, B., Ruffner, H., Aebi, A., Rausch, M., Bartneck, M., Weiskirchen, R., Tacke, F., Storm, G., Lammers, T., Ludwig, M. G. (2018): Glucocorticoid-loaded liposomes induce a pro-resolutive phenotype in human primary macrophages to support healing of chronic wounds. Biomaterials, 04.006, in press,
• Gibbert L. , Hermert D., Wang J., Breitkopf D. M., Alidousty C., Neusser M., Cohen C. D., Gröne E., Macheleidt I., Rauen T., Braun G. S., Floege J., Ostendorf T., Raffetseder U. (2018): YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy. Clin Immunol, 194, 67-74, [3.557]
• Gotot J. , Dhana E., Yagita H., Kaiser R., Ludwig-Portugall I., Kurts C. (2018): Antigen-specific Helios–, Neuropilin-1– Tregs induce apoptosis of autoreactive B cells via PD-L1. Immunol Cell Biol, 96(8), 852-862, [3.947]
• Grebe A. , Hoss F., Latz E. (2018): NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circulation Research, 122(12), 1722-1740, [15.862]
• Gross A. , Pack L. A. P., Schacht G. M., Kant S., Ungewiss S., Meir M., Schlegel N., Preisinger C., Boor P., Güldiken N., Krusche C. A., Sellge G., Trautwein C., Waschke J., Heuser A., Leube R. E., Strnad P. (2018): Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury. Mucosal Immunol, 11, 1630-1639, [7.352]
• Guo F. , Zheng K., Benede-Ubieto R., Cubero F. J., Nevzorova Y. A. (2018): The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease. Alcohol Clin Exp Res, 42, 1828-1840, [3.183]
• Heneka M. T. , McManus R. M., Latz E. (2018): Inflammasome signalling in brain function and neurodegenerative disease. Nature Reviews Neuroscience, 19, 610-621, [33.162]
• Herrmann E. , de Lédinghen V., Cassinotto C., Chu W. C., Leung V. Y., Ferraioli G., Filice C., Castera L., Vilgrain V., Ronot M., Dumortier J., Guibal A., Pol S., Trebicka J., Jansen C., Strassburg C., Zheng R., Zheng J., Francque S., Vanwolleghem T., Vonghia L., Manesis E. K., Zoumpoulis P., Sporea I., Thiele M., Krag A., Cohen-Bacrie C., Criton A., Gay J., Deffieux T., Friedrich-Rust M. (2018): Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis. Hepatology, 67(1), 260-272, [14.079]
• Hogstad B. , Berres M. L., Chakraborty R., Tang J., Bigenwald C., Serasinghe M., Lim K. P. H., Lin H., Man T. K., Remark R., Baxter S., Kana V., Jordan S., Karoulia Z., Kwan W. H., Leboeuf M., Brandt E., Salmon H., McClain K., Poulikakos P., Chipuk J., Mulder W. J. M., Allen C. E., Merad M. (2018): RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. Exp Med, 215(1), 319-336, [10.829]
• Jansen C. , Al-Kassou B., Lehmann J., Pohlmann A., Chang J., Praktiknjo M., Nickenig G., Strassburg C. P., Schrickel J. W., Andrié R., Linhart M., Trebicka J. (2018): Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis. PLoS One, 13(4), e0195631, [2.776]
• Jansen C. , Cox A., Schueler R., Schneider M., Lehmann J., Praktiknjo M., Pohlmann A., Chang J., Manekeller S., Nickenig G., Berlakovich G., Strassburg C. P., Hammerstingl C., Staufer K., Trebicka J. (2018): Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantation. Liver Transpl, 24(1), 15-25, [5.583]
• Jansen C. , Möller P., Meyer C., Kolbe C. C., Bogs C., Pohlmann A., Schierwagen R., Praktiknjo M., Abdullah Z., Lehmann J., Thomas D., Strassburg C. P., Latz E., Mueller S., Rössle M., Trebicka J. (2018): Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology, 67(4), 1472-1484, [14.079]
• Jenkitkasemwong, S. , Akinyode, N., Paulus, E., Weiskirchen, R., Hojyo, S., Fukada, T., Giraldo, G., Schrier, J., Garcia, A., Janus, C., Giasson, B., Knutson, M. D. (2018): SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice. Proc. Natl. Acad. Sci. U S A, 115, E1769-E1778,
• Kim P. , Weiskirchen S., Uerlings R., Kueppers A., Stellmacher F., Viveiros A., Zoller H., Weiskirchen R. (2018): Quantification of liver iron overload disease with laser ablation inductively coupled plasma mass spectrometry. BMC Med Imaging, 18, 51, [1.622]
• Koch A. , Weiskirchen R., Krusch A., Bruensing J., Buendgens L., Herbers U., Yagmur E., Koek G. H., Trautwein C., Tacke F. (2018): Visfatin serum levels predict mortality in critically ill patients. Dis Markers, 7315356, [2.761]
• Koch A. , Yagmur E., Hoss A., Buendgens L., Herbers U., Weiskirchen R., Koek G. H., Trautwein C., Tacke F. (2018): Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients. J Clin Lab Anal, , e22614, [1.728]
• Koch A. , Yagmur E., Linka J., Schumacher F., Bruensing J., Buendgens L., Herbers U., Koek G. H., Weiskirchen R., Trautwein C., Tacke F. (2018): High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients. Dis Markers, 8583121, [2.761]
• Koch, A. , Yagmur, E., Linka, J., Schumacher, F., Bruensing, J., Buendgens, L., Herbers, U., Koek, G. H., Weiskirchen, R., Trautwein, C., Tacke, F. (2018): High circulating caspase-cleaved keratin 18 fragments (M30) indicate short-term mortality in critically ill patients. Dis. Markers, 2018, 8583121,
• Koch, A. , Yagmur, E., Hoss, A., Buendgens, L., Herbers, U., Weiskirchen, R., Koek, G. H., Trautwein, C., Tacke, F. (2018): Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients. J. Clin. Lab. Anal., in press., doi: 10.1002/jcla.22614,
• Krenkel, O. , Puengel, T., Govaere, O., Abdallah, A. T., Mossanen, J. C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., Weiskirchen, R., Longerich, T., Costa, I. G., Anstee, Q. M., Trautwein, C., Tacke, F. (2018): Therapeutic inhibition of inflammatory monocytes reduces steatohepatitis and liver fibrosis. Hepatology, 67, 1270-1283,
• Labzin L. I. , Heneka M. T., Latz E. (2018): Innate Immunity and Neurodegeneration. Annual Review of Medicine, 69, 437-449, [10.091]
• Laleman W. , Claria J., Van der Merwe S., Moreau R., Trebicka J. (2018): Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough. Can J Gastroenterol Hepatol, , 1027152, [1.714]
• Lamas-Paz A. , Hao F., Nelson L. J., Vázquez M. T., Canals S., Gómez del Moral M., Martínez-Naves E., Nevzorova Y. A., Cubero F. J. (2018): Alcoholic liver disease: Utility of animal models. World J Gastroenterol, 24(45), 5063-5075, [3.365]
• Lange C. M. , Bechstein W. O., Berg T., Engelmann C., Bruns T., Canbay A., Moreau R., Trebicka J. (2018): Acute-on-Chronic Liver Failure. Visc Med, 34(4), 296-300, [2.290]
• Latz E. , Duewella P. (2018): NLRP3 inflammasome activation in inflammaging. Seminars in Immunology, 40, 61-73, [7.358]
• Lehmann J. M. , Claus K., Jansen C., Pohlmann A., Schierwagen R., Meyer C., Thomas D., Manekeller S., Claria J., Strassburg C. P., Trautwein C., Wasmuth H. E., Berres M. L., Trebicka J. (2018): Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality. Liver Int, 38(5), 875-884, [5.542]
• Lenk, L. , Pein, M., Will, O., Gomez, B., Viol, F., Hauser, C., Egberts, J.-H., Gundlach, P., Tiwari, S., Weiskirchen, R., Rose-John, S., Röcken, C., Mikulits, W., Wenzeli, P., Schneider, G., Saur, D., Schäfer, H., Sebens, S. (2018): The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma. OncoImmunology, 7, e1368603,
• Levada K. , Guldiken N., Zhang X., Vella G., Mo F., James L. P., Haybaeck J., Kessler S. M., Kiemer A. K., Ott T., Hartmann D., Hüser N., Ziol M., Trautwein C., Strnad P. (2018): Hsp72 protects from liver injury via attenuation of hepatocellular death, oxidative stress and JNK-signaling. J Hepatol, 68, 996-1005, [18.946]
• Loosen S. H. , Schulze-Hagen M., Leyh C., Benz F., Vucur M., Kuhl C., Trautwein C., Tacke F., Bruners P., Roderburg C., Luedde T. (2018): IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies. Int J Mol Sci, 19(6), 1766, [4.183]
• Loosen S. H. , Tacke F., Binnebosel M., Leyh C., Vucur M., Heitkamp F., Schoening W., Ulmer T. F., Alizai P. H., Trautwein C., Koch A., Longerich T., Roderburg C., Neumann U. P., Luedde T. (2018): Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases. Oncotarget, 9(43), 27027-27038, [5.168]
• Luedde M. , Spehlmann M. E., Hippe H.-J., Loosen S. H., Roy S., Cardenas D. V., Vucur M., Frey N., Koch A., Luedde T., Trautwein C., Tacke F., Roderburg C. (2018): Serum levels of kisspeptin are elevated in critically ill patients. PLoS ONE, 13(10), e0206064, [2.776]
• Luetkens J. A. , Klein S., Träber F., Schmeel F. C., Sprinkart A. M., Kuetting D. L. R., Block W., Uschner F. E., Schierwagen R., Hittatiya K., Kristiansen G., Gieseke J., Schild H. H., Trebicka J., Kukuk G. M. (2018): Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results. Radiology, 288(3), 748-754, [7.469]
• Luetkens J. A. , Klein S., Traeber F., Schmeel F. C., Sprinkart A. M., Kuetting D. L. R, Block W., Hittatiya K., Uschner F. E., Schierwagen R., Gieseke J., Schild H. H., Trebicka J., Kukuk G. M. (2018): Quantitative liver MRI including extracellular volume fraction for non-invasive quantification of liver fibrosis: a prospective proof-of-concept study. Gut, 67(3), 593-594, [17.160]
• Magdaleno F. , Schierwagen R., Uschner F. E., Trebicka J. (2018): Tipping" extracellular matrix remodeling towards regression of liver fibrosis: novel concepts. Minerva Gastroenterol Dietol, 64(1), 51-61, [0.460]
• Mangan M. S. J. , Olhava E. J., Roush W. R., Seidel H. M., Glick G. D., Latz E. (2018): Targeting the NLRP3 inflammasome in inflammatory diseases. Nature reviews drug discovery, 17, 588-606, [57.618]
• Martin I. V. , Bohner A., Boor P., Shagdarsuren E., Raffetseder U., Lammert F., Floege J., Ostendorf T., Weber S. N. (2018): Complement C5a receptors C5L2 and C5aR in renal fibrosis. Am J Physiol Renal Physiol, 314, F35-F46, [3.611]
• Meissner M. , Viehmann S. F., Kurts C. (2018): DAMPening sterile inflammation of the kidney. Kidney Int, 95(3), 489-491, [8.429]
• Meurer, S. K. , Weiskirchen, R. (2018): Usage of Mitogen-Activated Protein Kinase small molecule inhibitors: more than just inhibition!. Front. Pharmacol., 9:98,
• Meurer, S. K. , Weiskirchen, R. (2018): Activation by Inhibition. Atlas of Science,
• Moellmann J. , Klinkhammer B. M., Onstein J., Stöhr R., Jankowski V., Jankowski J., Lebherz C., Tacke F., Marx N., Boor P., Lehrke M. (2018): Glucagon-like peptide-1 and its cleavage products are renoprotective in murine diabetic nephropathy. Diabetes, 67(11), 2410-2419, [7.199]
• Mohr R. , Boesecke C., Dold L., Schierwagen R., Schwarze-Zander C., Wasmuth J. C., Weisensee I., Rockstroh J. K., Trebicka J. (2018): Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis. Medicine (Baltimore), 97(17), e0462, [1.870]
• Moreno, D. , Murillo, O., Gazquez, C., Hernandez-Alcoceba, R., Uerlings, R., Gonzalez-Aseguinolaza, G., Weiskirchen, R. (2018): Visualization of the therapeutic efficacy of a gene correction approach in Wilson's disease by laser-ablation inductively coupled mass spectrometry. J. Hepatol., 68, 199-201,
• Müller S. , Djudjaj S., Lange J., Iacovescu M., Goppelt-Struebe M., Boor P. (2018): HIF stabilization inhibits renal epithelial cell migration and is associated with cytoskeletal alterations. Sci Rep, 8, 9497, [4.011]
• Pelka K. , Bertheloot D., Reimer E., Phulphagar K., Schmidt S. V., ChristA., Stahl R., Watson N., Miyake K., Hacohen N., Haas A., Brinkmann M. M., Marshak-Rothstein A., Meissner F., Latz E. (2018): The Chaperone UNC93B1 Regulates Toll-like Receptor Stability Independently of Endosomal TLR Transport. Immunity, 48(5), 911-922, [21.522]
• Pombeiro I. , Loosen S. H, Roy S., Schueller F., Niewenhuisen L., Luedde M., Vucur M., Tacke F., Binnebösel M., Schoening W., Trautwein C., Luedde T., Neumann U. P., Roderburg C. (2018): Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer. J Clin Med, 7(7), 175, [5.583]
• Praktiknjo M. , Book M., Luetkens J., Pohlmann A., Meyer C., Thomas D., Jansen C., Feist A., Chang J., Grimm J., Lehmann J., Strassburg C. P., Abraldes J. G., Kukuk G., Trebicka J. (2018): Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology, 67(3), 1014-1026, [14.079]
• Praktiknjo M. , Krabbe V., Pohlmann A., Sampels M., Jansen C., Meyer C., Strassburg C. P., Trebicka J., Gonzalez Carmona M.A. (2018): Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma. PLoS One, 13(2), e0192897, [2.776]
• Praktiknjo M. , Lehmann J., Nielsen M. J., Schierwagen R., Uschner F. E., Meyer C., Thomas D., Strassburg C. P., Bendtsen F., Møller S., Krag A., Karsdal M. A., Leeming D. J., Trebicka J. (2018): Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis. Hepatol Commun, 2(2), 211-222, [0.800]
• Puengel T. , Tacke F. (2018): Repair macrophages in acute liver failure. Gut, 67(2), 202-203, [17.160]
• Rolfes V. , Idel C., Pries R., Plötze-Martin K., Habermann J., Gemoll T., Bohnet S., Latz E., Ribbat-Idel J., Franklin B. S., Wollenberg B. (2018): PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy. Oncotarget, 9, 27460-27470, [5.168]
• Ruiz-Margáin A. , Pohlmann A., Ryan P., Schierwagen R., Chi-Cervera L. A., Jansen C., Mendez-Guerrero O., Flores-García N. C., Lehmann J., Torre A., Macías-Rodríguez R. U., Trebicka J. (2018): Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis. Liver Transpl, 24(5), 595-605, [5.583]
• Sauerbruch T. , Schierwagen R., Trebicka J. (2018): Managing portal hypertension in patients with liver cirrhosis. F1000Res, 7, Rev-533,
• Schierwagen R. , Alvarez-Silva C., Madsen M. S. A., Kolbe C. C., Meyer C., Thomas D., Uschner F. E., Magdaleno F., Jansen C., Pohlmann A., Praktiknjo M., Hischebeth G. T., Molitor E., Latz E., Lelouvier B., Trebicka J., Arumugam M. (2018): Circulating microbiome in blood of different circulatory compartments. Gut, gutjnl-2018, 316227, [17.160]
• Schröder S. K. , Asimakopoulou A., Weiskirchen R. (2018): Lipocalin 2 as a potential diagnostic and/or prognostic biomarker in prostate, lung and liver cancer. Clinics of Oncology, 1(3), 1-16, [0.200]
• Schröder, S. K. , Asimakopoulou, A., Weiskirchen, R. (2018): Lipocalin 2 as a potential diagnostic and/or prognostic biomarker in prostate, lung and liver cancer. Clinics of Oncol., in press,
• Schwabl P. , Brusilovskaya K., Supper P., Bauer D., Königshofer P., Riedl F., Hayden H., Fuchs C. D., Stift J., Oberhuber G., Aschauer S., Bonderman D., Gnad T., Pfeifer A., Uschner F. E., Trebicka J., Rohr-Udilova N., Podesser B. K., Peck-Radosavljevic M., Trauner M., Reiberger T. (2018): The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats. Sci Rep, 8(1), 9372, [4.011]
• Simón-Talero M. , Roccarina D., Martínez J., Lampichler K., Baiges A., Low G., Llop E., Praktiknjo M., Maurer M. H., Zipprich A., Triolo M., Vangrinsven G., Garcia-Martinez R., Dam A., Majumdar A., Picón C., Toth D., Darnell A., Abraldes J. G., Lopez M., Kukuk G., Krag A., Bañares R., Laleman W., La Mura V., Ripoll C., Berzigotti A., Trebicka J., Calleja J. L., Tandon P., Hernandez-Gea V., Reiberger T., Albillos A., Tsochatzis E. A., Augustin S., Genescà J., Baveno VI-SPSS group from the Baveno Cooperation (2018): Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Gastroenterology, 154(6), 1694-1705, [20.773]
• Sonntag R. , Giebeler N., Nevzorova Y. A., Bangen J. M., Fahrenkamp D., Lambertz D., Haas U., Hu W., Gassler N., Cubero F. J., Müller-Newen G., Abdallah A. T., Weiskirchen R., Ticconi F., Costa I. G., Barbacid M., Trautwein C., Liedtke C. (2018): Cyclin E1 and Cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma. Proc Natl Acad Sci USA, 115, 9282-9287, [9.580]
• Stoppe C. , Averdunk L., Goetzenich A., Soppert J., Marlier A., Kraemer S., Vieten J., Coburn M., Stevanovic A., Kim B.-S., Marx G., Rex S., Ochi A., Leng L., Moeckel G., Linkermann A., El Bounkari O., Zarbock A., Bernhagen J., Djudjaj S., Bucala R., Boor P. (2018): The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci Transl Med, 10, 4886, [23.401]
• Tacke F. , Weiskirchen R. (2018): An update on the recent advances in antifibrotic therapies. Exp Rev Gastroenterol Hepatol, 12(11), 1143-1152, [2.991]
• Trebicka J. (2018): Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?. Semin Liver Dis, 38(1), 87-96, [4.167]
• Trebicka J. , Reiberger T., Laleman W. (2018): Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure. Visc Med, 34(4), 270-275, [2.290]
• Uerlings, R. , Moreno D., Murillo, O., Gazquez, C., Hernandez-Alcoceba, R., Gonzalez-Aseguinolaza, G., Weiskirchen, R. (2018): Brain copper storage after long-term correction of Wilson's disease in a murine model of gene therapy. Neurol. Genet., 4, e243,
• Ullmann P. , Rodriguez F., Schmitz M., Meurer S. K., Qureshi-Baig K., Felten P., Ginolhac A., Antunes L., Frasquilho S., Zügel N., Weiskirchen R., Haan S., Letellier E. (2018): The microRNA-371~373 cluster represses colon cancer initiation and metastatc colonization by inhibiting the TGFBR2/ID1 signaling axis. Cancer Res, 78, 3793-3808, [8.378]
• Ullmann, P. , Rodriguez, F., Schmitz, M., Meurer, S. K., Qureshi-Baig, K., Felten, P., Ginolhac, A., Antunes, L., Frasquilho, S., Zügel, N. Weiskirchen, R., Haan, S., Letellier, E. (2018): The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis. Cancer Res., in press,
• Uschner F. E. , Schueller F., Nikolova I., Klein S., Schierwagen R., Magdaleno F., Gröschl S., Loosen S., Ritz T., Roderburg C., Vucur M., Kristiansen G., Lammers T., Luedde T., Trebicka J. (2018): The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension. Oncotarget, 9(90), 36220-36237, [5.168]
• Vucur M. , Roderburg C., Kaiser L., Schneider A. T., Roy S., Loosen S. H., Luedde M., Trautwein C., Koch A., Tacke F., Luedde T. (2018): Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment. Dis Markers, , 1983421, [2.761]
• Warzecha K. T. , Bartneck M., Möckel D., Appold L., Ergen C., Al Rawashdeh W., Gremse F., Niemietz P. M., Jahnen‐Dechent W., Trautwein C., Kiessling F., Lammers T., Tacke F. (2018): Targeting and Modulation of Liver Myeloid Immune Cells by Hard-Shell Microbubbles. Adv Biosyst, 2(5), 1-24, [2.855]
• Weiskirchen R. , Tacke F. (2018): The role of radiologic modalities in diagnosing non-alcoholic steatohepatitis (NASH) and fibrosis. Curr Hepat Rep, 17, 324-335, [0.200]
• Weiskirchen S. , Weiskirchen R. (2018): A novel quantitative iron imaging strategy in hereditary hemochromatosis based on LA-ICP-MS. Atlas of Science, December, [0.200]
• Weiskirchen, R. , Weiskirchen, S., Tacke, F. (2018): Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Aspects Med., , in press. doi: 10.1016/j.mam.2018.06.003,
• Weiskirchen, R. , Weiskirchen, S., Tacke, F. (2018): Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000, Res. 7, 921,
• Weiskirchen, S. , Weiskirchen, R. (2018): Ultrapure cells for liver research. Atlas of Science, May 30, 2018,
• Welz M. , Eickhoff S., Abdullah Z., Trebicka J., Gartlan K. H., Spicer J. A., Demetris A. J., Akhlaghi H., Anton M., Manske K., Zehn D., Nieswandt B., Kurts C., Trapani J. A., Knolle P., Wohlleber D., Kastenmüller W. (2018): Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis. Nat Commun, 9(1), 4805, [11.878]
• Wenzel U. O. , Bode M., Kurts C., Ehmke H. (2018): Salt, inflammation, IL-17 and hypertension. Br. J Pharmacol, 176(2), 1853-1863, [6.810]
• Yagmur E. , Buendgens L., Herbers U., Beeretz A., Weiskirchen R., Koek G. H., Trautwein C., Tacke F., Koch A. (2018): High mobility group box 1 as a biomarker in critically ill patients. J Clin Lab Anal, 32(8), e22584, [1.728]
• Yagmur, E. , Koch, A., Weiskirchen, R. Trautwein, C., Tacke, F. (2018): Clinical relevance of elevated high-mobility group box 1 (HMGB1) in critically ill patients. J. Clin. Lab. Anal., 33, e22614,

2017

• Asimakopoulou A , Fülöp A., Borkham-Kamphorst E., de Leur E.V., Gassler N., Berger T., Beine B., Meyer H.E., Mak T.W., Hopf C., Henkel C., Weiskirchen R. (2017): "Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis.". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, (17) 30118-7, [5.158]
• Asimakopoulou A. , Borkham-Kamphorst E., Van de Leur E., Weiskirchen R. (2017): Lipocalin 2 and phosphatidylinositol 3-kinase signaling in a methionine- and choline-deficient model of non-alcoholic steatohepatitis. Data in Brief, August;13, 644-649, [0.200]
• Bábíčková J. , Klinkhammer B.M., Buhl E.M., Djudjaj S., Hoss M., Heymann F., Tacke F., Floege J., Becker J.U., Boor P. (2017): Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney International, 91(1), 70-85, [7.683]
• Bangen, J.M. , Hammerich, L., Sonntag, R., Baues, M., Haas, U., Lambertz, D., Longerich, T., Lammers, T., Tacke, F., Trautwein, C., Liedtke C. (2017): Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice. Hepatology, 66 (4), 1242-1257, [13.246]
• Brähler S. , Zinselmeyer B. H., Raju S., Nitschke M., Suleiman H., Saunders B. T., Johnson M. W., Boehner A., Viehmann S., Theisen D. J., Kretzer N. M., Briseno C. G., Zaitsev K., Ornatsky O., Chang Q., Carrero J., Kopp J. B., Artyomov M. N., Kurts C., Murphy K. M., Miner J. H., Shaw A. S. (2017): Opposing roles of dendritic cell subsets in experimental glomerulonephritis. J Am Soc Nephrol, 29(1), 138-154, [8.547]
• Brewitz A. , Eickhoff S., Dähling S., Quast T., Bedoui S., Kroczek R. A., Kurts C., Garbi N., Barchet W., Iannacone M., Klauschen F., Kolanus W., Kaisho T., Colonna M., Germain R. N., Kastenmüller W. (2017): CD8+ T Cells Orchestrate pDC-XCR1+ Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming. Immunity, 46(2), 205-219, [21.522]
• Bruns, T. , Nuraldeen, R., Mai, M., Stengel, S., Zimmermann, H., Yagmur, E., Trautwein, C., Stallmach, A., Strnad, P. (2017): Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis. Wiley Liver International, 37 (2), 232–241, [4.470]
• Buendgens, L. , Yagmur, E., Bruensing, J., Herbers, U., Baeck, C., Trautwein, C., Koch, A., Tacke, F. (2017): Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis. Disease Markers, 18, [2.348]
• Cubero, F. J. , Zoubek, M., Hu, W., Peng, J., Zhao, G., Nevzorova, Y. A., Al Masaoudi, M. , Bechmann, L., Boekschoten, M., Muller, M., Preisinger, C., Gassler, N., Canbay, A., Luedde, T., Davis, R., Liedtke,C., Trautwein, C. (2017): Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury. Gastroenterology, 150(4), 968–981, [18.187]
• De Gottardi A , Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J, Puente A, Müllhaupt B, Navascuès C, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek FWG, Valla D, Garcia-Pagan JC (2017): Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.. Liver International, 37(5), 694–699, [4.470]
• Dhana E. , Ludwig-Portugall I., Kurts C. (2017): Role of immune cells in crystal-induced kidney fibrosis.. Mat Biol, 68-69, 280-292, [6.986]
• Dietzel E. , Weiskirchen S., Floehr J., Horiguchi M., Todorovic V., Rifkin D.B., Jahnen-Dechent W., Weiskirchen R. (2017): Latent TGF-β binding protein-1 deficiency decreases female fertility. Biochemical and Biophysical Research Communications, 482(4), 1387-1392, [2.371]
• Djudjaj, S. , Martin, I.V., Buhl, E.M., Nothofer, N.J., Leng, L., Piecychna, M., Floege, J., Bernhagen, J., Bucala, R., Boor, P. (2017): Macrophage Migration Inhibitory Factor limits renal Inflammation and fibrosis by counteracting tubular cell cycle arrest. Journal of the American Society of Nephrology, 28 (12), [8.491]
• Drescher, H , Schippers, A., Clahsen, T., Sahin, H., Noels, H., Hornef, M., Wagner, N., Trautwein, C., Streetz, K.L., Kroy, D.C. (2017): β7-Integrin and MAdCAM-1 Play Opposing Roles During the Development of Non-Alcoholic Steatohepatitis. Journal of Hepatology, 66(6), 1251-1264, [10.590]
• Görtzen J. , Trebicka J. (2017): Rho-kinase inhibition is beneficial in fibrosis. Hepatology, 65(5), 1780–1781, [11.711]
• Hao, F. , Cubero, F.J., Ramadori, P., Liao, L., Haas, U., Lambertz, D., Sonntag, R., Bangen, J.M., Gassler, N., Hoss, M., Streetz, K.L., Reissing, J., Zimmermann, H.W., Trautwein, C., Liedtke, C., Nevzorova, Y.A. (2017): Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice. Cell Death & Disease, 8 (10), [5.378]
• Heier E.C. , Meier A., Julich-Haertel H., Djudjaj S., Rau M., Tschernig T., Geier A., Boor P., Lammert F., Lukacs-Kornek V. (2017): CD103+ dendritic cells protect against steatosis progression towards steatohepatitis. Journal of Hepathology, 66(6), 1241-1250, [10.590]
• Heine A. , Flores C., Gevensleben H., Diehl L., Heikenwälder M., Ringelhan M., Janssen K. P., Nitsche U., Garbi N., Brossart P., Knolle P. A., Kurts C., Höchst B. (2017): Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination. Onkoimmunol, 6(8), e1338995, [5.333]
• Herrmann E. , de Lédinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, Dumortier J, Guibal A, Pol S, Trebicka J, Jansen C, Strassburg C, Zheng R, Zheng J, Francque S, Vanwolleghem T, Vonghia L, Manesis EK, Zoumpoulis P, Sporea I, Thiele M, Krag A, Cohen-Bacrie C, Criton A, Gay J, Deffieux T, Friedrich-Rust M. (2017): Assessment of biopsy-proven liver fibrosis by 2D-shear wave elastography: An individual patient data based meta-analysis. Hepatology, [11.711]
• Heuser C., Gotot J. , Piotrowski E. C., Philipp M. S., Courrèges J. F., Otte M. S., Guo L., Schmid-Burgk J. L., Hornung V., Heine A. K., Knolle P. A., Garbi N., Serfling E., Evaristo C., Thaiss F., Kurts C. (2017): Prolonged IKKβ inhibition improves ongoing CTL antitumor responses by incapacitating regulatory T cells. Cell Rep, 21(3), 578–586, [7.815]
• Holland T. , Wohlleber D., Marx S., Kreutzberg T., Vento-Asturias S., Schmitt-Mbamunyo S., Welz M., Janas M., Komander K., Eickhoff S., Brewitz A., Hasenberg M., Männ L., Gunzer M., Wilhelm C., Kastenmüller W., Knolle P., Abdullah Z., Kurts C., Garbi N. (2017): Rescue of T-cell function during persistent pulmonary adenoviral infection by TLR9 activation. J Allergy Clin Immun, 141(1), 416-419, [3.557]
• Jansen C , Bogs C, Verlinden W, Thiele M, Möller P, Görtzen J, Lehmann J, Vanwolleghem T, Vonghia L, Praktiknjo M, Chang J, Krag A, Strassburg CP, Francque S, Trebicka J. (2017): Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study. Liver International, 37(3), 396-405, [4.470]
• Jantsch J. , Schultze J. L., Kurts C. (2017): Immunophysiology: Macrophages as key regulators of homeostasis in various organs. Pflugers Arch - Eur J Physiol, 469, 363-364, [2.208]
• Kjærgaard M , Thiele M, Jansen C, Stæhr Madsen B, Görtzen J, Strassburg C, Trebicka J, Krag A. (2017): High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. PLoS One, 12 (4), [3.057]
• Klingberg A. , Hasenberg A., Ludwig-Portugall I., Medyukhina A., Männ L., Brenzel A., Engel D. R., Figge M. T., Kurts C., Gunzer M. (2017): Fully automated evaluation of total glomerular number and capillary tuft size in murine nephritic kidneys using lightsheet microscopy. J Am Soc Nephrol, 28(2), 452-459, [8.547]
• Klinkhammer B.M. , Goldschmeding R., Floege J., Boor P. (2017): Treatment of Renal Fibrosis – turning challenges into opportunities. Advances in Chronic Kidney Disease, 24(2),, 117–129, [2.703]
• Koch A. , Weiskirchen R., Ludwig S., Buendgens L., Bruensing J., Yagmur E., Baeck C., Herbers U., Trautwein C., Tacke F (2017): Relevance of serum sclerostin concentrations in critically ill patients. Journal of Critical Care, 37, 38-44, [2.053]
• Kuttkat, N. , Mohs, A., Ohl, K., Hooiveld, G., Longerich, T., Tenbrock, K., Cubero, F.J., Trautwein, C. (2017): Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease. BMJ Journals, 66 (5), [14.921]
• Lambertz J , Weiskirchen S., Landert S., Weiskirchen R. (2017): Fructose: A dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease. Frontiers in Immunology, [5.695]
• Lambertz, J. , Berger, T., Mak, T.W., van Helden, J., Weiskirchen, R. (2017): Lipocalin-2 in Fructose-Induced Fatty Liver Disease. frontiers in Physiology, [4.031]
• Loosen, S.H. , Roderburg, C., Kauertz, K.L., Koch, A., Vucur, M., Schneider, A.T., Binnebösel, M., Ulmer, T.F., Lurje, G., Schoening, W., Tacke, F., Trautwein, C., Longerich, T., Dejong, C.H., Neumann, U.P., Luedde, T. (2017): CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Scientific Reports, 7, [5.228]
• Lunova, M. , Schwarz, P., Nuraldeen, R., Levada, K., Kuscuoglu, D., Stützle, M., Vuji´c Spasi´c, M., Haybaeck, J., Ruchala, P., Jirsa, M., Deschemin, J.-C., Vaulont, S., Trautwein, C., Strnad, P. (2017): Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells. Journal of Pathology, 241(1), 104–114, [7.381]
• Lutz P , M Haimid M, Pohlmann A, Lehmann J, Jansen C, Schierwagen R, Klein S, Strassburg CP, Spengler U, Trebicka J. (2017): MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis. Scientific Reports, 7, 40556, [5.228]
• Magdaleno F , Trebicka J. (2017): Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression. Gut, [14.921]
• Martin, I.V. , Bohner, A., Boor, P., Shagdarsuren, E., Raffetseder, U., Lammert, F., Floege, J., Ostendorf, T., Weber, S.N. (2017): Complement C5a receptors C5L2 and C5aR in renal fibrosis. American Journal of Physiology, 314 (1), 35-46, [27.312]
• Meurer S.K. , Weiskirchen R. (2017): Endoglin (ENG). Encyclopedia of Signaling Molecules, 2nd Edition 2017 ISBN: 978-1-4419-0460-7, [0.200]
• Mohs, A. , Kuttkat, N., Reißing, J., Zimmermann, H., Sonntag, R., Proudfoot, A., Youssef, S., de Bruin, A., Cubero, F. J., Trautwein, C. (2017): Functional role of CCL5/RANTES for HCC progression during chronic liver disease. Journal of Hepathology, 66(4), 743–753, [10.590]
• Mossanen J.C. , Pracht J., Jansen T.U., Buendgens L., Stoppe C., Goetzenich A., Struck J., Autschbach R., Marx G., Tacke F. (2017): Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery. International Journal of Molecular Sciences, 18 (8), 1662, [3.257]
• Mossanen, J. , Krenkel, O., Ergen, C., Govaere, O., Liepelt, A., Puengel, T., Heymann, F., Kalthoff, S., Lefebvre, E., Eulberg, D., Luedde, T., Marx, G., Strassburg, C., Roskams, T., Trautwein, C., Tacke, F. (2017): CCR2+ monocytes aggravate the early phase of acetaminophen induced acute liver injury. Journal of Hepathology, 64(5), 1667–1682, [10.590]
• Mridha A.R. , Wree A., Robertson A.A.B., Yeh M.M., Johnson C.D., Van Rooyen D.M., Haczeyni F., Teoh N.C., Savard C., Ioannou G.N., Masters S.L., Schroder K., Cooper M.A., Feldstein A.E., Farrell G.C. (2017): NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal of Hepatology, 66(5), 1037-1046, [10.590]
• Pieper CC , Jansen C, Meyer C, Nadal J, Lehmann J, Schild HH, Trebicka J, Thomas D. (2017): Prospective Evaluation of Passive Expansion of Partially Dilated Transjugular Intrahepatic Portosystemic Shunt Stent Grafts-A Three-Dimensional Sonography Study. Journal of Vascular and Interventional Radiology, 28(1), 117-125 [2.570], [2.570]
• Pohl J. M. , Gutweiler S., Thiebes S., Woeste M., Job A., Gunzer M., Jung S., Agace W., Kurts C., Engel D. R. (2017): Irf4-dependent CD103+ CD11b+ dendritic cells and the microbiome regulate monocyte and macrophage activation and intestinal peristalsis in postoperative Ileus. Gut, 12, 2110-20, [17.160]
• Praktiknjo M , Strassburg CP, Trebicka J. (2017): Recent thrombosis of splanchnic veins: Two case reports of catheter-assisted local thrombolysis and thrombus aspiration. Der Internist, [0.336]
• Puengel, T. , Krenkel, O., Kohlhepp, M., Lefebvre, E., Luedde, T., Trautwein, C., Tacke, F. (2017): Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury. PLoS One, [3.057]
• Ramadori, P , Drescher, H., Erschfeld, S., Fragoulis, A., Kensler, T., Wruck, C., Cubero, J., Trautwein, C., Streetz, K., Kroy, D. (2017): Genetic Nrf2 over-activation inhibits the deleterious effects induced by hepatocyte specific c-met deletion during the progression of NASH. Oxidative Medicine and Cellular Longevity, [4.492]
• Reich B. , Viehmann S., Kurts C. (2017): Plasmacytoid dendritic cells: important players in human kidney allograft rejection. Kidney Int, 93(2), 301-303, [8.306]
• Rieck M. , Kremser C., Jobin K., Mettke E., Kurts C., Gräler M., Willecke K., Kolanus W. (2017): Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice. Eur J Immunol, 47(4), 677-684, [4.695]
• Schierwagen R , Uschner FE, Magdaleno F, Klein S, Trebicka J. (2017): Rationale for the use of statins in liver disease. American Journal of Physiology Gastrointestinal and Liver Physiology, 312, 407-412, [3.297]
• Schneider, A. , Gautheron, J., Feoktistova, M., Roderburg, C., Loosen, S. H., Roy, S., Benz, F., Schemmer, P., Büchler, M. W., Nachbur, U., Neumann, U. P., Tolba, R., Luedde, M., Zucman-Rossi, J., Panayotova-Dimitrova, D., Leverkus, M., Preisinger, C., Tacke, F., Trautwein, C., Longerich, T., Vucur, M., Luedde, T. (2017): RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer. Cancer Cell, 31 (1), 94–109, [23.214]
• Schwab S , Lehmann J, Lutz P, Jansen C, Appenrodt B, Lammert F, Strassburg CP, Spengler U, Nischalke HD, Trebicka J. (2017): Influence of genetic variations in the SOD1 gene on the development of ascites and spontaneous bacterial peritonitis in decompensated liver cirrhosis.. European Journal of Gastroenterology & Hepatology, 29(7), 800-804, [2.093]
• Schwab S. , Jobin K., Kurts C. (2017): Urinary tract infection: Recent insight into the evolutionary arms race between uropathogenic E.coli and our immune system. Nephrol Dial Transplant 1, 32(12), 1977-1983, [4.198]
• Strnad, P. , Tacke, F., Koch, A., Trautwein (2017): Liver - guardian, modifier and target of sepsis. Nature Reviews Gastroenterology & Hepatology, 14(1), 55-66, [14.435]
• Trebicka J , Gluud LL (2017): Reply to "Adding embolization to TIPS implantation: A better therapy to control bleeding from ectopic varices?. Journal of Hepatology, [10.590]
• Trebicka J. (2017): Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?. Journal of Hepatology, 66(2), 442–450, [10.590]
• Uerlings, R. , Weiskirchen, R. (2017): An At-A-Glance Visualizatioon of Regional Metal Accretion in Tissue Samples via Image Overlay in Laser Ablation Inductively Coupled Plasma Mass Spectrometry. Laser Ablation: Advances in Research an Applications, Nova Science Publishers, 3, ISBN: 978-1-53612-408-8, [0.200]
• Viehmann S. , Böhner A. S., Kurts C., Brähler S. (2017): The multifaceted role of the renal mononuclear phagocyte system. Cell Immunol, 330, 97-104, [8.213]
• Vucur, M. , Roderburg, C., Kaiser, L., Schneider, A.T., Roy, S., Loosen, S., Luedde, M., Trautwein, C., Koch, A., Tacke, F., Luedde, T. (2017): Elevated serum levels of the mixed lineage kinase domain-like protein (MLKL) predict survival of patients during intensive care unit treatment. Hindawi, [2.348]
• Wang, J. , Djudjaj, S., Gibbert, L., Lennartz, V., Breitkopf, D., Rauen, T., Hermert, D., Martin, I.V., Boor, P., Braun, G.S., Floege, J., Ostendorf, T., Raffetseder, U. (2017): YB-1 mediates both, onset an resolution of inflammation. Journal of Cellular and Molecular Medicine, [5.090]
• Weiskirchen R. (2017): Fast progression of liver damage in lysosomal acid lipase deficiency. Current Medical Research and Opinion, [2.643]
• Weiskirchen R. (2017): Therapeutic targeting of the mitochondrial reactive oxygen species engine prevents portal hypertension and hepatic fibrogenesis. Liver International, 37 (7), 963-965, [4.470]
• Weiskirchen R. , Tacke F. (2017): Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells. Cellular & Molecular Immunology, 14 (2), 143-145, [5.193]
• Weiskirchen S. , Tag C.G., Sauer-Lehnen S., Tacke F., Weiskirchen R. (2017): Isolation and culture of primary murine hepatic stellate cells. Methods in Molecular Biology, 1627, 165-191, [1.170]
• Weiskirchen, S. , Weiskirchen R. (2017): Resveratrol: Is It Really Good for Liver Health?. Hepatitis Monthly, 17 (8), [1.932]
• Wittlich M. , Dudek M., Böttcher J. P., Schanz O., Hegenbarth S., Bopp T., Schmitt E., Kurts C., Garbers C., Rose John S., Knolle P. A., Wohlleber D. (2017): Liver sinusoidal endothelial cell cross-priming is supported by CD4 T cell-derived IL-2. J Hepatol, 66(5), 978-986, [18.946]
• Zheng K. , Cubero F.J., Nevzorova Y.A. (2017): c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease. Genes, 8(4), 123, [3.242]

2016

• Abdullah Z. , Kurts C. (2016): More trouble with FGF23: a novel role in systemic immunosuppression. Kidney International, 89(6), 1176–1177, [7.683]
• Ariza X. , Graupera I, Coll M, Solà E, Barreto R, García E, Moreira R, Elia C, Morales-Ruiz M, Llopis M, Huelin P, Solé C, Fabrellas N, Weiss E, Nevens F, Gerbes A, Trebicka J, Saliba F, Fondevila C, Hernández-Gea V, Fernández J, Bernardi M, Arroyo V, Jiménez W, Deulofeu C, Pavesi M, Angeli P, Jalan R, Moreau R, Sancho-Bru P, Ginès P; CANONIC Investigators, EASL CLIF Consortium (2016): Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. J Hepatol, Jul;65(1), 57-65. doi: 10.1016/j.jhep.2016.03.002. Epub 2016 Mar 14. PubMed PMID: 26988732, [10.590]
• Asimakopoulou A. , Weiskirchen S, Weiskirchen R. (2016): Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy. Front Physiol, in press, [4.031]
• Asimakopoulou, A. , Borkham-Kamphorst, E., Tacke, F., Weiskirchen, R. (2016): Lipocalin-2 (NGAL/LCN2), a "HELP-ME" signal in organ inflammation.. Hepatology, 63, 669-671, [11.711]
• Bartneck M. , Fech V., Ehling J., Govaere O., Theresa Warzecha K., Hittatiya K., Vucur M., Gautheron J., Luedde T., Trautwein C., Lammers T., Roskams T., Jahnen-Dechent W., Tacke F. (2016): Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Hepatology, 63(4), 1310-24,
• Berres M.L. , Lehmann J, Jansen C, Görtzen J, Meyer C, Thomas D, Zimmermann HW, Kroy D, Schumacher F, Strassburg CP, Sauerbruch T, Trautwein C, Wasmuth HE, Trebicka J. (2016): Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Liver Int., Mar, 36(3):386-94. doi: 10.1111/liv.12922. Epub 2015 Aug 17. PubMed PMID: 26212075., [4.470]
• Bertheloot, D. , Latz, E. (2016): HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cellular & Molecular Immunology, 14 (1), 43-64, [5.193]
• Beyer M. , Abdullah Z, Chemnitz JM, Maisel D, Sander J, Lehmann C, Thabet Y, Shinde PV, Schmidleithner L, Köhne M, Trebicka J, Schierwagen R, Hofmann A, Popov A, Lang KS, Oxenius A, Buch T, Kurts C, Heikenwalder M, Fätkenheuer G, Lang PA, Hartmann P, Knolle PA, Schultze JL (2016): Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.. Nat Immunol, May;17(5), 593-603. doi: 10.1038/ni.3399. Epub 2016 Mar 7. PubMed PMID: 26950238,
• Beyer, M. , Abdullah Z., Chemnitz J.M., Maisel D., Sander J., Lehmann C., Thabet Y., Shinde P.V., Schmidleithner L., Köhne M., Trebicka J., Schierwagen R., Hofmann A., Popov A., Lang K.S., Oxenius A., Buch T., Kurts C., Heikenwalder M., Fätkenheuer G., Lang P.A., Hartmann P., Knolle P.A., Schultze J.L. (2016): Tumor necrosis factor impairs CD4+ T Cell-mediated immune control in chronic viral infection. Nature Immunology, , accepted, [19.381]
• Bissonnette J. , Garcia-Pagán JC, Albillos A, Turon F, Ferreira C, Tellez L, Nault JC, Carbonell N, Cervoni JP, Abdel Rehim M, Sibert A, Bouchard L, Perreault P, Trebicka J, Trottier-Tellier F, Rautou PE, Valla DC, Plessier A. (2016): Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology, Jul;64(1), 224-31. doi: 10.1002/hep.28547. Epub 2016 May 13. PubMed PMID: 26990687, [11.711]
• Bissonnette, J. , Garcia-Pagán J.C., Albillos A., Turon F., Ferreira C., Tellez L., Nault J.C., Carbonell N., Cervoni J.P., Abdel Rehim M., Sibert A., Bouchard L., Perreault P., Trebicka J., Trottier-Tellier F., Rautou P.E., Valla D.C., Plessier A. (2016): Role of TIPS in the Management of Complications of Idopathic Noncirrhotic Portal Hypertension. Hepatology, , accepted, [11.050]
• Boor P. (2016): Albuminuria — a marker of systemic microvascular function. Nature Reviews Nephrology, 12(8), 449-50, [9.463]
• Borhofen S.M. , Gerner C, Lehmann J, Fimmers R, Görtzen J, Hey B, Geiser F, Strassburg CP, Trebicka J. (2016): The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis. Digestive Diseases and Sciences, 61(6), 735-743, [2.516]
• Borkham-Kamphorst E. , Steffen B. T., Van de Leur E., Tihaa L., Haas U., Weiskirchen R. (2016): Adenoviral CCN gene transfers induce in vitro and in vivo endoplasmic reticulum stress and unfolded protein response. BBA Mol Cell Res., 1863, 2604-2612, [5.128]
• Borkham-Kamphorst, , Weiskirchen, R. (2016): The PDGF system and its antagonists in liver fibrosis.. Cytokine Growth Factor Rev, 28C, 53-61, [6.571]
• Borkham-Kamphorst, E. , Steffen, B. T., van de Leur, E., Haas, U., Tihaa, L., Friedman, S. L., Weiskirchen, R. (2016): CCN1/CYR61 overexpression in hepatic stellate cells induces ER stress-related apoptosis.. Cell Signal, 28, 34-42, [4.191]
• Bossaller, L , Christ, A., Pelka, K., Nündel, K., Chiang, P.-I., Pang, C., Mishra, N., Busto, P., Bonegio, R.G., Schmidt, R.E., Latz, E., Marshak-Rothsteinet, A. (2016): TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus. Journal of Immunology, 197 (4), 1044–1053, [4.985]
• Braun, G. S. , Nagayama, Y., Maruta, Y., Heymann, F., van Roeyen, C. R., Klinkhammer, B. M., Boor, P., Villa, L., Salant, D. J., Raffetseder, U., Rose-John, S., Ostendorf, T., Floege, J. (2016): Interleukin-6 trans-signaling drives murine crescentic glomerulonephritis.. Journal of the American Society of Nephrology, 27 (1), 132-142, [8.491]
• Buhl, E. M. , Djudjaj, S., Babickova, J., Klinkhammer, B. M., Folestad, E., Borkham-Kamphorst, E., Weiskirchen, R., Hudkins, K., Alpers, C. E., Eriksson, U., Floege, J., Boor, P. (2016): Role of PDGF-D in healthy and fibrotic kidneys.. Kidney Int, 89, 848-861, [7.683]
• Celec P. , Tóthová L., Šebeková L., Podracká L., Boor P. (2016): Salivary markers of kidney function - potentials and limitations. Clinica Chimica Acta, 453, 28-37, [2.799]
• Clària J , Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, Amorós À, Titos E, Alcaraz-Quiles J, Oettl K, Morales-Ruiz M, Angeli P, Domenicali M, Alessandria C, Gerbes A, Wendon J, Nevens F, Trebicka J, Laleman W, Saliba F, Welzel TM, Albillos A, Gustot T, Benten D, Durand F, Ginès P, Bernardi M, Arroyo V (2016): Systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure. Hepatology, 64 (4), 1249-1264, [11.711]
• Clària J. , Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, Amorós À, Titos E, Alcaraz-Quiles J, Oettl K, Morales-Ruiz M, Angeli P, Domenicali M, Alessandria C, Gerbes A, Wendon J, Nevens F, Trebicka J, Laleman W, Saliba F, Welzel TM, Albillos A, Gustot T, Benten D, Durand F, Ginès P, Bernardi M, Arroyo V; (2016): CANONIC Study Investigators of the EASL-CLIF Consortium and the European Foundation for the Study of Chronic Liver Failure (EF-CLIF). systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure.. Hepatology, 64 (4), 1249-1264, [11.711]
• Cubero, F. J. , Zoubek ME, Hu W, Peng J, Zhao G, Nevzorova YA, Al Masaoudi M, Bechmann LP, Boekschoten MV, Muller M, Preisinger C, Gassler N, Canbay AE, Luedde T, Davis RJ, Liedtke C, Trautwein C. (2016): Combined activities of JNK1 and JNK2 in hepatocytes protect against toxic liver injury.. Gastroenterology, Apr;150(4), 968-81, [18.187]
• Djudjaj S. , Papasotiriou M., Bülow R.D., Wagnerova A., Lindenmeyer M.T., Cohen C.D., Bucala R., Strnad P., Goumenos D.S., Floege J., Boor P. (2016): Keratins as Novel Markers of Renal Epithelial Cell Injury. Kidney International, 89 (4), 792-808, [7.683]
• Djudjaj, S. , Lue, H. J., Rong, S., Papasotiriou, M., Klinkhammer, B. M., Zok, S., Klaener, O., Braun, G. S., Lindenmeyer, M. T., Cohen, C. D., Bucala, R., Tittel, A. P., Kurts, C., Moeller, M. J., Floege, J., Boor, P. (2016): Macrophage migration inhibitory factor mediates proliferative glomerulonephritis via CD74. Journal of the American Society of Nephrology, 27 (6), 1650-1664, [8.491]
• Ehling, J. , Bábíčková, J., Gremse, F., Klinkhammer, B. M., Baetke, S. H., Knuechel, R., Kiessling, F., Floege, J., Lammers, T., Boor, P. (2016): Quantitative micro-CT imaging of micro-to-macrovascular dysfunction in progressive kidney diseases. Journal of the American Society of Nephrology], 27(2), 520–532, [8.491]
• Evers B.D.G. , Engel D.R., Böhner A.M.C., Tittel A.P., Krause T.A., Heuser C., Garbi N., Kastenmüller W., Mack M., Tiegs G., Panzer U., Boor P., Ludwig-Portugall I., Kurts C. (2016): CD103+ Kidney Dendritic Cells Protect against Crescentic GN by Maintaining IL-10–Producing Regulatory T Cells. Journal of the American Society of Nephrology, 27(11), 3368-3382, [8.491]
• Genovese F. , Boor P., Papasotiriou M., Leeming D.J., Karsdal M.A., Floege J. (2016): Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy. Nephrology Dialysis Transplantation, 31(3), 472-479, [4.085]
• Görtzen J , Hunka LM, Vonnahme M, Praktiknjo M, Kaifie A, Fimmers R, Jansen C, Heine A, Lehmann J, Goethert JR, Gattermann N, Goekkurt E, Platzbecker U, Brossart P, Strassburg CP, Brummendorf TH, Koschmieder S, Wolf D, Trebicka J. (2016): γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm. Medicine (Baltimore), May;95(20), e3355. doi: 10.1097/MD.0000000000003355. PubMed PMID: 27196445; PubMed Central PMCID: PMC4902387,
• Gotot J. , Piotrowski E., Otte M.S., Tittel A.P., Linlin G., Yao C., Ziegelbauer K., Panzer U., Garbi N., Kurts C., Thaiss F (2016): Inhibitor of NFkB Kinase Subunit 2 Blockade Hinders the Initiation but Aggravates the Progression of Crescentic GN. Journal of the American Society of Nephrology, 27(7), 1917-1924, [8.491]
• Guldiken N. , Ensari G.K., Lahiri P., Couchy G., Preisinger C., Liedtke C., Zimmermann H.W., Ziol M., Boor P., Zucman-Rossi J., Trautwein C., Strnad P. (2016): Keratin 23 is a general stress-inducible marker of mouse and human ductular reaction in liver disease. Journal of Hepatology, 65(3), 552–559, [10.590]
• Hackstein CP , Assmus LM, Welz M, Klein S, Schwandt T, Schultze J, Förster I, Gondorf F, Beyer M, Kroy D, Kurts C, Trebicka J, Kastenmüller W, Knolle PA, Abdullah Z. (2016): Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis. Gut,, , 1-12, [14.921]
• Han, C.Y. , Koo, J.H., Kim, S.H., Gardenghi, S., Rivella, S., Strnad, P., Hwang, S.J., Kim, S.G. (2016): Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt. Nature Communication, 7, [11.329]
• Hartmann P. , Tacke F. (2016): Tiny RNA with great effects: miR-155 in alcoholic liver disease. Journal of Hepatology, 64 (6), 1214-1216, [10.590]
• Heymann F. , Tacke F. (2016): Immunology in the liver - from homeostasis to disease. Nat Rev Gastroenterol Hepatol, 13(2), 88-110, [14.435]
• Horr, F. , Rodriguez-Alcazar, J. F., Latz, E (2016): Assembly and regulation of ASC specks. Cellular and Molecular Life Sciences, 74(7), 1211–1229, [5.694]
• Hüneburg R. , Marwitz T, van Heteren P, Weismüller TJ, Trebicka J, Adam R, Aretz S, Perez Bouza A, Pantelis D, Kalff JC, Nattermann J, Strassburg CP (2016): “Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. Endoscopy International Open, 4(12), 1305-1310, [5.634]
• Jansen C , Bogs C, Krag A, Francque S, Trebicka J. (2016): Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease.. Gut, 66 (3), 558-559, [14.921]
• Jansen, C. (2016): Algorithm to rule-out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multi-center study. Gut, 65 (6), 1057-1058, [14.660]
• Jansen, C. , Bogs, C.K.-P., Verlinden, W., Thiele, M., Moeller, P., Goertzen, J., Lehmann, J., Praktiknjo, M., Chang, J., Krag, A., Strassburg, C., Franque, S., Trebicka, J. (2016): Algorithm to rule-out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multi-center study. Journal of Hepatology, 64 (2), 718, [10.590]
• Jobin K. , Heuser C., Kurts C. (2016): A grain of salt on kidney dendritic cell function in allograft rejection. Kidney International, 89(1), 14–16 ], [7.683]
• Ju C. , Tacke F. (2016): Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cellular & Molecular Immunology, 13, 315-327, [5.193]
• Kanta J. , Mrkvicová A., Weiskirchen R. (2016): Editorial: Liver myofibroblasts. Frontiers in Physiology, 7, 343, [4.031]
• Kanta J. , Mrkvicová A., Weiskirchen R. (2016): Liver myofibroblasts. E-Book, , in press.,
• Klein S , Hinüber C, Hittatiya K, Schierwagen R, Uschner FE, Strassburg CP, Fischer HP, Spengler U, Trebicka J. (2016): Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension. PLoS One, 11(9)PLoS One, e0162144, [3.057]
• Koch A. , Weiskirchen R., Ludwig S., Buendgens L., Bruensing J., Yagmur E., Baeck C., Herbers U., Trautwein C., Tacke F. (2016): Relevance of serum sclerostin concentrations in critically ill patients. Journal of Critical Care, 37, 38-44,
• Koppe C. , Verheuged P., Gautheron J., Reisinger F., Kreggenwinkel K., Roderburg C., Quagliata L., Terracciano L., Gassler N., Tolba R., Boege Y., Weber A., Karin M., Luedde M., Neumann U. P., Weiskirchen R., Tacke F., Vucur M., Trautwein C., Lüscher B., Preisinger C., Heikenwälder M., Lüdde T. (2016): IKKα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylation the cell death mediator RIPK1. Hepatology, 64 (4), 1217-1231, [11.711]
• Korner, C. , Kramer, B., Schulte, D., Coenen, M., Mauss, S., Fatkenheuer, G., Oldenburg, J., Nattermann, J., Rockstroh, J. K., Spengler, U. (2016): Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.. Clin Sci (Lond), 116, 861-870,
• Ku, N.O. , Strnad, P., Bantel, H., Omary, M.B. (2016): Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology, 64(3), 966-76, [11.711]
• Kurts C. (2016): “Der SFB Transregio 57: Organfibrose in Leber und Niere: Von den Mechanismen der Schädigung zur Beeinflussung der Erkrankung. DGfN [...],
• Labzin, L.I. , Lauterbach, M.A.R., Latz, E. (2016): Interferons and inflammasomes: Cooperation and counterregulation in disease. Journal of Allergy and Clinical Immunology, 1, 37-46, [12.485]
• Laleman W. , Trebicka J., Verbeke L. (2016): Evolving insights in the pathophysiology of complications of cirrhosis: The Farnesoid-X receptor (FXR) to the rescue?. Hepatology, 64 (5), 1792-1794, [11.711]
• Ludwig-Portugall I., , Bartok E., Dhana E., Evers B.D.G., Primiano M.J., Hall J.P., Franklin B.S., Knolle P.A., Hornung V., Hartmann G., Boor P, Latz E., Kurts C. (2016): An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney International, 90(3), 525–539, [7.683]
• Merle U. , Weiskirchen R. (2016): Wilson's disease: An inherited, silent, copper intoxication disease. Eur Med J. Neurol., 4:, 74-83, [1.920]
• Merz W.M. , Rüland AM, Hippe V, Poetzsch B, Meyer C, Pollok JM, Gembruch U, Trebicka J. (2016): Pregnancy in Budd-Chiari Syndrome: Case Report and Proposed Risk Score. Medicine (Baltimore), 95(22), e3817, [2.133]
• Meurer S. K. , Weiskirchen R. (2016): Endoglin (ENG). Encyclopedia of Signaling Molecules, 2nd Edition (Springer), in press, [0.200]
• Meurer S.K. , Neß M, Weiskirchen S, Kim P, Tag CG, Kauffmann M, Huber M, Weiskirchen R. (2016): Isolation of mature (peritoneum-derived) mast cells and immature (bone marrow-derived) mast cell precursors from mice. PLoS One, 11(6), e0158104, [3.057]
• Nahon, N. , Nuraldeen R., Rufat P., Sutton A., Trautwein C., Strnad P. (2016): In alcoholic cirrhosis, low serum hepcidin levels associate with poor long-term survival.. Liver International, 36 (2), 185-188, [4.470]
• Nevzorova, Y. A. , Cubero F.J., Hu W., Hao F., Haas U., Ramadori P., Gassler N., Hoss M., Strnad P., Zimmermann H.W., Tacke F., Trautwein C., Liedtke C. (2016): Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. J Hepatology, 64(3), 628-40, [11.340]
• Rudolph J. , Heine A, Quast T, Kolanus W, Trebicka J, Brossart P, Wolf D. (2016): The JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK. Leukemia, 30, 2119-2123, [12.104]
• Schierwagen R , Maybüchen L, Hittatiya K, Klein S, Uschner FE, Braga TT, Franklin BS, Nickenig G, Strassburg CP, Plat J, Sauerbruch T, Latz E, Lütjohann D, Zimmer S, Trebicka J (2016): Statins improve NASH via inhibition of RhoA and Ras. Liver Physiology, 311(4), 724-733, [3.297]
• Schon H.-T. , Weiskirchen R. (2016): Exercise-induced release of pharmacologically active substances and their relevance for therapy of hepatic injury. Frontiers in Pharmacology, 7, 283, [4.418]
• Schon H.T. , Bartneck M., Borkham-Kamphorst E., Nattermann J., Lammers T., Tacke F., Weiskirchen R. (2016): Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis. Frontiers in Pharmacology, 7, 33, [4.418]
• Sevelsted Møller L , Fialla AD, Schierwagen R, Biagini M, Liedtke C, Laleman W, Klein S, Reul W, Koch Hansen L, Rabjerg M, Singh V, Surra J, Osada J, Reinehr R, de Muckadell OB, Köhler R, Trebicka J. (2016): The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury. Scientific Reports, 6, 28770, [5.228]
• Shirvani-Dastgerdi, E. , Pourkarim M.R., Herbers U., Amini-Bavil-Olyaee S., Yagmur E., Alavian S.M., Trautwein C., Tacke F (2016): Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro.. Clinical Microbiology and Infection, 22(1), e1-6, [5.575]
• Susnea, I. , Weiskirchen, R. (2016): Trace metal imaging in diagnostic of hepatic metal disease.. Mass Spectrometry Reviews, 35 (6), 666-686, [9.346]
• Tacke F. , Nuraldeen R., Koch A., Strathmann K., Hutschenreuter G., Trautwein C., Strnad P. (2016): Iron Parameters Determine the Prognosis of Critically Ill Patients. Critical Care Medicine, 44 (6), 1049-1058, [7.422]
• Tacke, F. (2016): Biomarker and Therapeutic Potential of CSF1 in Acute Liver Failure.. Gastroenterology, 149 (7), 1675-1678, [18.187]
• Tetzner A , Gebolys K, Meinert C, Klein S, Uhlich A, Trebicka J, Villacañas Ó, Walther T (2016): G-Protein-Coupled Receptor MrgD Is a Receptor for Angiotensin-(1-7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A. Hypertension, ;68(1), 185-94, [6.350]
• Thiele M. , Detlefsen S, Sevelsted Møller L, Madsen BS, Fuglsang Hansen J, Fialla AD, Trebicka J, Krag A. (2016): Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis. Gastroenterology, 150 (1), 123-33, [18.187]
• Trebicka J. (2016): Predisposing Factors in Acute-on-Chronic Liver Failure. Seminars Liver Disease, 36(2), 167-73, [5.667]
• Trebicka J. , Schierwagen R. (2016): Hepatic mitochondrial dysfunction in nonalcoholic steatohepatitis: Read-out or reason?. Hepatology, 63(5), 1729-32, [11.711]
• Trebicka J. , von Heydebrand M, Lehmann J, Tofteng F, Busk T, Jensen HL, Rohde J, Reiberger T, Mortensen C, Schierwagen R, Klein S, Møller S, Bendtsen F, Krag A. (2016): Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients. Journal of Hepatology, 64(6), 1265-73, [10.590]
• Trebicka, J. (2016): Assessment of beta-blocker response by expression fo beta-Arrestin2 and Rho/ROCK2 in antrum mucosa in cirrhotic patients. J Hepatol, , accepted, [11.370]
• Uerlings R. , Matusch A., Weiskirchen R. (2016): Standardization and normalization of data from laser ablation inductively coupled plasma mass spectrometry. Laser Ablation (Ed. Yang D.). Intech Publishing. ISBN: 978-953-51-4892-0., [0.200]
• Uerlings, R , Matusch, A., Weiskirchen, R. (2016): Reconstruction of laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) spatial distribution images in Microsoft Excel 2007.. Int J Mass Spectrom, 395, 27-35, [1.183]
• van Helden, J. , Weiskirchen, R. (2016): Diagnostischer Wert der quantitativen HBsAg Bestimmung bei der Hepatitis B Infektion (Diagnostic value of the quantitative HBsAg determination in hepatitis B infections).. Zeitschrift für Gastroenterologie, 54, 319-326, [1.357]
• Verbeke L , Mannaerts I, Schierwagen R, Govaere O, Klein S, Vander Elst I, Windmolders P, Farre R, Wenes M, Mazzone M, Nevens F, van Grunsven LA, Trebicka J, Laleman W (2016): FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Scientific Reports, 6, [5.228]
• von Kolontaj, K. , Horvath, G. L., Latz, E., Büscher, M. (2016): Automated nanoscale flow cytometry for assessing protein-protein interactions. Cytometry Part A, 89(9), 835–843, [3.181]
• von Stillfried S. , Apitzsch J.C., Ehling J., Penzkofer T., Mahnken A.H., Knüchel R., Floege J., Boor P. (2016): Contrast-enhanced CT imaging in patients with chronic kidney disease. Angiogenesis, 19(4), 525–535, [4.301]
• Wang J. , Gibbert L., Djudjaj S., Alidousty C., Rauen T., Kunter U., Rembiak A., Enders D., Jankowski V., Braun G. S., Floege J., Ostendorf T., Raffetseder U. (2016): Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis. Kidney Int, 90, 1226-1237, [8.395]
• Wang J. , Gibbert L., Djudjaj S., Alidousty C., Rauen T., Kunter U., Rembiak A., Enders D., Jankowski V., Braun G. S., Floege J., Ostendorf T., Raffetseder U. (2016): Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis. Kidney Int, 90, 1226-1237, [8.395]
• Weiskirchen R. , Tacke F. (2016): Leberfibrose: von der Pathologie zu den Therapiemöglichkeiten. Falk Gastro-Kolleg., , 1-11, [0.200]
• Weiskirchen R. , Tacke F. (2016): Liver fibrosis – which mechanisms matter?. Clinical Liver Disease, 8 (4), 94-99, [0.360]
• Weiskirchen S. , Weiskirchen R. (2016): Resveratrol: How much wine do you have to drink to stay healthy?. Advances in Nutrition, 7, 706-718, [5.201]
• Weiskirchen S. , Tag C.G., Sauer-Lehnen S., Tacke F., Weiskirchen R. (2016): Isolation and culture of primary murine hepatic stellate cells. Methods Mol Biol, , in press,
• Weiskirchen, R. (2016): Intratumor heterogeneity, variability and plasticity: Questioning the current concepts in classification and treatment of hepatocellular carcinoma.. Hepatobiliary Surg Nutr, 5, 183-187, [3.050]
• Weiskirchen, R. , Tacke, F. (2016): Neue Therapieoptionen für die Leberfibrose: Aus der Forschung in die Klinik. New treatment options for liver fibrosis: From-bench-to-bedside.. Der Gastroenterologe, 11, 40-46, [0.200]
• Weiskirchen, R. , Tacke, F. (2016): Liver fibrosis: from pathogenesis to novel therapies.. Digestive Diseases and Sciences, 34, 410-422, [2.516]
• Weiskirchen, R. (2016): Hepatoprotective and anti-fibrotic agents: It’s time to take the next step.. Frontiers in Pharmacology, 6, 303, [4.418]
• Zimmer S. , Grebe A, Bakke SS, Bode N, Halvorsen B, Ulas T, Skjelland M, De Nardo D, Labzin LI, Kerksiek A, Hempel C, Heneka MT, Hawxhurst V, Fitzgerald ML, Trebicka J, Björkhem I, Gustafsson JÅ, Westerterp M, Tall AR, Wright SD, Espevik T, Schultze JL, Nickenig G, Lütjohann D, Latz E. (2016): Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sciience Translational Medicine, 8 (333), 333ra50, [16.264]

2015

• Anadol, E. P. , Schierwagen, R., Elfimova, N., Tack, K., Schwarze-Zander, C., Eischeid, H., Noetel, A., Boesecke, C., Jansen, C., Dold, L., Wasmuth, J. C., Strassburg, C. P., Spengler, U., Rockstroh, J. K., Odenthal, . (2015): Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.. Hepatology, 61(1), 46-55, [11.050]
• Asimakopoulou, A. (2015): Lipocalin 2 in the pathogenesis of fatty liver disease and non-alcoholic steatohepatitis.. Clin. Lipidol, 10, 47-67, [0.870]
• Bartneck, M. , Topuz, F., Tag, C. G., Sauer-Lehnen, S., Warzecha, C. T., Trautwein, C., Weiskirchen, R., Tacke, F. (2015): Molecular response of liver sinusoidal endothelial cells on hydrogels. Mater Sci Eng C Mater Biol, Appl 51, 64-72, [3.420]
• Bartneck, M. (2015): Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases.. Biomaterials, [8.560]
• Bartneck, M. , Warzecha, K. T., Tag, C. G., Sauer-Lehnen, S., Heymann, F., Trautwein, C., Weiskirchen, R., Tacke, F. (2015): Isolation and time lapse microscopy of highly pure hepatic stellate cells.. Anal Cell Pathol (Amst), Article ID-417023, [0.850]
• Benz, F. (2015): Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness.. Disease Markers, [1.560]
• Berres, M. L. , Asmacher, S. S., Lehmann, J., Jansen, C., Görtzen, J., Klein, S., Meyer, C., Strunk, H. M., Fimmers, R., Tacke, F., Strassburg, C. P., Trautwein, C., Sauerbruch, T., Wasmuth, H. E., Trebicka (2015): CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.. J Hepatol, 62(2), 332-339, [11.370]
• Berres, M. L. , Lehmann, J., Jansen, C., Görtzen, J., Meyer, C., Thomas, D., Zimmermann, H. W., Kroy, D., Schuhmacher, F., Strassburg, C. P., Sauerbruch, T., Trautwein, C., Wasmuth, H. E., Trebicka, J. (2015): Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.. Liver Int, Mar;36(3), 386-94, [4.850]
• Boaru, S. G. , Borkham-Kamphorst, E., Van de Leur, E., Lehnen, E., Liedtke, C., Weiskirchen, R. (2015): NLRP3 inflammasome expression is driven by NF-kB in cultured hepatocytes.. Biochem Biophys Res Commun, 458, 700-706, [2.300]
• Boaru, S. G. , Merle, U., Uerlings, R., Zimmermann, A., Willheim, C., Ferenci, P., Stremmel, W., Weiskirchen, R. (2015): Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.. J Cell Mol Med, 19, 806-814, [4.010]
• Boor, P , Perkuhn, M., Weibrecht, M., Zok, S., Martin, I. V., Gieseke, J., Schoth, F., Ostendorf, T., Kuhl, C., Floege, J. (2015): Diffusion-weighted MR imaging does not reflect kidney fibrosis in rat model of fibrosis.. JMRI, 1002/jmri, 24853, [2.510]
• Boor, P. , Papasptiriou, M. E. (2015): If you lose your nerves, at least you will not get kidney fibrosis!. Kidney Int, 87(2), 275-277, [8.560]
• Boor, P. , Floege, J. (2015): Renal Allograft Fibrosis: Biology and Therapeutic Targets.. Am J Transplant, 15, 863-886, [5.680]
• Boor, P. , Bábíčková, J., Steegh, F., Hautvast, P., Martin, I. V., Djudjaj, S., Nakagawa, T., Ehling, J., Gremse, F., Bücher, E., Eriksson, U., van Roeyen, C. R. C., Eitner, F., Lammers, T., Floege, T. (2015): Role of PDGF-CC in capillary rarefaction in renal fibrosis.. Am J Pathol, 185, 2132-2142, [4.590]
• Borkham-Kamphorst, E. , Alexi, P., Tihaa, L., Haas, U., Weiskirchen, R. (2015): Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities.. Biochem Biophys Res, Commun 457, 307-313, [2.300]
• Borkham-Kamphorst, E. , Meurer, S. K., Van de Leur, E., Haas, U., Tihaa, L., Weiskirchen, R. (2015): PDGF-D signalling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β.. Cell Signal, 27, 1305-1314, [4.320]
• Böttcher JP , Beyer M., Meissner F., Abdullah Z., Sander J., Höchst B., Eickhoff S., Rieckmann J.C., Russo C., Bauer T., Flecken T., Giesen D., Engel D., Jung S., Busch D.H., Protzer U., Thimme R., Mann M., Kurts C., Schultze J.L., Kastenmüller W., Knolle P.A. (2015): Functional classification of memory CD8(+) T cells by CX3CR1 expression.. Nature Communications, [11.470]
• Chen, Y. , Guldiken, N., Spurny, M., Haybaeck, J., Pollheimer, M. J., Fickert, P., Gassler, N., Jeon, M. K., Trautwein, C., Strnad, P. (2015): Loss of keratin 19 favours the development of cholestatic liver disease via decreased Notch-mediated ductular reaction.. J Pathol, [7.430]
• Coll, R. C. (2015): A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.. Nat Med, [28.220]
• Cubero, F. J. (2015): Haematopoietic cell-derived jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.. J Hepatology, [11.340]
• de Franchis R. , Baveno VI Faculty (2015): Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol, Sep;63(3), 743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3. PubMed PMID: 26047908,
• Dickerhof, N. (2015): Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.. Free Radical Biol Med, [5.740]
• Djudjaj, S , Lue, H. J., Rong, S., Papasotiriou, M., Klinkhammer, B. M., Zok, S., Klaener, O., Braun, G. S., Lindenmeyer, M. T., Cohen, C. D., Bucala, R., Tittel, A. P., Kurts, C., Moeller, M. J., Floege, J., Boor, P. (2015): Macrophage migration inhibitory factor mediates proliferative glomerulonephritis via CD74.. J Am Soc Nephrol, , in press, [9.340]
• Ehling, J. , Bábíčková , J., Gremse, F., Klinkhammer, B. M., Baetke, S. H., Knuechel, R., Kiessling, F., Floege, J., Lammers, T., Boor, P. (2015): Quantitative micro-CT imaging of micro-to-macrovascular dysfunction in progressive kidney diseases.. J Am Soc Nephrol, ASN.2015020204, [9.340]
• Engel, D. R. , Krause, T., Snelgrove, S., Thiebes, S., Boor, P., Kitching, R., Kurts, C. (2015): (2015): CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages.. J Immunol, 194, 1628-1638, [4.920]
• Eslam, M. , Hashem, A. M., Leung, R., Romero-Gomez, M., Berg, T., Dore, G. J., Chan, H. L., Irving, W. L., Sheridan, D., Abate, M. L., Adams, L. A., Mangia, A., Weltman, M., Burgianesi, E., Spengler, U., Shaker, O., Fischer, J., Mollison, L., Cheng, W., Powell, E., Nattermann, J., Riordan, S., McLeod, D., Armstrong, N. J., Douglas, M. W., Liddle, C., Booth, D. R., George, J., Ahlenstiel, G., International Hepatitis, C. G. C. (2015): Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun, 6, 6422,
• Franken L (2015): Splenic red pulp macrophages are intrinsically superparamagnetic and contaminate magnetic cell isolates.. Sci Rep, [5.580]
• Genovese, F. , Boor, Ü., Üaüasotiriou, M., Leeming, D. J., Karsdal, M. A., Floege, J. (2015): Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.. Nephrol Dial Transplant, pii, gfv, 301, [3.580]
• Goeser F. (2015): HIV mono-infection is associated with an impaired anti-HCV activity of NK cells. AIDS, [5.550]
• Görtz, D. (2015): Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery. Sci Rep, [5.580]
• Görtzen J. , Schierwagen R, Bierwolf J, Klein S, Uschner FE, van der Ven PF, Fürst DO, Strassburg CP, Laleman W, Pollok JM, Trebicka J. (2015): Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis. Front Physiol, Dec 2;6, 359. doi: 10.3389/fphys.2015.00359. eCollection 2015. PubMed PMID: 26696895; PubMed Central PMCID: PMC4667086,
• Görtzen, J. (2015): Interplay of Matric Stiffness and c-SRC in Hepatic Fibrosis. Front Physiol, [3.530]
• Gotot J (2015): IKK2 blockade inhibits the initiation, but aggravates the progression of crescentic glomerulonephritis. J Am Soc Nephrol, [9.340]
• Gottschalk C (2015): The debate about dendritic cells and macrophages in the kidney.. Front Immunol,
• Guldiken, N. , Zhou, Q., Kucukoglu, O., Rehm, M., Levada, K., Gross, A., Kwan, R., James, L. P., Trautwein, C., Omary, M. B., Strnad, P. (2015): Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with JNK activation and protein adduct formation.. Hepatology, , in press, [11.050]
• Guldiken, N. , Usachov, V., Levada, K., Trautwein, C., Ziol, M., Nahon, P., Strnad, P. (2015): Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease.. Liver Int, 35, 1203-1212, [4.850]
• Gustot, T. , Fernandez, J., Garcia, E., Morando, F., Caraceni, P., Alessandria, C., Laleman, W., Trebicka, J., Elkrief, L., Hopf, C., Solis-Munoz, P., Saliba, F., Zeuzem, S., Albilos, A., Benten, M. T., Concepción, M., Córdoba, J., McCormick, A., Stauber, R., Vogel, W., de Gottardi, A., Welzel, T. M., Domenicali, M., Risso, A., Wndon, J., Deulofeu, C., Angeli,P., Durand, F., Pavesi, M., Gerbes, A., Jalan, R., Moreau, R., Ginés, P.,Bernardi, M., Arroyo, V. (2015): Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.. Hepatology, 62(1), 243-252, [11.050]
• Hamesch, K. , Borkham-Kamphorst, E., Strnad, P., Weiskirchen, R. (2015): Lipopolysaccharide-induced inflammatory liver injury in mice.. Lab Anim, 49(S1), 37-46, [1.120]
• Hammerich, L. (2015): CREMα overexpression impairs function of hepatic myeloid derived suppressor cells and aggravates immune-mediated hepatitis in mice.. Hepatology, [11.050]
• Hammerich, L. (2015): Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.. World J Gastrointest Pathophysiol,
• Hatting, M. (2015): Lack of gp130 expression in hepatocytes attenuates tumor progression in the den model.. Cell death & disease, [5.010]
• Heinrichs, D. , Berres, M. L., Coeuru, M., Knauel, M., Nellen, A., Fischer, P., Philippeit, C., Bucala, R., Trautwein, C., Wasmuth, H. E., Bernhagen, J. (2015): Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis.. FASEB J, 28(12), 5136-5147, [5.040]
• Heymann, F. , Peusquens, J., Ludwig-Portugall, I., Kohlhepp, M., Ergen, C., Niemietz, P., Martin, C., van Rooijen, N., Ochando, J.C., Randolph, G.J., Luedde, T., Ginhoux, F., Kurts, C., Trautwein, C., Tacke, F (2015): Liver inflammation abrogates immunological tolerance induced by Kupffer cells.. Hepatology, 62 (1), 279-91, [11.711]
• Heymann, F. (2015): Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter mice.. J Vis Exp, [1.320]
• Heymann, F. , Hamesch, K., Weiskirchen, R., Tacke, F. (2015): The Concanavalin A model of acute hepatitis in mice.. Lab Anim, 49(S1), 12-20., [1.120]
• Hoechst, B. , Mikulec ,J., Baccega, T., Metzger, C., Welz, M., Peusquens, J., Tacke, F., Knolle, P., Kurts, C., Diehl, L., Ludwig-Portugall, I. (2015): Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis.. PLoS One, 10 (3) e0119662, [3.057]
• Horiguchi, M. , Todorovic, V., Hadjiolova, K., Weiskirchen, R., Rifkin, D. B. (2015): Abrogation of both short and long forms of latent transforming growth factor-β binding protein-1 causes defective cardiovascular development and is perinatally lethal. Matrix Biol, 41, 61-70, [4.470]
• Idrissova, L. , Malhi H., Werneburg N.W., LeBrasseur N.K., Bronk S.F., Fingas C., Tchkonia T., Pirtskhalava T., White T.A., Stout M.B., Hirsova P., Krishnan A., Liedtke C., Trautwein C., Finnberg N., El-Deiry W.S., Kirkland J.L., Gores G.J. (2015): Trail receptor deletion in mice suppresses the inflammation of nutrient excess. Journal of hepatology.. J Hepatology, 62(5), 1156-63, [10.590]
• Jalan, R. , Pavesi, M., Saliba, F., Amorós, A., Fernandez, J., Holland-Fischer, P., Sawhney, R., Mookerjee, R., Caraceni, P., Moreau, R., Caraceni, P., Moreau, R., Ginès, P., Durand, F., Angeli, W., Trebicka, J., Samuel, D., Zeuzem, S., Gustot, T., Gerbes, A. L., Wendon, J., Bernardi, M., Arroyo, V. (2015): The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.. J Hepatol, 62(4), 831-840, [10.590]
• Jansen, C. , Reiberger, T., Huang, J., Eischeid, H., Schierwagen, R., Mandorfer, M., Anadol, E., Schwabl, P., Schwarze-Zander, C., Warmecke-Eberz, U., Strassburg, C. P., Rockstroh, J. K., Peck-Radosavljevic, M., Odenthal, M., Trebicka, . (2015): Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.. PLoS One, 10(2), e0116768-, [3.057]
• Kalenski, J. , ., Mancina, E., Paschenda, P., Beckers, C., Bleilevens, C., Tóthová, L'., Boor, P., Doorschodt, B. M., Tolba, R.H. (2015): Improved Preservation of Warm Ischemia Damaged Porcine Kidneys after Cold Storage in Ecosol, a Novel Preservation Solution.. Annals of Transplantation, 20, 233-242, [1.032]
• Kim, B. S. , Pallua, N., Bernhagen, J., Bucala, R. (2015): The macrophage migration inhibitory factor protein superfamily in obesity and wound repair.. Experimental & Molecular Medicine, 47 e161, [5.164]
• Klein S. , Herath CB, Schierwagen R, Grace J, Haltenhof T, Uschner FE, Strassburg CP, Sauerbruch T, Walther T, Angus PW, Trebicka J. (2015): Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis. PLoS One, Sep, 25;10(9):e0138732. doi: 10.1371/journal.pone.0138732. eCollection 2015. PubMed PMID: 26406236; PubMed Central PMCID: PMC4583473,
• Klein, S. , Rick J., Lehmann J., Schierwagen R., Schierwagen I.G., Verbeke L., Hittatiya K., Uschner F.E., Manekeller S., Strassburg C.P., Wagner K.U., Sayeski P.P., Wolf D., Laleman W., Sauerbruch T., Trebicka J. (2015): Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.. Gut, [14.921]
• Klein, S. (2015): Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis.. PLoS One, 10 (9), e0138732, [3.057]
• Kokordelis, P. , Krämer. B., Boesecke, C., Voigt, E., Ingiliz, P., Glässner, A., Wolter, F., Strassburg, C.P., Spengler, U., Rockstroh, J.K., Nattermann, J. (2015): CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.. Journal of Acquired Immune Deficiency Syndrome, 70 (4), 338-346, [3.806]
• Kukuk, G. M. , Hittatiya, K., Sprinkart, A. M., Eggers, H., Gieseke, J., Block, W., Moeller, P., Willinek, W. A., Spengler, U., Trebicka, J., Fischer, H. P., Schild, H. H., Träber, F. (2015): Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol, , [Epub ahead of print], [3.640]
• Kuppe, C. , Gröne, H. J., Ostendorf, T., van Kuppevelt, T. H., Boor, P., Floege, J., Smeets, B., Moeller, M. J. (2015): Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.. Kidney Intdoi, 10.1038, ki.2015.116, [7.683]
• Langhans, B. , Alwan, A. W., Kramer, B., Glassner, A., Lutz, P., Strassburg, C. P., Nattermann, J., Spengler, U. (2015): Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type.. J Hepatol, 62, 398-404, [10.590]
• Leeming, D. J. , Veidal, S. S., Karsdal, M. A., Nielsen, M. J., Trebicka, J., Busk, T., Bendtsen, F., Krag, A., Møller, S. (2015): Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis. Scand J Gastroenterol, 50(5), 584-592, [2.199]
• Liepelt, A. (2015): Healing the scars of life-targeting redox imbalance in fibrotic disorders of the elderly.. Ann Transl Med,
• Lunova, M. , Trautwein, C., Nahon, P., Strnad, P. (2015): Hepcidin in chronic liver disease and hepatocellular carcinoma: The plot thickens. J Hepatol, 62, 979-980, [10.590]
• Marcías-Rodríguez, R. U. , Duarte-Rojo, A., Cantú-Brito, C., Sauerbruch, T., Ruiz-Margáin, A., Trebicka, J., Green-Gómez, M., Díaz Ramírez, J. B., Sierra Beltrán, M., Uribe-Esquivel, M., Torre, A. (2015): Cerebral haemodynamics in cirrhotic patients with hepatic encephalopathy.. Liver Int, 35(2), 344-352, [4.470]
• Moeller, M. J. , Kuppe C. (2015): Point: Proposing the electrokinetic model.. Perit Dial Int, [1.298]
• Mohr R. , Schierwagen R, Schwarze-Zander C, Boesecke C, Wasmuth JC, Trebicka J, Rockstroh JK. (2015): Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?. Medicine (Baltimore), Dec;94(50), Dec;94(50):e2127. doi: 10.1097/MD.0000000000002127. PubMed PMID: 26683921, [2.133]
• Mohr, R. , Schierwagen R., Schwarze-Zander C., Boesecke C., Wasmuth J.C., Trebicka J., Rockstroh J.K. (2015): Liver Fibrosis in HIV Patients Receiving a Modern cART. Medicine, [5.720]
• Mossanen, J. (2015): Acetaminophen-induced acute liver injury in mice.. Lab Anim, [1.553]
• Murray D.D. , Suzuki K, Law M, Trebicka J, Neuhaus J, Wentworth D, Johnson M, Vjecha MJ, Kelleher AD, Emery S; INSIGHT ESPRIT and SMART Study Groups (2015): Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study. PLoS One, Oct 14, 10(10):e0139981. doi: 10.1371/journal.pone.0139981. eCollection 2015. PubMed PMID: 26465293; PubMed Central PMCID: PMC4605674, [3.057]
• Nair, D. G. , Weiskirchen, R., Al-Musharafi, S. K. (2015): Marine-derived bioactive compounds as potential hepatoprotective agents. Acta Phamacol Sinica, 36, 158-170, [1.677]
• Nevzorova, Y. A. (2015): Partial hepatectomy in mice.. Lab Anim, [1.553]
• Nielsen M.J. , Lehmann J, Leeming DJ, Schierwagen R, Klein S, Jansen C, Strassburg CP, Bendtsen F, Møller S, Sauerbruch T, Karsdal MA, Krag A, Trebicka J. (2015): Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS. Dig Dis Sci., Nov, 60(11):3456-64. doi: 10.1007/s10620-015-3783-9. Epub 2015 Jul 3. PubMed PMID: 26138655, [2.516]
• Nielsen, M. J. , Lehmann, J., Leeming, D. J., Schierwagen, R., Klein, S., Jansen, C., Strassburg, C. P., Bendtsen, F., Møller, S., Sauerbruch, T., Karsdal, M. A., Krag, A., Trebicka, J. (2015): Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.. Dig Dis Sci, Nov;60(11), 3456-64. doi: 10.1007/s10620-015-3783-9. Epub 2015 Jul 3., [2.610]
• Panstruga, R. (2015): Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.. BMC Evol Biol, [3.406]
• Papasotiriou, M. , Genovese, F., Klinkhammer, B. M., Kunter, U., Nielsen, S. H., Karsdal, M. A., Floege, J., Boor, P. (2015): Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.. Nephrol Dial Transplant, 30, 1112-1121, [4.085]
• Pawig, L. , Klasen, C., Weber, C., Bernhagen, J., Noels, H. (2015): Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives.. Front Immunol, 6, 429, [5.695]
• Plompen, E. P. , Valk, P. J., Chu, I., Darwish Murad, S., Plessier, A., Turon, F., Trebicka, J., Primignani, M., Garcia-Pagán, J. C., Valla, D. C., Janssen, H. L., Leebeek, F. W. (2015): Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis. Haematologica, 100(6), e226-e228., [6.671]
• Ramadori, P , Weiskirchen, R., Trebicka, J., Streetz, K. (2015): Mouse models of metabolic liver injury.. Lab Animals, 49(S1), 47-58., [1.553]
• Ramadori, P (2015): Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.. Hepatobiliary Surg Nutr, 4(1), 11-23, [3.050]
• Ramadori, P. , Drescher, H., Erschfeld, S., Schumacher, F., Berger, C., Fragoulis, A., Schenkel, J., Kensler, T.W., Wruck, C.J., Trautwein, C., Kroy, D.C., Streetz K.L. (2015): Hepatocyte-specific KEAP1 deletion reduces liver steatosis but not inflammation during non-alcoholic–steatohepatitis devolopment.. Free Radical Biol Med, 91, 114-26, [5.784]
• Roderburg, C. , Benz, F., Vargas Cardenas, D., Koch, A., Janssen, J., Vucur, M., Gautheron, J., Schneider, A.T., Koppe, C., Kreggenwinkel, K., Zimmermann, H.W., Luedde, M., Trautwein, C., Tacker F., Luedde, T. (2015): Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases.. Liver Int, 35 (4), 1182-1184, [4.470]
• Roderburg, C. , Benz, F., Cardenas, D.V., Lutz, M., Hippe, H.J., Luedde, T., Trautwein, C., Tacke, F., Luedde, M. (2015): Persistently elevated osteopontin serum levels predict mortality in critically ill patients.. Crit Care, 19, 271, [4.950]
• Roy, S. , Benz, F., Vargas Cardenas, D., Vucur, M., Gautheron, J., Schneider, A., Hellerbrand, C., Pottier, N., Alder, J., Tacke, F., Trautwein, C., Roderburg, C., Luedde, T. (2015): miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis.. Journal of Digestive Diseases, 16 (9), 513-524, [1.887]
• Saritas, T. , Kuppe, C., Moeller, M.J. (2015): Progress and controversies in unraveling the glomerular filtration mechanism.. Curr Opin Nephrol Hypertens, 24 (3), 208-216, [3.232]
• Sauerbruch, T , Trebicka, J. (2015): Future therapy of portal hypertension in liver cirrhosis - a guess.. Review, F1000Prime Rep 6, 95, [4.430]
• Sauerbruch, T. , Mengel, M., Dollinger, M., Zipprich, A., Panther, E., Wiest, R., Caca, K., Hoffmeister, A., Lutz, H., Schoo, R., Lorenzen, H., Trebicka, J., Appenrodth, B., Schepke, M., Fimmers, . (2015): Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.. Gastroenterology, 60 (11), 3456-3465, [18.187]
• Schierwagen R. , Maybüchen L, Zimmer S, Hittatiya K, Bäck C, Klein S, Uschner FE, Reul W, Boor P, Nickenig G, Strassburg CP, Trautwein C, Plat J, Lütjohann D, Sauerbruch T, Tacke F, Trebicka J. (2015): Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. Scientific Reports, 5, 3456-64, [5.228]
• Schierwagen, R. , Maybüchen, L., Zimmer, S., Hittatiya, K., Bäck, C., Klein, S., Uschner, F. E., Reul, W., Boor, P., Nickenig, G., Strassburg, C. P., Trautwein, C., Plat, J., Lütjohann, D., Sauerbruch, J. (2015): Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. Sci Rep, Aug 11;5, 12931, [5.580]
• Schneider, K. M. , Bieghs V., Heymann F., Hu W., Dreymueller D., Liao L., Frissen M., Ludwig A., Gassler N., Pabst O., Latz E., Sellge G., Penders J., Tacke F., Trautwein C. (2015): CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis.. Hepatology, 62 (5), 1405-1416, [11.711]
• Scholten, D. , Trebicka, J., Liedtke, C., Weiskirchen, R. (2015): The carbon tetrachloride model in mice.. Laboratory Animals, 49(1), 4-11, [1.553]
• Schulte, K. , Kunter, U., Moeller, M.J. (2015): The evolution of blood pressure and the rise of mankind.. Nephrology Dialysis Transplantation, 30 (5), 713-723, [4.575]
• Shirvani-Dastgerdi, E. , Amini-Bavil-Olyaee, S., Alavin, S.M., Trautwein, C., Tacke, F. (2015): Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression.. Clinical Microbiology and Infection, 21 (5), 510e11-510.e23, [4.575]
• Shirvani-Dastgerdi, E. , Tacke, F. (2015): Molecular interactions between hepatitis B virus and delta virus.. World Journal of Virology, 4 (2), 36-41,
• Strnad, P. , Guldiken N., Helenius T.O., Misiorek J.O., Nyström J.H., Lähdeniemi I.A., Silvander J.S., Kuscuoglu D., Toivola D.M. (2015): Simple Epithelial Keratins. Methods Enzymol, [2.090]
• Sunami, Y. , Von Figura, G., Kleger, A., Strnad, P., Hüser, N., Hartmann, D. (2015): The Role of Telomeres in Liver Disease. Prog Mol Biol Transl Sci, 125, 159-172,
• Szabo, S. , Wögenstein, K. L., Österreicher, C. H., Guldiken, N., Chen, Y., Doler, C., Wiche, G., Haybaeck, J., Strnad, P., Fuchs, P. (2015): Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization.. J Hepatol, 62, 1357-1366, [11.340]
• Tacke, F. (2015): Mechanisms of liver fibrosis resolution.. J Hepatol, [11.340]
• Tag, C. G , Sauer-Lehnen, S., Weiskirchen, S., Borkham-Kamphorst, E., Tolba, R. H., Tacke, F., Weiskirchen, R. (2015): Bile duct ligation in mice: Induction of inflammatory liver injury and fibrosis by obstructive cholestasis.. Journal of Visualized Experiments, 96, e52438, [1.240]
• Tag, C. G. , Weiskirchen, S. K., Hittatiya, K., Tacke, F., Tolba, R. H., Weiskirchen, R. (2015): Induction of experimental obstructive cholestasis in mice.. Laboratory Animals, 49(1), 70-80, [1.553]
• Thiele, M. , Detlefsen S., Sevelsted Moeller L., Madsen B.S., Fuglsang Hansen J., Fialla A.D., Trebicka J., Krag A. (2015): Transient and 2-dimensional Shear-Wave Elastography provide comparable assessment of Alcoholic Liver Fibrosis and Cirrhosis.. Gastroenterology, 150 (1), 123-133, [18.187]
• Toivola, D. M. , Boor, P., Alam, C., Strnad, P. (2015): Keratins in health and disease.. Current Opinion in Cell Biology, 32, 73-81, [8.851]
• Tolba, R. H. , Riediger, B. M., Weiskirchen, R. (2015): Standard Operating Procedures in experimental liver research: time to achieve uniformity. Lab Animals, 49(S1), 21-29, [1.553]
• Tolba, R. H. , Kraus, T., Liedtke, C., Schwarz, M., Weiskirchen, R. (2015): Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice.. Laboratory Animals, 49(1), 59-69, [1.553]
• Trebicka, J. , Schierwagen, R. (2015): new mechanistic insight into liver fibrosis and portal hypertension. Gut, Sep;64(9), 1349-50, [14.921]
• Trebicka, J. , Wix, C., von Heydebrand, M., Hittatiya, K., Reiberger, T., Klein, S., Schierwagen, R., Kristiansen, G., Peck-Radosavljevic, M., Fischer, H. P., Møller , S., Bendtsen, F., Krag, A., Sauerbruch, T. (2015): Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.. Liver International, 35(4), 1993-1402, [4.470]
• Uerlings, R. , Weiskirchen, R. (2015): Laser ablation inductively coupled plasma mass spectrometry in biomedicine and clinical diagnosis.. Cellular & Molecular Medicine, open access 1, 1:-1, [5.193]
• Usachov, V. , Urban, T. J., Fontana, R. J., Gross, A., Iyer, S., Omary, M. B., Strnad, P. (2015): Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury.. BMC Medicine, 13, 196, [2.726]
• Uschner F.E. , Ranabhat G, Choi SS, Granzow M, Klein S, Schierwagen R, Raskopf E, Gautsch S, van der Ven PF, Fürst DO, Strassburg CP, Sauerbruch T, Diehl AM, Trebicka J. (2015): Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension. Scientific Reports, 5, 14573, [5.228]
• Uschner, F. E. (2015): Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.. Sci Rep, [5.580]
• van Helden, J. , Weiskirchen, R. (2015): Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1α, 25-Dihydroxy-Vitamin D. Clin Chem Lab Med, 53, 761-770, [3.017]
• Verbeke, L. , Farre, R., Verbinnen, B., Covens, K., Vanuytsel, T., Verhaegen, J., Komuta, M., Roskams, T., Chatterjee, S., Annaert, P., Vander Elst, I., Windmolders, P., Trebicka, J., Nevens, F., Laleman, (2015): The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.. American Journal of Pathology, 185(2), 409-419, [4.206]
• Verdier, J. (2015): Biliary Mucosal Barrier and Microbiome.. Viszeralmedizin, 31, 156-161,
• Wallace, M. C., , Hamesch, K., Lunova, M., Kim, Y., Weiskirchen, R., Strnad, P., Friedman, S. L. (2015): Standard Operating Procedures in experimental liver research: Thioacetamide model in mice. Laboratory Animals, 49(1), 59-69, [1.120]
• Wehr, A. (2015): The Roles of CXCL16 and CXCR6 in Liver Inflammation and Fibrosis. Curr Pathobiol Rep, 3 (4), 283-290,
• Weiskirchen, R (2015): Supplement to “Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver.”. World Biomed Front, (Section Diabetes and Obesity),
• Weiskirchen, R. , Tacke, F. (2015): Small heterodimer partner (SHP) links hepatitis C and liver fibrosis: a small protein on the big stage. Liver Int, 35, 2218-2221, [4.470]
• Weiskirchen, R. (2015): Potential diagnostic applications of trace metal Imaging in hepatic metal overload and deficiency diseases.. Mass Spectrom. Rev., 35 (6), 666-686, [9.436]
• Weiskirchen, R. (2015): CCN1, a molecular switch that imposes a self-limiting control on inflammation and wound healing in a multitude of organs?. Am J Physiol Lung Cell Mol Physiol, 309, L747-L748, [4.721]
• Weiskirchen, R. , Mahli, A., Weiskirchen, S., Hellerbrand, C. (2015): The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels.. Front Physiol, 6, 140, [4.031]
• Wertenbruch, S. , Drescher, H., Grossarth, V., Kroy, D., Giebeler, A., Erschfeld, S., Heinrichs, D., Soehnlein, O., Trautwein, C., Brandenburg, L.O., Streetz, K. (2015): The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients with Liver Diseases and Acts as a Protective Factor during Mouse Liver Injury.. Digestion, 91, 309-317, [1.884]
• Wolter, F. , Glassner, A., Kramer, B., Korkordelis, P., Finneman, C., Kacmarek, D., Goeser, F., Lutz, P., Nischalke, H. D., Strassburg, C. P., Spengler, U., Nattermann. (2015): Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.. Journal of Hepatology, 63 (6), 1334-41, [10.590]
• Zimmermann, H. W. , Tacke, F. (2015): In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications?. Expert Review Gastroenterology & Hepatology, 9 (9), 1139-1141, [2.796]

2014

• Abdullah, Z , Knolle, P.A. (2014): Scaling of immune responses against intracellular bacterial infection.. The EMBO Journal, 33 (20), 2283-94, [9.643]
• Abnaof, K. , Mallela, N., Vinoid, N., Walenda, G., Meurer, S. K., Seré, K., Lin, Q., Smeets, B., Hoffmann, K., Wagner, W., Zenke, M., Weiskirchen, R., Fröhlich, H. (2014): TGF-beta stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level. BMC Systems Biol, 8, 55, [2.208]
• Alidousty, C. , Rauen, T., Hanssen, L., Wang, Q., Alampour-Rajabi, S., Mertens, P.R., Bernhagen, J., Floege, J., Ostendorf, T., Raffetseder, U. (2014): Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiation.. Journal of Biological Chemistry, [4.258]
• Asimakopoulou, A. , Borkham-Kamphorst, E., Henning, M., Yagmur, E., Gassler, N., Berger, T., Mak, T. W., Weiskirchen, R. (2014): Lipocalin 2 (LCN2) regulates OXPAT expression and intracellular lipid droplet formation in the liver.. BBA Mol Cell Biol Lipids, 1841 (10), 1513-1524, [4.779]
• Asimakopoulou, A. (2014): Lipocalin-2 (lcn2) regulates plin5 expression and intracellular lipid droplet formation in the liver.. BBA Mol Cell Biol, [5.160]
• Assis, D. N. , Leng, L., Du, X., Zhang, C. K., Grieb, G., Merk, M., Garcia, A. B., McCrann, C., Chapiro, J., Meinhardt, A., Mizue, Y., Nikolic-Paterson, D. J., Bernhagen, J., Kaplan, M. M., Zhao, H., Boyer, J. L., Bucala, R. (2014): The role of macrophage migration inhibitory factor in autoimmune liver disease.. Hepatology, 59(2), 580-591, [11.711]
• Baeck, C. , Wie, X., Bartneck, M., Fech, V., Heymann, F., Gassler, N., Hittatiya, K., Eulberg, D., Luedde, T., Trautwein, C., Tacke, F. (2014): Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice.. Hepatology, 59(3), 1060-1072, [11.711]
• Bartneck, M. , Peters, F. M., Warzecha, K. T., Bienert, M., van Bloois, L., Trautwein, C., Lammers, T., Tacke, F. (2014): Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages.. Nanomedicine, 10(6), 1209-1220, [5.671]
• Bartneck, M. , Warzecha, K.T., Tacke, F. (2014): Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.. Hepatobiliary Surgery and Nutrition, 3(6), 364-376, [3.050]
• Berger, K. , Bangen, J. M., Hammerich, L., Liedtke, C., Floege, J., Smeets, B., Moeller, M. J. (2014): Origin of regenerating tubular cells after acute kidney injury.. Proc Natl Acad Sci U S A, 111(4), 1533-1538, [9.423]
• Berger, K. , Schulte, K., Boor, P., Kuppe, C., van Kuppevelt, T. H., Floege, J., Smeets, B., Moeller, M. J. (2014): The Regenerative Potential of Parietal Epithelial Cells in Adult Mice.. J Am Soc Nephrol., 25(4), 693-705, [8.491]
• Berger, K. , Moeller, M. J. (2014): Podocytopenia, parietal epithelial cells and glomerulosclerosis.. Nephrol Dial Transplant, 29(5), 948-950, [4.085]
• Berger, K. , Moeller, M. J. (2014): Mechanisms of epithelial repair and regeneration after acute kidney injury.. Semin Nephrol, 34 (4), 394-403, [3.773]
• Berres, M. L. (2014): Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?. British Journal of Haematology, 169 (1), 3-13, [5.812]
• Boaru, S. G. , Merle, U., Uerlings, R., Zimmermann, A., Weiskirchen, S., Stremmel, W., Weiskirchen, R. (2014): Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson's disease by laser ablation inductively coupled plasma mass spectrometry.. BMC Neuroscience, , 15-98., [2.304]
• Boor, P. , Ostendorf, T., Floege, J. (2014): PDGF and the progression of renal disease. Nephrology Dialysis Transplantation, 29, 45-54, [4.085]
• Borkham-Kamphorst E. , Schaffrath, C., van de Leur, E., Haas, U., Tihaa, L., Meurer, S. K., Nevzorova, Y. A., Liedtke, C., Weiskirchen, R. (2014): The anti-fibrotic effects of ccn1/cyr61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated tgf-beta signaling.. Biochim Biophys Acta, 1843(5), 902-914, [5.128]
• Böttcher J.P. , Schanz, O., Garbers, C., Zaremba, A., Hegenbarth, S., Kurts, C., Beyer, M., Schultze, J.L., Kastenmüller, W., Rose-John, S., Knolle, P.A. (2014): IL-6 trans-signaling dependent rapid development of cytotoxic CD8+ T cell function.. Cell Reports, 8 (5), 1318-1327, [7.870]
• Buendgens, L. , Bruensing, J., Matthes, M., Dückers, H., Luedde, T., Trautwein, C., Tacke, F., Koch, A. (2014): Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. Journal of Critical Care, 29(4), 696, [2.445]
• Bultmann, C. A. , Weiskirchen, R. (2014): MAKERGAUL: An innovative MAK-based model and software for real-time PCR quantification.. Clin Biochem, 47(1-2), 117-122, [2.382]
• Ehling, J. , Bartneck, M., Wie, X., Gremse, F., Fech, V., Möckel, D., Baeck, C., Hittatiya, K., Eulberg, D., Luedde, T., Kiessling, F., Trautwein, C., Lammers, T., Tacke, F. (2014): CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.. Gut, 63(12), 1960-71, [14.921]
• Eisenhardt, M. , Glässner, A., Wolter, F., Krämer, B., Kokordelis, P., Nischalke, H.D., Boesecke, C., Rockstroh, J.K., Spengler, U., Nattermann, J. (2014): CD27(+)CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients.. AIDS, 28 (13), 1879-84, [4.407]
• Endlich N. , Simon O, Göpferich A, Wegner H, Moeller MJ, Rumpel E, Kotb AM, Endlich K. (2014): Two-photon microscopy reveals stationary podocytes in living zebrafish larvae. Journal of the American Society of Nephrology, 25(4), 681-6, [8.491]
• Gautheron, J. , Vucur, M., Reisinger, F., Cardenas. D.V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A.T., Bartneck, M., Neumann, U.P., Canbay, A., Reeves, H.L., Luedde, M., Tacke, F., Trautwein, C., Heikenwalder, M., Luedde, T. (2014): A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis.. EMBO Molecular Medicine, 6 (8), 1062-74, [9.547]
• Genovese, F. , Manresa, A. A., Leeming, D. J., Karsdal, M. A., Boor, P. (2014): The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?. Fibrogenesis &Tissue Repair, 7(1), 4, [2.329]
• Granzow, M. , Schierwagen, R., Klein, S., Kowallick, B., Huss, S., Linhart, M., Mazar, I. G., Görtzen, J., Vogt, A., Schildberg, F. A., Gonzalez-Carmona, M. A., Wojtalla, A., Krämer, B., Nattermann, J., Siegmund, S. V., Werner, N., Fürst, D. O., Laleman, W., Knolle, P., Shah, V. H., Sauerbruch, T., Trebicka, J. (2014): Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis. Hepatology, 60(1), 334-348, [11.711]
• Hammerich, L. , Bangen, J. M., Govaere, O., Zimmermann, H. W., Gassler, N., Huss, S., Liedtke, C., Prinz, I., Lira, S. A., Luedde, T., Roskams, T., Trautwein, C., Heymann, F., Tacke, F. (2014): Chemokine receptor ccr6-dependent accumulation of gammadelta t cells in injured liver restricts hepatic inflammation and fibrosis.. Hepatology, 59(2), 630-642, [11.711]
• Hammerich, L. , Tacke, F. (2014): Interleukins in chronic liver disease: lessons learned from experimental mouse models.. Clinical and Experimental Gastroenterology, 7, 297-306, [4.010]
• Hammerich, L. , Tacke, F. (2014): Role of gamma-delta T cells in liver inflammation and fibrosis.. World Journal of Gastrointestinal Pathophysiology, 5 (2), 107-113, [3.700]
• Jalan, R. , Saliba, F., Pavesi, M., Amoros, A., Moreau, R., Ginès, P., Levesque, E., Durand, F., Angeli, P., Caraceni, P., Hopf, C., Alessandria, C., Rodriguez, E., Solis-Muñoz, P., Laleman, W., Trebicka, J., Zeuzen, S., Gustot, T., Mookerjee, R., Elkrief, L., Soriano, G., Cordoba, J., Morando, F., Gerbes, A., Agarwal, B., Samuel, D., Bernardi, M., Arroyo, V., CANONIC Study Iinvestigators, EASL-CLIF Consortium. (2014): Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.. Journal of Hepatology, 61(5), 1038-1047, [10.950]
• Jansen, C. , Leeming, D. J., Mandorfer, M., Byrjalsen, I., Schierwagen, R., Schwabl, P., Karsdal, M. A., Anadol, E., Strassburg, C. P., Rockstroh, J., Peck-Radosavljevic, M., Møller , S., Bendtsen, F., Krag, A., Reiberger, T., Trebicka, J. (2014): PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.. PLoS One, 9(9), e108544, [3.057]
• Jansen, C. , Eischeid, H., Goertzen, J., Schierwagen, R., Anadol, E., Strassburg, C.P., Sauerbruch, T., Odenthal, M., Trebicka, J. (2014): The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.. PLos One, 9(7), e103779, [3.057]
• Kaldenbach, M. , Cubero, F.J., Erschfeld, S., Liedtke, C., Trautwein, C., Streetz, K. (2014): Hepatic tissue environment in nemo-deficient mice critically regulates positive selection of donor cells after hepatocyte transplantation.. PLoS One, 9 (6), e100786, [3.057]
• Kim, S. , Becker, J., Bechheim, M., Kaiser, V., Noursadeghi, M., Fricker, N., Beier, E., Klaschik, S., Boor, P., Hess, T., Hofmann, A., Holdenrieder, S., Wendland, J., Fröhlich, H., Hartmann, G., Nöthen, M., Müller-Myhsok, B., Pütz, B., Hornung, V., Schumacher, J. (2014): Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes. Nature Communications, 5, 5236, [11.329]
• Klinkhammer, B. M. , Kramann R., Mallau M., Makowska A., van Roeyen C.R., Rong S., Buecher E.B.. Boor P., Kovacova K., Zok S., Denecke B., Stuettgen E., Otten S., Floege J., Kunter U. (2014): Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS One, 9 (3), e92-115, [3.057]
• Koch, A. , Zimmermann, H. W., Gassler, N., Jochum, C., Weiskirchen, R., Bruensing, J., Buendgens, L., Dückers, H., Bruns, T., Gerken, G., Neumann, U. P., Adams, D. H., Trautwein, C., Canbay, A., Tacke, F. (2014): Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.. Liver International, 34(9), 13301339, [4.470]
• Kokordelis, P. , Kramer, B., Korner, C., Boesecke, C., Voigt, E., Ingiliz, P., Glassner, A., Eisenhardt, M., Wolter, F., Kaczmarek, D., Nischalke, H. D., Rockstroh, J. K., Spengler, U., Nattermann, J. (2014): An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients. Hepatology, 59 (3), 814-827, [11.711]
• Kraemer, S. , Alampour-Rajabi, S., El Bounkari, O., Bernhagen, J. (2014): Hetero-oligomerization of chemokine receptors: diversity and relevance for function. Current Medicinal Chemistry, 20, 2524-2536, [3.455]
• Krause, T. A. , Alex, A.F., Engel, D.R., Kurts, C., Eter, N. (2014): VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization. PLos One, 9 (4), [3.057]
• Krenkel, O. , Mossanen, J.C., Tacke, F. (2014): Immune mechanisms in acetaminophen-induced acute liver failure.. Hepatobiliary Surgery and Nutrition, 3 (6), 331-43, [3.050]
• Kroy, D. C. (2014): Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic–steatohepatitis in mice.. Journal of Hepatology, 61 (4), 883-90, [10.590]
• Kucukoglu, O. , Guldiken, N., Chen, Y., Usachov, V., Elheliebi, A., Haybaeck, J., Denk, H. W., Trautwein, C., Strnad, P. (2014): High-fat diet triggers Mallory-Denk body formation via misfolding and crosslinking of excess keratin 8.. Hepatology, 60 (1), 169-178, [11.711]
• Leeming, D. J. , Anadol, E., Schierwagen, R., Karsdal, M. A., Byrjalsen, I., Nielsen, M. J., Schwarzer-Zander, C., Boesecke, C., Bendtsen, F., Møller , S., Strassburg, C. P., Spengler, U., Krag, A., Rockstroh, J., Trebicka, J. K. (2014): Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.. AIDS, 28(14), 2081-2090, [4.407]
• Li, T. , Eheim, A. L., Klein, S., Uschner, F. E., Smith, A. C., Brandon-Warner, E., Ghosh, S., Bonkovsky, H. L., Trebicka, J., Schrum, L. W. (2014): Novel role of nuclear receptor Rev-erbα in hepatic stellate cell activation: potential therapeutic target for liver injury.. Hepatology, 59(6), 2383-2396, [11.711]
• Luedde, T. (2014): Cell death and cell death responses in liver disease: mechanisms and clinical relevance.. Gastroenterology, 147 (4), 765-783, [18.187]
• Lunova, M. , Goehring, C., Mueller, K., Chen, Y., Walther, P., Vaulont, S., Haybaeck, J., Lackner, C., Trautwein, C., Strnad, P. (2014): Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload.. Journal of Hepatology, 61 (3), 633-641, [10.590]
• Marra, F. , Tacke, F. (2014): Roles for Chemokines in Liver Disease.. Gastroenterology, 147 (3), 577-594, [18.187]
• Martinez-Palacian, A. , Martinez-Palacian, A., Kanse, S. M., Weiskirchen, R. (2014): Factor VII activating protease (FSAP): A novel protective factor in liver fibrosis. Proteomics Clinical Applications, 8(5-6), 438-446, [2.959]
• Meurer, S. K. , Alsamman, M., Scholten, D., Weiskirchen, R. (2014): Endoglin in liver fibrogenesis – Bridging basic science and clinical practice.. World J. Biol Chem, 5(2), 180-203,
• Moeller, M. J. , Tanner, G. A. (2014): Reply: podocytes are key-although albumin never reaches the slit diaphragm.. Nature Reviews Nephrology, 10(3), 180, [9.453]
• Moeller, M. J. , Smeets, B. (2014): Role of Parietal Epithelial Cells in Kidney Injury: The Case of Rapidly Progressing Glomerulonephritis and Focal and Segmental Glomerulosclerosis. Nephron Experimental Nephrology, 126 (2), 97, [1.531]
• Moeller, M.J , Kuppe C. (2014): Glomerular disease: the role of parietal epithelial cells in hyperplastic lesions. Nature Reviews Nephrology, 10(11), 615-6, [9.463]
• Nagayama, Y. (2014): Gp130-dependent signaling in the podocyte.. American Journal of Physiology Renal Physiology, 307 (3), F346-F355, [3.390]
• Nischalke, H.D. , Lutz P, Krämer B, Söhne J, Müller T, Rosendahl J, Fischer J, Berg T, Hittatiya K, Fischer HP, Soyka M, Semmo N, Nattermann J, Sauerbruch T, Strassburg CP, Stickel F, Spengler U. (2014): A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.. Journal of Hepatology, 61 (5), 1073-1079, [10.590]
• Ostendorf, T. , Boor, P., van Roeyen, C. R. C., Floege, J. (2014): Platelet Derived Growth Factors (PDGFs) in Glomerular and Tubulointerstitial Fibrosis.. Kidney International Supplements, 4, 65-69, [7.026]
• Roderburg, C. (2014): Circulating microRNAs as markers of liver inflammation, fibrosis and cancer.. Journal of Hepatology, 61 (6), 1434-1437, [10.590]
• Saritas, T. (2014): Pre-eclampsia, podocyturia and the role of parietal epithelial cells. Nat Rev Nephrol, [8.540]
• Schiwon M. , Weisheit, C., Franken, L., Gutweiler, S., Dixit, A., Meyer-Schwesinger, C., Pohl, J. M., Maurice, N. J., Thiebes, S., Lorenz, K., Quast, T., Fuhrmann, M., Baumgarten, G., Lohse, M. J., Opdenakker, G., Bernhagen, J., Bucala, R., Panzer, U., Kolanus, W., Gröne, H. J., Garbi, N., Kastenmüller, W., Knolle, PA., Kurts, C., Engel, D. R. (2014): Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium.. Cell, 156(3), 456-468, [28.710]
• Schölzel K (2014): Transfer of MHC-class-I molecules among liver sinusoidal cells facilitates hepatic immune surveillance.. Journal of Hepatology, 61 (3), 600-608, [10.590]
• Schon, H. T , Weiskirchen, R. (2014): Immunmodulatory effects of transforming growth factor-β in the liver.. Hepatobiliary Surgery and Nutrition, 3, 386-406, [3.050]
• Schulte, K. , Berger, K., Boor, P., Jirak, P., Gelman, I. H., Arkull, K. P., Neal, C. R., Kriz, W., Floege, J., Smeets, B., Moeller, M. J. (2014): Origin of Parietal Podocytes in Atubular Glomeruli Mapped by Lineage Tracing. Journal of the American Society of Nephrology, 25(1), 129-141, [8.491]
• Schwabl, P. , Payer, B. A., Grahovac, J., Klein, S., Horvatits, T., Mitterhauser, M., Stift, J., Boucher, Y., Trebicka, J., Trauner, M., Angermayr, B., Fuhrmann, V., Reiberger, T., Peck-Radosavljevic, M. (2014): Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.. Journal of Hepatology, 60(6), 1135-1142, [10.590]
• Šebekova, K. , Dušinska, M., Simon Klenovics, K., Kollarova, R., Kebis, A., Staruchova, M., Vlkova, B., Boor, P., Celec, P., Hodosy, J., Beňo, M., Tulinska, J., Pribojova, J., Bilaničova, D., Pojana, G., Marcomini, A., Volkovova, K. (2014): Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultrasmall superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats. Nanotoxicology, 8(2), 142-157, [7.913]
• Shankland, S.J. , Smeets, B., Pippin, J. W., Moeller, M. J. (2014): The emergence of the glomerular parietal epithelial cell.. Nat Rev Nephrol, 10(3), 158-173, [9.463]
• Smeets, B. , Stucker, F., Wetzels, J., Brocherigou, I., Ronco, P., Gröne, H. J., D'Agati, V., Fogo, A., van Kuppevelt, T. H., Fischer, H. P., Boor, P., Floege, J., Ostendorf, T., Moeller, M. J. (2014): Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. The American Journal of Pathology, 184, 3240-3248, [4.206]
• Strnad, P. , Nuraldeen, R., Guldiken, N., Hartmann, D., Mahajan, V., Denk, H., Haybaeck, J. (2014): Broad Spectrum of Hepatocyte Inclusions in Humans, Animals, and Experimental Models. Comprehensive Physiology, 3 (4), 1393-1436, [6.364]
• Strnad, P. , Nuraldeen, R., Fischer, J., Berg, T., Trautwein, C. (2014): Hepcidin as a predictor of treatment response in chronic hepatitis C infection.. Hepatology, 59 (4), 1648, [11.711]
• Tacke, F. , Weiskirchen, R. (2014): Liver immunology: new perspectives. Hepatobiliary Surg Nutr, 3 (6), 330, [3.050]
• Tacke, F. , Zimmermann, H. W. (2014): Macrophage heterogeneity in liver injury and fibrosis.. Journal of Hepatology, 60(5), 1090-1096, [10.590]
• Tacke, F. , Roderburg, C., Benz, F., Cardenas, D. V., Luedde, M., Hippe, H. J., Frey, N., Vucur, M., Gautheron, J., Koch, A., Trautwein, C., Luedde, T. (2014): Levels of Circulating miR-133a Are Elevated in Sepsis and Predict Mortality in Critically Ill Patients.. Critocal Care Medicine, 42(5), 1096-1104, [7.422]
• Tacke, F. , Galm, O., Kanig, N., Yagmur, E., Brandt, S., Lindquist, J. A., Eberhardt, C. S., Raffetseder, U., Mertens, P. R. (2014): High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.. BMC Cancer, 14, 33, [3.265]
• van Helden , J. , Weiskirchen, R (2014): Hepatitis C diagnostics: clinical evaluation of the HCV-core antigen determination (Hepatitis C Diagnostik: Klinische Evaluierung der HCV-core Antigen Bestimmung). Zeitschrift für Gastroenterologie, 52(10), 1164-1170, [1.357]
• Verbeke, L. , Farre, R., Trebicka, J., Komuta, M., Roskans, T., Klein, S., Elst, I. V., Windmolders, P., Vanuytsel, T., Nevens, F., Laleman, W. (2014): Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats.. Hepatology, 59(6), 2286-2298, [11.711]
• Wanner, N. , Hartleben, B., Herbach, N., Goedel, M., Stickel, N., Zeiser, R., Walz, G., Moeller, M. J., Grahammer, F., Huber, T. B. (2014): Unraveling the role of podocyte turnover in glomerular aging and injury.. Journal of American Society of Nephrology, 25(4), 707-716, [8.491]
• Wehr, A. (2014): Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury.. PLoS One, 9 (11), [3.050]
• Weisheit C (2014): Dendritic Cells and Macrophages: Sentinels in the Kidney. Clinical Jpurnal of the American Society of Nephrology, 10 (10), 1841-1851, [4.657]
• Weiskirchen, R. , Tacke, F. (2014): Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.. Hepatobiliary Surgery and Nutrition, 3 (6), 344-363, [3.050]
• Winkler, S. , Borkham-Kamphorst, E., Stock, P., Brückner, S., Weiskirchen, R., Christ, B. (2014): Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model.. Experimental Cell Research, 326 (2), 230-239, [3.930]
• Wögenstein, K. L. , Szabo, S., Lunova, M., Wiche, G., Haybaeck, J., Strnad, P., Boor, P., Wagner, M., Fuchs, P. (2014): Epiplakin-deficiecy aggravates caerulein-induced murine pancreatitis by impaired acinar keratin filament reorganization. PLoS One, 18 (9), e108323, [3.057]
• Wolf, M.J. , Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohleber, D., Lorentzen, A., Einer, C., Schulz., Clavel, T., Protzer, U., Thiele, C., Zischka, H., Moch, H., Tschöp, M., Tumanov, A.V., Haller, D., Unger, K., Karin, M., Kopf, M., Knolle, P., Weber, A., Heikenwalder, M. (2014): Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes.. Cancer Cell, 26 (4), 549-564, [23.214]
• Zhao, G. , Hatting, M., Nevzorova, Y.A., Peng, J., Hu, W., Boekschoten, M.V., Roskams, T., Muller, M., Gassler, N., Lidtke, C., Davis, R.J., Cubero, F.J., Trautwein, C. (2014): Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis.. GUT, 63 (7), 1159-1172, [14.921]

2013

• Bábíčková, J. , Tóthová Ľ, Boor P, Celec P. (2013): In vivo phage display – A discovery tool in molecular biomedicine.. Biotechnology Advances, 31 (8), 1247-1259, [11.800]
• Benz, F. , Roderburg, C., Cardenas, D.V., Vucur, M., Gautheron, J., Koch, A., Zimmermann, H., Janssen, J., Nieuwenhuijsen, L., Luedde, M., Frey, N., Tacke, F., Trautwein, C., Luedde, T. (2013): U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.. Experimental & Molecular Medicine, 45 (9), [5.164]
• Borkham-Kamphorst, E. , Zimmermann, H. W., Gassler, N., Bissels, U., Bosio, A., Tacke, F., Weiskirchen, R., Kanse, S. M. (2013): Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.. Journal of Hepatology, 58 (1), 104-111, [10.590]
• Borkham-Kamphorst, E. , van de Leur, E., Zimmermann, H.W., Karlmark, K.R., Tihaa, L., Haas, U., Tacke, F., Berger, T., Mak, T.W., Weiskirchen, R., (2013): Protective effects of Lipocalin-2 (LCN2) in acute and chronic liver injury suggesting a novel function in liver homeostasis.. BBA Molecular Basis of Disease, 1832 (5), 660-73, [5.128]
• Borkham-Kamphorst, E. , van de Leur, E., Zimmermann, H. W., Karlmark, K. R., Tihaa, L., Haas, U., Tacke, F., Berger, T., Mak, T. W., Weiskirchen, R. (2013): Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.. Biochim Biophys Acta, 1832, 660-673, [4.880]
• Bossaller, L. , Rathinam, V. A., Bonegio, R., Chiang, P. I., Busto, P., Wespiser, A. R., Caffrey, D. R., Li, Q. Z., Mohan, C., Fitzgerald, K. A., Latz, E., Marshak-Rothstein, A. (2013): Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.. The Journal of Immunology, 191 (5), 2104-2114, [4.179]
• Böttcher JP , Schanz, O., Wohlheber, D., Abdullah, Z., Debey-Pascher, S., Staratschek-Jox, A., Höchst, B., Hegenbarth, S., Grell, J., Limmer, A., Atreya, I., Neurath, M.F., Busch, D.H., Schmitt, E., van Endert, P., Kolanus, W., Kurts, C., Schultze, J.L., Diehl, L., Knolle, P.A., (2013): Liver-Primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity. Cell Reports, 3 (3), 779-795, [7.870]
• Chaudhary, K. (2013): Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.. Journal of Hepatology, 59 (6), 1292-1298, [10.590]
• Cubero, F. J. , Singh, A., Borkham-Kamphorst, E., Nevzorova, Y. A., Al Masaoudi, M., Haas, U., Boekschoten, M. V., Gassler, N., Weiskirchen, R., Muller, M., Liedtke, C., Trautwein, C. (2013): Tnfr1 determines progression of chronic liver injury in the ikkgamma/nemo genetic model.. Cell Death & Differentiation, 20 (11), 1580-1592, [8.218]
• Ehling, J. , Bartnack, M., Fech, V., Butzbach, P., Cesati, R., Botnas, R., Lammers,T., Tacke, F. (2013): Elastin-based molecular MRI of liver fibrosis.. Hepatology, 58 (4), 1517-1518, [11.711]
• Glässner, A. , Eisenhardt, M., Kokordelis, P., Kramer, B., Wolter, F., Nischalke, H. D., Boesecke, C., Sauerbruch, T., Rockstroh, J. K., Spengler, U., Nattermann, J. (2013): Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients. Journal of Hepatology, 59 (3), 427-433, [10.590]
• Gottschalk, C. , Damuzzo, V., Gotot, J., Kroczek, R.A., Yagita, H., Murphy, K.M., Knolle, P.A., Ludwig-Portugall, I., Kurts, C. (2013): Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens.. Journal of the American Society of Nephrology, 24 (4), 543-549, [8.491]
• Grace, J. A. , Klein, S., Herath, C. B., Granzow, M., Schierwagen, R., Masing, N., Walther, T., Sauerbruch, T., Burrell, L. M., Angus, P. W., Trebicka, J. (2013): Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.. Gastroenterology, 145 (4), 874-884, [18.187]
• Hanssen, L. , Alidoutsy, C., Djudjaj, S., Frye, B.C., Rauen, T., Boor, Pr., Mertens, P.R., van Roeyen, C.R., Tacke, F., Heymann, F., Tittel, A.P., Koch, A., Floege, J., Ostendorf, T., Raffetseder, U. (2013): YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo.. The Journal of Immunology, 191(5), 2604-2613, [4.179]
• Hatting, M. , Zhao, G., Schumacher, F., Sellge, G., Al Masaoudi, M., Gabetaler, N., Boekschoten, M., Muller, M., Liedtke, C., Cubero, F. J., Trautwein, C. (2013): Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents.. Hepatology, 57 (69, 2189-2201, [11.711]
• Heinrichs, D , Berres, M.L., Nellen, A., Fischer, P., Scholten, D., Trautwein, C., Wasmuth, H.E., Sahin, H. (2013): The chemokine CCL3 promotes experimental liver fibrosis in mice.. PLoS One, 8(6), [3.057]
• Herbers, U. , Amini-Bavil-Olyaee, S., Mueller, A., Luedde, T., Trautwein, C., Tacke, F. (2013): Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains. Journal of Viral Hepatology, 20 (2), 141-148, [4.179]
• Hochheiser, K. , Heuser, C., Krause, T.A., Teteris, S., Ilias, A., Weisheit, C., Hoss, F., Tittel, A.P., Knolle, P.A., Panzer, U., Engel, D.R., Tharaux, P.-L., Kurts, C. (2013): Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression.. The Journal of Clinical Investigation, 123 (10), 4242-4254, [12.575]
• Huang L.R. , Wohlleber, D., Reisinger, F., Jenne, C.N., Cheng, R.L., Abdullah, Z., Schildberg, F.A., Odenthal, M., Dienes, H.P., van Roijen, N., Schmitt, E., Garbi, N., Croft, M., Kurts, C., Kubes, P., Protzer, U., Heikenwalder, M., Knolle, P.A. (2013): Intrahepatic myeloid cell-aggregates enable local CD8+ T cell expansion and successful immunotherapy against chronic viral liver infection.. Nature Immunology, 14 (6), 5742-583, [19.381]
• Huss, S. , Stellmacher, C., Goltz, D., Khlistunova, I., Adam, A. C., Trebicka, J., Kirfel, J., Buttner, R., Weiskirchen, R. (2013): Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice.. BMC Gastroenterology, 13, 8, [2.101]
• Kabgani N, , Moeller M.J. (2013): The terminator mouse: salvation for primary cell culture. Kidney International, 84(5), 866-8, [7.683]
• Kellner, P. , Anadol, E., Huneburg, R., Hundt, F., Bos, D., Klein, B., Woitas, R. P., Spengler, U., Sauerbruch, T., Trebicka, J. (2013): The effect of hemodialysis on liver stiffness measurement: a single-center series.. European Journal of Gastroenterol & Hepatology, 25 (3), 368-372, [2.093]
• Koch, A. , Buendgens, L., Dückers, H., Bruensing, J., Matthes, M., Kunze, J., Lutz, H. H., Luedde, T., Tischendorf, J. J. W., Trautwein, C., Tacke, F. (2013): Ursachen, patientenspezifische Risikofaktoren und prognostische Indikatoren bei akuter gastrointestinaler Blutung und intensivmedizinischer Therapieindikation. . Medizinische Klinik - Intensivmedizin und Notfallmedizin, 108, 214-222,
• Koch, A. , Weiskirchen, R., Kunze, J., Duckers, H., Bruensing, J., Buendgens, L., Matthes, M., Luedde, T., Trautwein, C., Tacke, F. (2013): Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.. Journal Critical Care, 28 (6), 947-953, [2.445]
• Koch, A. , Buendgens, L., Duckers, H., Bruensing, J., Matthes, M., Kunze, J., Herbers, U., Lutz, H. H., Luedde, T., Tischendorf, J. J., Trautwein, C., Tacke, F. (2013): Gastrointestinal bleeding in liver cirrhosis at the ICU. Zeitschrift für Gastroenterologie, 51 (1), 19-25, [1.357]
• Koch, A. , Buendgens, L., Dückers, H., Bruensing, J., Matthes, M., Kunze, J., Llutz, H.H., Luedde, T., Tischendorf, J.J., Trautwein, C., Tacke, F. (2013): Bleeding origin, patient-related risk factors, and prognostic indicators in patients with acute gastrointestinal hemorrhages requiring intensive care treatment : A retrospective analysis from 1999 to 2010. Medizinische Klinik Intensivmedizin und Notfallmedizin, 108 (3), 214-222, [0.564]
• Koch, A. , Weiskirchen, R., Bruensing, J., Duckers, H., Buendgens, L., Kunze, J., Matthes, M., Luedde, T., Trautwein, C., Tacke, F. (2013): Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.. Mediators of Inflammation, 2013, [3.418]
• Kurts, C. , Panzer, U., Anders, H.J., Rees, A.J. (2013): The immune system and kidney disease: basic concepts and clinical implications.. Nature Reviews Immunology, 13 (10), 738-753, [39.416]
• Labbus, K. , Henning, M., Borkham-Kamphorst, E., Geisler, C., Berger, T., Mak, T. W., Knuchel, R., Meyer, H. E., Weiskirchen, R., Henkel, C. (2013): Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions.. Journal of Proteomics, 78, 188-196, [3.867]
• Langhans, B. , Krämer, B., Louis, M., Nischalke, H.D., Hüneburg, R., Staratschek-Jox, A., Odenthal, M., Manekeller, S., Schepke, M., Kalff, J., Fischer, H.P., Schultze, J.L., Spengler, U. (2013): Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis C.. Journal of Hepatology, 59 (2), 229-235, [10.590]
• Leeming, D. J. , Karsdal, M. A., Byrjalsen, I., Bendtsen, F., Trebicka, J., Nielsen, M. J., Christiansen, C., Moller, S., Krag, A. (2013): Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.. Aliment Pharmacol Ther, 38, 1086-1096, [5.730]
• Liedtke, C. , Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, Tolba R, Trautwein C, Trebicka J, Weiskirchen R. (2013): Experimental liver fibrosis research: Update on animal models, legal issues and translational aspects.. Fibrogenesis & Tissue Repair, 6(1), 19, [2.329]
• M-M, P. , Merle, U., Weiskirchen, R., Becker, J. S. (2013): Bioimaging of copper deposition in Wilson’s diseases mouse liver by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MSI).. International Journal of Mass Spectrometry, 354-355, 281-287, [2.183]
• M-M, P. , Weiskirchen, R., Gassler, N., Bosserhoff, A. K., Becker, J. S. (2013): Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders.. PLoS One, 8 (3), [3.057]
• Martin, I. V. , Borkham-Kamphorst E, Zok S, van Roeyen CRC, Eriksson U, Boor P, Hiththetiya K, Fischer HP, Wasmuth HE, Weiskirchen R, Eitner F, Floege J, Ostendorf T. (2013): Platelet-Derived Growth Factor (PDGF)-C Neutralization Reveals Differential Roles of PDGF Receptors in Liver and Kidney Fibrosis. The American Journal of Pathology, 182 (1), 107-117, [4.206]
• Meurer, S. K. , Alsamman, M., Sahin, H., Wasmuth, H. E., Kisseleva, T., Brenner, D. A., Trautwein, C., Weiskirchen, R., Scholten, D. (2013): Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell line.. PLoS One, 8 (2), [3.057]
• Moeller, M. J. (2013): Streaming potentials as novel driving force for capillary permeability. Biophysical Journal, 104 (7), 1395-1396, [3.632]
• Moeller, M. J. , Tenten, V. (2013): Renal albumin filtration: alternative models to the standard physical barriers.. Nature Reviews Nephrology, 9 (5), 266-277, [9.463]
• Moeller, M. J. (2013): Novel target in the treatment of RPGN: the activated parietal cell. Nephrology Dialysis Transplantation, 28 (3), 489-492, [4.085]
• Moreau, R. , Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., Gerbes, A., Wendon, J., Alessandria, C., Laleman, W., Zeuzem, S., Trebicka, J., Bernardi, M., Arroyo, V., Consortium, C. S. I. o. t. E.-C. (2013): Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.. Gastroenterology, 144 (7), 1426-1437, [18.187]
• Mossanen, J. C. , Tacke F. (2013): Role of lymphocytes in liver cancer.. Oncolmmunology, 2(11), [7.644]
• Mueller, K. , Sunami, Y., Stuetzle, M., Güldiken, N., Kucukoglu, O., Mueller, S., Kulaksiz, H. W., Schwarz, P., Strnad, P. (2013): CHOP-mediated hepcidin suppression modulates hepatic iron load. The Journal of Pathology, 231 (4), 532-542, [7.381]
• Nevzorova, Y. A. , Hu, W., Cubero, F. J., Haas, U., Freimuth, J., Tacke, F., Trautwein, C., Liedtke, C. (2013): Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.. Biochimica et Biophysica Acta, 1832(10), 1765-75, [5.158]
• Nischalke, H.D , Berger, C., Lutz, P., Langhans, B., Wolter., Eisenhardt, M., Krämer, B., Kokordelis, P., Glässner, A., Müller, T., Rosendahl, J., Berg, T., Grünhgae, F., Leifeld, L., Soyka, M., Nattermann, J. Sauerbruch, T., Stickel, F., Spengler, U. (2013): Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent. PLoS One, 8 (11), [3.057]
• Roderburg, C. , Luedde, M., Vargas Cardenas, D., Vucur, M., Mollnow, T., Zimmermann, H. W., Koch, A., Hellerbrand, C., Weiskirchen, R., Frey, N., Tacke, F., Trautwein, C., Luedde, T. (2013): miR-133a mediates TGF-ß-dependant derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. Journal of Hepatology, 58 (4), 736-742, [10.590]
• Roderburg, C. , Koch, A., Tacke, F., Nieuwenhuijsen, L., Bruensing, J., Vargas Cardenas, D., Kreggenwinkel, K., Vucur, M., Koppe, C., Jungebluth, P., Seikrit, C., Luedde, M., Trautwein, C., Luedde, T., (2013): Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients.. Journal Critical Care, 28 (5), [2.445]
• Roderburg, C. , Luedde, M., Vargas Cardenas, D., Vucur, M., Scholten, D., Frey, N., Koch, A., Trautwein, C., Tacke, F., Luedde, T. (2013): Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis.. PLoS One, 8 (1), [3.057]
• Sahin, H. , Borkham-Kamphorst, E., do, O. N., Berres, M. L., Kaldenbach, M., Schmitz, P., Weiskirchen, R., Liedtke, C., Streetz, K. L., Maedler, K., Trautwein, C., Wasmuth, H. E. (2013): Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes.. Hepatology, 57 (2), 797-805, [11.711]
• Schierwagen, R. , Leeming, D. J., Klein, S., Granzow, M., Nielsen, M. J., Sauerbruch, T., Krag, A., Karsdal, M. A., Trebicka, J. (2013): Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats.. Frontiers in Physiology, 4, 195, [4.031]
• Schulte, W. , Bernhagen, J., Bucala, R. (2013): Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.. Mediators of Inflammation, [3.418]
• Seijo, S. , Plessier, A., Hoekstra, J., Dell'era, A., Mandair, D., Rifai, K., Trebicka, J., Morard, I., Lasser, L., Abraldes, J. G., Darwish Murad, S., Heller, J., Hadengue, A., Primignani, M., Elias, E., Janssen, H. L., Valla, D. C., Garcia-Pagan, J. C., European Network for Vascular Disorders of the, L. (2013): Good long-term outcome of Budd-Chiari syndrome with a step-wise management.. Hepatology, 57 (59, 1962-1968, [11.711]
• Seikrit, C. , Henkel C, van Roeyen CRC, Bokemeyer D, Eitner F, Martin IV, Boor P, Ruth Knüchel, Meyer HE, Müller-Newen G, Eriksson U, Floege J, Ostendorf T. (2013): Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts. Nephrol Dial Transplant, Apr;28(4), 889-900, [4.085]
• Smeets, B. , Boor P, Dijkman H, Sharma SV, Jirak P, Khera S, Mooren F, Berger K, Bornemann J, Gelman IH, Floege J, van der Vlag J, Wetzels JFM, Moeller MJ. (2013): Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. The Journal of Pathology, 229 (5), 645-59, [7.381]
• Sobierajski, J. , Hendgen-Cotta, U. B., Luedike, P., Stock, P., Rammos, C., Meyer, C., Kraemer, S., Stoppe, C., Bernhagen, J., Kelm, M., Rassaf, T. (2013): Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels.. Free Radical Biology and Medicine, 63, 236-242, [5.784]
• Strnad, P. , Von Figura, G., Gruss, R., Jareis, K. M., Stiehl, A., Kulaksiz, H. (2013): Oblique Bile Duct Predisposes to the Recurrence of Bile Duct Stones. Plos One, 8(1), [3.057]
• Strüßmann, T. , Tillmann, S., Wirtz, T., Bucala, R., von Hundelshausen, P., Bernhagen, J. (2013): Platelets are a previously unrecognised source of MIF.. Thromb Haemost, 110(5), 1004-1013, [5.565]
• Tacke, F. (2013): From NAFLD to NASH to fibrosis to HCC: Role of dendritic cell (DC) populations in the liver.. Hepatology, 58 (2), 494-496, [11.711]
• Tenten, T. , Menzel S, Kunter U, Sicking EM, van Roeyen CVR, Sanden SK, Kaldenbach M, Boor P, Fuss A, Uhlig S, Lanzmich R, Dijkman H, Grepl M, Wild K, Kriz W, Smeets B, Floege J, Moeller MJ. (2013): Albumin is recycled from the primary urine by tubular transcytosis.. Journal of the American Society of Nephrology, 24 (12), 1966-1980, [8.491]
• Trebicka, J. , Anadol, E., Elfimova, N., Strack, I., Roggendorf, M., Viazov, S., Wedemeyer, I., Drebber, U., Rockstroh, J., Sauerbruch, T., Dienes, H. P., Odenthal, M. (2013): Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.. J Hepatol, 58, 234-239, [11.370]
• Trebicka, J. , Krag A, Gansweid S, Schiedermaier P, Strunk HM, Fimmers R, Strassburg CP, Bendtsen F, Møller S, Sauerbruch T, Spengler U. Soluble (2013): Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension.. PLoS One, 8(12), [3.057]
• van Roeyen, C. R. , Zok, S., Pruessmeyer, J., Boor, P., Nagayama, Y., Fleckenstein, S., Cohen, C. D., Eitner, F., Grone, H. J., Ostendorf, T., Ludwig, A., Floege, J. (2013): Growth arrest-specific protein 1 is a novel endogenous inhibitor of glomerular cell activation and proliferation. Kidney International, 83 (2), 251-263, [7.683]
• Villa, L. , Boor P, Konieczny A, Kunter U, van Roeyen CRC, Denecke B, Gan L, Neusser MA and Cohen CD for the ERCB-Consortium, Eitner F, Scholl T, Ostendorf T, Floege J (2013): Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms. The Journal of Pathology, 229 (5), 672-84, [7.430]
• Vucur, M. , Reisinger, F., Gautheron, J., Janssen, J., Roderburg, C., Cardenas, D.V., Kreggenwinkel, K., Koppe, C., Hammerich, L., hakem, R., Unger, K., Weber, A., Gassler, N., Luedde, M., Frey, N., Neumann, U.P., Tacke, F., Trautwein, C., Heikenwalder, M., Luedde, T., (2013): RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation.. Cell Reports, 4 (4), 776-790, [7.780]
• Wehr, A. , Baeck, C., Heymann, F., Niemietz, P. M., Hammerich, L., Martin, C., Zimmermann, H. W., Pack, O., Gassler, N., Hittatiya, K., Ludwig, A., Luedde, T., Trautwein, C., Tacke, F. (2013): Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis.. The Journal of Immunology, 190 (10), 5226-5236, [4.179]
• Weiskirchen, R. , Weimer, J., Meurer, S. K., Kron, A., Seipel, B., Vater, I., Arnold, N., Siebert, R., Xu, L., Friedman, S. L., Bergmann, C. (2013): Genetic characteristics of the human hepatic stellate cell line LX-2.. PLoS One, 8 (10), [3.057]
• Weiskirchen, R. , Meurer, S. K. (2013): BMP-7 counteracting TGF-beta1 activities in organ fibrosis. Frontiers in Bioscience (Landmark Ed), 18, 1407-1434, [2.484]
• Zimmermann H. W. , Mueller, J. R., Seidler, S., Luedde, T., Trautwein, C., Tacke, F. (2013): Frequency and Phenotype of Human Circulating and Intrahepatic Natural Killer Cell Subsets Is Differentially Regulated according to Stage of Chronic Liver Disease.. Digestion, 88 (1), 1-16, [1.884]
• Zimmermann, H. W. , Reuken, P. A., Koch, A., Bartneck, M., Adams, D. H., Trautwein, C., Stallmach, A., Tacke, F., Bruns, T. (2013): Soluble urokinase plasminogen activator receptor (suPAR) is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.. J Intern Med, 274 (1), 86-100, [1.679]

2012

• Baeck, C. , Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., Trautwein, C., Tacke, F. (2012): Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut, 61 (3), 416-426, [14.921]
• Bartneck, M. , Ritz, T., Keul, H. A., Wambach, M., Bornemann, J., Gbureck, U., Ehling, J., Lammers, T., Heymann, F., Gassler, N., Ludde, T., Trautwein, C., Groll, J., Tacke, F. (2012): Peptide-functionalized gold nanorods increase liver injury in hepatitis. ACS Nano, 6 (10), 8767-8777, [13.334]
• Bergmann, C. , Weiskirchen, R. (2012): It's not all in the cilium, but on the road to it: Genetic interaction network in polycystic kidney and liver diseases and how trafficking and quality control matter. Journal of Hepatology, 56, 1201-1203, [10.590]
• Boaru, S. G. , Borkham-Kamphorst, E., Tihaa, L., Haas, U., Weiskirchen, R. (2012): Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. Journal of Inflammation (Lond), 9, 49. 2012, [1.975]
• Boor P. , Floege J. (2012): The renal (myo-)fibroblast: a heterogenous group of cells. Nephrol Dial Transplant, 27, 3027–3036, [4.085]
• Borkham-Kamphorst, E. , Huss, S., Van de Leur, E., Haas, U., Weiskirchen, R. (2012): Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liverer International, 32 (9), 1342-1353, [4.470]
• Borkham-Kamphorst, E. , van Roeyen, C. R., Van de Leur, E., Floege, J., Weiskirchen, R. (2012): CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC. Journal of Cell Communication and Signaling, 6, 11-25, [3.123]
• Bossaller, L. , Chiang, P. I., Schmidt-Lauber, C., Ganesan, S., Kaiser, W. J., Rathinam, V. A., Mocarski, E. S., Subramanian, D., Green, D. R., Silverman, N., Fitzgerald, K. A., Marshak-Rothstein, A., Latz, E. (2012): Cutting edge: FAS (CD95) mediates noncanonical IL-1beta and IL-18 maturation via caspase-8 in an RIP3-independent manner. Journal of Immunology, 189, 5508-5512, [4.179]
• Bounkari, O. E. , Bernhagen, J. (2012): MIF and autophagy: a novel link beyond "eating". Cell Research, 22, 950-953, [14.812]
• Fatima, H. , Moeller, M. J., Smeets, B., Yang, H. C., D'Agati, V. D., Alpers, C. E., Fogo, A. B. (2012): Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clinical Journal of the American Society of Nephrology, 7 (11), 1852-1858, [4.657]
• Glassner, A. , Eisenhardt, M., Kramer, B., Korner, C., Coenen, M., Sauerbruch, T., Spengler, U., Nattermann, J. (2012): NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Laboratory Investigation, 92, 967-977, [4.202]
• Gotot, J. , Gottschalk, C., Leopold, S., Knolle, P. A., Yagita, H., Kurts, C., Ludwig-Portugall, I. (2012): Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo. Proceedings of the National Academy of Sciences of the USA, 109 (26), 10468-10473, [9.423]
• Grouls, S. , Iglesias, D. M., Wentzensen, N., Moeller, M. J., Bouchard, M., Kemler, R., Goodyer, P., Niggli, F., Grone, H. J., Kriz, W., Koesters, R. (2012): Lineage specification of parietal epithelial cells requires beta-catenin/Wnt signaling. Journal of the American Society of Nephrology, 23 (1), 63-72, [8.491]
• Hausmann, R. , Grepl, M., Knecht, V., Moeller, M. J. (2012): The glomerular filtration barrier function: new concepts. Curr Opin Nephrol Hypertens, 21 (4), 441-449, [3.232]
• Heymann, F. , Hammerich, L., Storch, D., Bartneck, M., Huss, S., Russeler, V., Gassler, N., Lira, S. A., Luedde, T., Trautwein, C., Tacke, F. (2012): Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology, 55 (3), 898-909, [11.711]
• Hochst, B. , Schildberg, F. A., Bottcher, J., Metzger, C., Huss, S., Turler, A., Overhaus, M., Knoblich, A., Schneider, B., Pantelis, D., Kurts, C., Kalff, J., Knolle, P., Diehl, L. (2012): Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance towards circulating carcinoembryonic antigen in mice. Hepatology, 56(5), 1924-33, [11.711]
• Huang, L. R. , Gabel, Y. A., Graf, S., Arzberger, S., Kurts, C., Heikenwalder, M., Knolle, P. A., Protzer, U. (2012): Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice. Gastroenterology, 142, 1447-1450, [18.187]
• Hucke, S. , Flossdorf, J., Grutzke, B., Dunay, I. R., Frenzel, K., Jungverdorben, J., Linnartz, B., Mack, M., Peitz, M., Brustle, O., Kurts, C., Klockgether, T., Neumann, H., Prinz, M., Wiendl, H., Knolle, P., Klotz, L. (2012): Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor gamma. Brain-Journal of Neurology, 135 (5), 1586-1605, [10.103]
• Kabgani N. , Grigoleit T, Schulte K, Sechi A, Sauer-Lehnen S, Tag C, Boor P, Kuppe C, Warsow G, Schordan S, Mostertz J, Chilukoti R, Homuth G, Endlich N, Tacke F, Weiskirchen R, Fuellen G, Endlich K, Floege J, Smeets B, Moeller MJ. (2012): Primary cultures of glomerular parietal epithelial cells or podocytes with proven origin. PLoS ONE, 7, [3.057]
• Kaldenbach, M. , Giebeler, A., Tschaharganeh, D. F., Erschfeld, S., Wasmuth, H. E., Dolle, L., Floege, J., Trautwein, C., Streetz, K. L. (2012): Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes. Gut, 61 (8), 1209-1218, [14.921]
• Kleffmann, J. , Frank, V., Ferbert, A., Bergmann, C. (2012): Dosage-sensitive network in polycystic kidney and liver disease: Multiple mutations cause severe hepatic and neurological complications. Journal of Hepatology, 57(2), 476-7, [10.590]
• Klein, S. , Klosel, J., Schierwagen, R., Korner, C., Granzow, M., Huss, S., Mazar, I. G., Weber, S., van den Ven, P. F., Pieper-Furst, U., Furst, D. O., Nattermann, J., Lammert, F., Sauerbruch, T., Trebicka, J. (2012): Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats. Laboratory Investigation, 92, 1440-1450, [4.202]
• Klein, S. , Van Beuge, M. M., Granzow, M., Beljaars, L., Schierwagen, R., Kilic, S., Heidari, I., Huss, S., Sauerbruch, T., Poelstra, K., Trebicka, J. (2012): HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects. Journal of Hepatology, 57, 1220-1227, [10.590]
• Koch, A. , Zimmermann, H. W., Baeck, C., Schneider, C., Yagmur, E., Trautwein, C., Tacke, F. (2012): Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosis. Clinical Biochemistry, 45, 429-435, [2.382]
• Korner, C. , Riesner, K., Kramer, B., Eisenhardt, M., Glassner, A., Wolter, F., Berg, T., Muller, T., Sauerbruch, T., Nattermann, J., Spengler, U., Nischalke, H. D. (2012): TRAIL receptor I (DR4) polymorphisms C626G und A638C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients. BMC Cancer, 12, 85, [3.265]
• Kraemer, S. , Weber, C., Bernhagen, J. (2012): The MIF Handbook. 2, [6.085]
• Kramer, B. , Korner, C., Kebschull, M., Glassner, A., Eisenhardt, M., Nischalke, H. D., Alexander, M., Sauerbruch, T., Spengler, U., Nattermann, J. (2012): NKp46(High) expression defines a NK cell subset that is potentially involved in control of HCV replication and modulation of liver fibrosis. Hepatology, 56(4), 1201-13, [11.711]
• Ludwig-Portugall, I. , Gotot, J., Leopold, S., Knolle, P. A., Yagita, H., Kurts, C. (2012): Direct PD-1-mediated suppression of autoreactive B cells by regulatory T cells. The Journal of Immunology, 137, 40, [4.179]
• Luedike, P. , Hendgen-Cotta, U. B., Sobierajski, J., Totzeck, M., Reeh, M., Dewor, M., Lue, H., Krisp, C., Wolters, D., Kelm, M., Bernhagen, J., Rassaf, T. (2012): Cardioprotection Through S-Nitros(yl)ation of Macrophage Migration Inhibitory Factor. Circulation, 125, 1880-1889, [17.202]
• Meurer, S. K. , Esser, M., Tihaa, L., Weiskirchen, R. (2012): BMP-7/TGF-beta1 signalling in myoblasts: Components involved in signalling and BMP-7-dependent blockage of TGF-beta-mediated CTGF expression. European Journal of Cell Biology, 91, 450-463, [4.011]
• Motzkau, M. , Meyer, P., Mertens, P. R., Klose, S. (2012): Monogenic diabetes in a family with 2 unknown HNF-4A gene mutations. Experimental and Clinical Endocrinology & Diabetes, 120, 89-90, [1.665]
• Nelson, P. J. , Rees, A. J., Griffin, M. D., Hughes, J., Kurts, C., Duffield, J. (2012): The renal mononuclear phagocytic system. Journal of Americal Society of Nephrology, 23, 194-203, [8.491]
• Neukam, K. , Camacho, A., Caruz, A., Rallon, N., Torres-Cornejo, A., Rockstroh, J. K., Macias, J., Rivero, A., Benito, J. M., Lopez-Cortes, L. F., Nattermann, J., Gomez-Mateos, J., Soriano, V., Pineda, J. A. (2012): Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load. Journal of Hepatology, 56, 788-794, [10.590]
• Nevzorova, Y. A. , Bangen, J. M., Hu, W., Haas, U., Weiskirchen, R., Gassler, N., Huss, S., Tacke, F., Sicinski, P., Trautwein, C., Liedtke, C. (2012): Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice.. Hepatology, 56 (3), 1140-1149, [11.711]
• Nischalke, H. D. , Berger, C., Luda, C., Muller, T., Berg, T., Coenen, M., Kramer, B., Korner, C., Trebicka, J., Grunhage, F., Lammert, F., Nattermann, J., Sauerbruch, T., Spengler, U. (2012): The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients. Journal of Hepatology, 56, 758-764, [10.590]
• Nischalke, H. D. , Coenen, M., Berger, C., Aldenhoff, K., Muller, T., Berg, T., Kramer, B., Korner, C., Odenthal, M., Schulze, F., Grunhage, F., Nattermann, J., Sauerbruch, T., Spengler, U. (2012): The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. International Journal of Cancer, 130 (6), 1470-1475, [5.531]
• Ostendorf, T. , Eitner, F., Floege, J. (2012): The PDGF family in renal fibrosis. Pediatr Nephrol, 27, 1041-1050, [2.338]
• Parahuleva, M. S. , Holschermann, H., Zandt, D., Pons-Kuhnemann, J., Parviz, B., Weiskirchen, R., Staubitz, A., Tillmanns, H., Erdogan, A., Kanse, S. M. (2012): Circulating factor VII activating protease (FSAP) is associated with clinical outcome in acute coronary syndrome. Circulation Journal, 76, 2653-2661, [4.124]
• Protzer, U. , Maini, M. K., Knolle, P. A. (2012): Living in the liver: hepatic infections. Nature Reviews Immunology, 12 (3), 201-213, [39.416]
• Reichenbach, V. , Fernandez-Varo, G., Casals, G., Oro, D., Ros, J., Melgar-Lesmes, P., Weiskirchen, R., Morales-Ruiz, M.W., Jimenez, W. (2012): Transduction of the liver with dominant-negative soluble PDGFRbeta improves systemic hemodynamics, portal pressure and fibrosis in CCl4-treated rats. Journal of Hepatology, 57, 967-973, [10.590]
• Roderburg, C. , Mollnow, T., Bongaerts, B., Elfimova, N., Vargas Cardenas, D., Berger, K., Zimmermann, H., Koch, A., Vucur, M., Luedde, M., Hellerbrand, C., Odenthal, M., Trautwein, C., Tacke, F., Luedde, T. (2012): Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One, 7 (3), e32999, [3.057]
• Sahin, H. , Borkham-Kamphorst, E., Kuppe, C., Zaldivar, M. M., Grouls, C., Al-Samman, M., Nellen, A., Schmitz, P., Heinrichs, D., Berres, M. L., Doleschel, D., Scholten, D., Weiskirchen, R., Moeller, M. J., Kiessling, F., Trautwein, C., Wasmuth, H. E. (2012): Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice. Hepatology, 55 (5), 1610-1619, [11.711]
• Schneider, C. , Teufel, A., Yevsa, T., Staib, F., Hohmeyer, A., Walenda, G., Zimmermann, H. W., Vucur, M., Huss, S., Gassler, N., Wasmuth, H. E., Lira, S. A., Zender, L., Luedde, T., Trautwein, C., Tacke, F. (2012): Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut, 61(12), 1733-43, [14.921]
• Schwartz, V. , Kruttgen, A., Weis, J., Weber, C., Ostendorf, T., Lue, H., Bernhagen, J. (2012): Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF. European Journal of Cell Biology, 91, 435-449, [4.011]
• Seidler, S. , Zimmermann, H. W., Weiskirchen, R., Trautwein, C., Tacke, F. (2012): Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes. BMC Gastroenterology, 12, 38, [2.101]
• Sicking, E. M. , Fuss, A., Uhlig, S., Jirak, P., Dijkman, H., Wetzels, J., Engel, D. R., Urzynicok, T., Heidenreich, S., Kriz, W., Kurts, C., Ostendorf, T., Floege, J., Smeets, B., Moeller, M. J. (2012): Subtotal ablation of parietal epithelial cells induces crescent formation. Journal of the American Society of Nephrology, 23, 629-640, [8.491]
• Smeets, B. , Moeller, M. J. (2012): Parietal epithelial cells and podocytes in glomerular diseases.. Seminars in Nephrology, 32 (4), 357-367, [3.773]
• Snelgrove, S. L. , Kausman, J. Y., Lo, C., Lo, C., Ooi, J. D., Coates, P. T., Hickey, M. J., Holdsworth, S. R., Kurts, C., Engel, D. R., Kitching, A. R. (2012): Renal dendritic cells adopt a pro-inflammatory phenotype in obstructive uropathy to activate T cells but do not directly contribute to fibrosis. The American Journal of Pathology, 180 (1), 91-103, [4.206]
• Stoppe, C. , Grieb, G., Rossaint, R., Simons, D., Coburn, M., Gotzenich, A., Strussmann, T., Pallua, N., Bernhagen, J., Rex, S. (2012): High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ dysfunction in patients after cardiac surgery.. Molecular Medicine, 18, 843-50, [3.530]
• Tacke, F. (2012): Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo. Fibrogenesis Tissue Repair, 5 (1), 27, [2.329]
• Tacke, F. , Shirvani-Dastgerdi, E. (2012): Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro. Hepatitis Monthly, 12, 357-360, [1.932]
• Tacke, F. , Weiskirchen, R. (2012): Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Review of Gastroenterology Hepatology, 6, 67-80, [2.796]
• Teteris, S. A. , Hochheiser, K., Kurts, C. (2012): Isolation of functional dendritic cells from murine kidneys for immunological characterization. Nephrology (Carlton), 17, 364-371,
• Tittel, A. P. , Heuser, C., Ohliger, C., Llanto, C., Yona, S., Hammerling, G. J., Engel, D. R., Garbi, N., Kurts, C. (2012): Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nature Methods, 9 (4), 385-390, [25.328]
• van Roeyen CRC, Boor P. , Borkham-Kamphorst E, Rong S, Kunter U, Martin IV, Kaitovic A, Fleckenstein S, Perbal B, Weiskirchen R, Ostendorf T, Floege J. (2012): A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and anti-mesangioproliferative effects. American Journal of Pathology, 180, 1979-1990, [4.206]
• van Roeyen, C. R , Ostendorf, T., Floege, J. (2012): The platelet-derived growth factor system in renal disease: An emerging role of endogenous inhibitors. European Journal of Cell Biology, 91 (6-7), 542-551, [4.011]
• Wojtalla, A. , Herweck, F., Granzow, M., Klein, S., Trebicka, J., Huss, S., Lerner, R., Lutz, B., Schildberg, F. A., Knolle, P. A., Sauerbruch, T., Singer, M. V., Zimmer, A., Siegmund, S. V. (2012): The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes. American Journal of Physiology, Gastrointestinal and Liver Physiology, 302 (8), G873-887, [3.297]
• Yagmur, E. , Koch, A., Haumann, M., Kramann, R., Trautwein, C., Tacke, F. (2012): Hyaluronan serum concentrations are elevated in critically ill patients and associated with disease severity. Clinical Biochemistry, 45, 82-87, [2.382]
• Zimmermann, H. W. , Koch, A., Seidler, S., Trautwein, C., Tacke, F. (2012): Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis. Liver International, 32, 500-509, [4.470]
• Zimmermann, H. W. , Trautwein, C., Tacke, F. (2012): Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Frontiers in Physiology, 3, 56, [4.031]

2011

• Amini-Bavil-Olyaee, S. , Pourkarim, M. R., Schaefer, S., Mahboudi, F., Van Ranst, M., Adeli, A., Trautwein, C., Tacke, F. (2011): Single-step real-time PCR to quantify hepatitis B virus and distinguish genotype D from non-D genotypes. Journal of Viral Hepatology, 18, 300-304, [4.179]
• Beraza, N. , Ofner-Ziegenfuss, L., Ehedego, H., Boekschoten, M., Bischoff, S. C., Mueller, M., Trauner, M., Trautwein, C. (2011): Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis. Gut, 60, 387-396, [14.921]
• Berger, K. , Moeller, M. J. (2011): Cofilin-1 in the podocyte: a molecular switch for actin dynamics. Internatinal Urology and Nephrology, 43, 273-275, [1.292]
• Bergmann, C. (2011): Educational paper: Ciliopathies. Eur J Pediatr, 171 (9), 1285-1300, [1.791]
• Bergmann, C. , von Bothmer, J., Ortiz Bruchle, N., Venghaus, A., Frank, V., Fehrenbach, H., Hampel, T., Pape, L., Buske, A., Jonsson, J., Sarioglu, N., Santos, A., Ferreira, J. C., Becker, J. U., Cremer, R., Hoefele, J., Benz, M. R., Weber, L. T., Buettner, R., Zerres, K. (2011): Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. Journal of American Society of Nephrology, 22, 2047-2056, [8.491]
• Berres, M. L. , Trautwein, C., Schmeding, M., Eurich, D., Tacke, F., Bahra, M., Neuhaus, P., Neumann, U. P., Wasmuth, H. E. (2011): Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Hepatology, 53 (2), 596-603, [11.711]
• Boor, P. , Celec, P., Martin, I. V., Villa, L., Hodosy, J., Klenovicsova, K., Esposito, C., Schafer, S., Albrecht-Kupper, B., Ostendorf, T., Heidland, A., Sebekova, K. (2011): The peroxisome proliferator-activated receptor-alpha agonist, BAY PP1, attenuates renal fibrosis in rats.. Kidney International, 80, 1182-1197, [7.683]
• Borkham-Kamphorst, E. , Drews, F., Weiskirchen, R. (2011): Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1beta through nuclear factor-kappaB activation. Liver International, 31 (5), 656-665, [4.470]
• Coenen, M. , Nischalke, H. D., Kramer, B., Langhans, B., Glassner, A., Schulte, D., Korner, C., Sauerbruch, T., Nattermann, J., Spengler, U. (2011): Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2. Lab Invest, 91, 1375-1382, [4.202]
• Davis, E. E. , Zhang, Q., Liu, Q., Diplas, B. H., Davey, L. M., Hartley, J., Stoetzel, C., Szymanska, K., Ramaswami, G., Logan, C. V., Muzny, D. M., Young, A. C., Wheeler, D. A., Cruz, P., Morgan, M., Lewis, L. R., Cherukuri, P., Maskeri, B., Hansen, N. F., Mullikin, J. C., Blakesley, R. W., Bouffard, G. G., Program, N. C. S., Gyapay, G., Rieger, S., Tonshoff, B., Kern, I., Soliman, N. A., Neuhaus, T. J., Swoboda, K. J., Kayserili, H., Gallagher, T. E., Lewis, R. A., Bergmann, C., Otto, E. A., Saunier, S., Scambler, P. J., Beales, P. L., Gleeson, J. G., Maher, E. R., Attie-Bitach, T., Dollfus, H., Johnson, C. A., Green, E. D., Gibbs, R. A., Hildebrandt, F., Pierce, E. A., Katsanis, N. (2011): TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nature Genetics, 43, 189-196, [31.616]
• Dowdle, W. E. , Robinson, J. F., Kneist, A., Sirerol-Piquer, M. S., Frints, S. G., Corbit, K. C., Zaghloul, N. A., van Lijnschoten, G., Mulders, L., Verver, D. E., Zerres, K., Reed, R. R., Attie-Bitach, T., Johnson, C. A., Garcia-Verdugo, J. M., Katsanis, N., Bergmann, C., Reiter, J. F. (2011): Disruption of a ciliary B9 protein complex causes Meckel syndrome.. American Journal of Human Genetics, 89, 94-110, [10.794]
• Gotot, J. , Leopold, S., Knolle, P. A., Yagita, H., Kurts, C., Ludwig-Portugall, I. (2011): Direct PD-1-mediated suppression of autoreactive B cells by regulatory T cells.. Proc. Natl. Acad. Sci. USA,
• Grieb, G. , Steffens, G., Pallua, N., Bernhagen, J., Bucala, R. (2011): Circulating fibrocytes--biology and mechanisms in wound healing and scar formation. International Review of Cell and Molecular Biology, 291, 1-19, [3.752]
• Hammerich, L. , Heymann, F., Tacke, F. (2011): Role of IL-17 and Th17 cells in liver diseases. Clinical and Developmental Immunology, [3.603]
• Hanssen, L. , Frye, B. C., Ostendorf, T., Alidousty, C., Djudjaj, S., Boor, P., Rauen, T., Floege, J., Mertens, P. R., Raffetseder, U. (2011): Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney. Journal of Immunology, 187 (1), 298-308, [4.179]
• Heinrichs, D. , Knauel, M., Offermanns, C., Berres, M. L., Nellen, A., Leng, L., Schmitz, P., Bucala, R., Trautwein, C., Weber, C., Bernhagen, J., Wasmuth, H. E. (2011): Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proceedings of the National Academy of Sciences of the U S A, 108 (42), 17444-17449, [9.423]
• Hellerbrand, C. , Weiskirchen, R. (2011): Does it matter not only how much but also when we eat to induce fatty liver?. Hepatology, 54 (3), 1096-1099, [11.711]
• Henkel, C. , Schwamborn, K., Zimmermann, H. W., Tacke, F., Kuhnen, E., Odenthal, M., Groseclose, M. R., Caprioli, R. M., Weiskirchen, R. (2011): From proteomic multimarker profiling to interesting proteins: thymosin-beta(4) and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions. Journal of Cellular an Molecular Medicine, 15 (10), 2176-2188, [4.938]
• Hennenberg, M. , Trebicka, J., Kohistani, Z., Stark, C., Nischalke, H. D., Kramer, B., Korner, C., Klein, S., Granzow, M., Fischer, H. P., Heller, J., Sauerbruch, T. (2011): Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis.. Laboratory Investigation, 91, 241-251, [4.202]
• Hochheiser, K. , Engel, D. R., Hammerich, L., Heymann, F., Knolle, P. A., Panzer, U., Kurts, C. (2011): Kidney Dendritic Cells Become Pathogenic during Crescentic Glomerulonephritis with Proteinuria. Journal of American Society of Nephrology, 22 (8), 1435-1441, [8.491]
• Huss, S. , Fronhoffs, F., Buttner, R., Heukamp, L. C. (2011): Web-based database for the management of tissue specimens in a transregional histological research facility. Diagnostic Pathology, 6, 17, [1.895]
• Koch, A. , Voigt, S., Sanson, E., Duckers, H., Horn, A., Zimmermann, H. W., Trautwein, C., Tacke, F. (2011): Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients. Critical Care, 15 (1), R45, [4.950]
• Koch, A. , Voigt, S., Kruschinski, C., Sanson, E., Duckers, H., Horn, A., Yagmur, E., Zimmermann, H., Trautwein, C., Tacke, F. (2011): Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical Care, 15 (1), [4.950]
• Koch, A. , Sanson, E., Voigt, S., Helm, A., Trautwein, C., Tacke, F. (2011): Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. Journal of Critical Care, 26, 166-174, [2.445]
• Koch, A. , Horn, A., Duckers, H., Yagmur, E., Sanson, E., Bruensing, J., Buendgens, L., Voigt, S., Trautwein, C., Tacke, F. (2011): Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU. Critical Care, 15, R266, [4.950]
• Koch, A. , Horn, A., Duckers, H., Yagmur, E., Sanson, E., Bruensing, J., Buendgens, L., Voigt, S., Trautwein, C., Tacke, F. (2011): Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU. Crit Care, 15, R266,
• Korner, C. , Tolksdorf, F., Riesner, K., Kramer, B., Schulte, D., Nattermann, J., Rockstroh, J. K., Spengler, U. (2011): Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients. Antiviral Therapy, 16, 1047-1055, [2.916]
• Kramann, R. , Moeller, M. J. (2011): The next level of complexity: post-transcriptional regulation by microRNAs. Kidney International, 80 (7), 692-693, [7.683]
• Kramann, R. , Couson, S. K., Neuss, S., Kunter, U., Bovi, M., Bornemann, J., Knuchel, R., Jahnen-Dechent, W., Floege, J., Schneider, R. K. (2011): Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Bio, 31 (9), e45-54, [5.969]
• Kramer, B. , Eisenhardt, M., Glassner, A., Korner, C., Sauerbruch, T., Spengler, U., Nattermann, J. (2011): Do lambda-IFNs IL28A and IL28B act on human natural killer cells?. Proceedings of the National Academy of Sciences of the U S A, 108 (34), 519-520, [9.423]
• Krawczyk, M. , Grunhage, F., Zimmer, V., Lammert, F. (2011): Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. Journal of Hepatology, 55 (2), 299-306, [10.590]
• Kunter, U. , Rong, S., Moeller, M. J., Floege, J. (2011): Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks. Kidney International Supplements, 1 (3), 68-73, [7.026]
• Kurts, C. (2011): Constructing an immune system for glomerulonephritis studies. Journal of American Society Nephrology, 22 (3), 398-399, [8.491]
• Langhans, B. , Kupfer, B., Braunschweiger, I., Arndt, S., Schulte, W., Nischalke, H. D., Nattermann, J., Oldenburg, J., Sauerbruch, T., Spengler, U. (2011): Interferon-lambda serum levels in hepatitis C. Journal of Hepatology, 54 (5), 859-865, [10.590]
• Lettow, I. , Berres, M. L., Schmitz, P., Muller, T., Berg, T., Neumann, U. P., Trautwein, C., Wasmuth, H. E. (2011): A Duffy antigen receptor for chemokines (DARC) polymorphism that determines pro-fibrotic chemokine serum concentrations is not directly associated with severity of hepatitis C infection. Human Immunology, 72 (3), 273-277, [2.127]
• Liedtke, C. , Bangen, J. M., Freimuth, J., Beraza, N., Lambertz, D., Cubero, F. J., Hatting, M., Karlmark, K. R., Streetz, K. L., Krombach, G. A., Tacke, F., Gassler, N., Riethmacher, D., Trautwein, C. (2011): Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology, 141 (6), 2176-2187, [18.187]
• Liu, Y. , Meyer, C., Muller, A., Herweck, F., Li, Q., Mullenbach, R., Mertens, P. R., Dooley, S., Weng, H. L. (2011): IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta-independent Smad signaling. Journal of Immunology, 187 (5), 2814-2823, [4.179]
• Louvet, A. , Teixeira-Clerc, F., Chobert, M. N., Deveaux, V., Pavoine, C., Zimmer, A., Pecker, F., Mallat, A., Lotersztajn, S. (2011): Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology, 54 (4), 1217-1226, [11.711]
• Lue, H. , Dewor, M., Leng, L., Bucala, R., Bernhagen, J. (2011): Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cellular Signalling, 23 (1), 135-144, [4.191]
• Luedde, T. , Schwabe, R. F. (2011): NF-kappaB in the liver--linking injury, fibrosis and hepatocellular carcinoma. National Review of Gastroenterology & Hepatology, 8 (2), 108-118, [14.435]
• Menzel, S. , Moeller, M. J. (2011): Role of the podocyte in proteinuria. Pediatric Nephrology, 26 (10), 1775-1780, [2.338]
• Merk, M. , Zierow, S., Leng, L., Das, R., Du, X., Schulte, W., Fan, J., Lue, H., Chen, Y., Xiong, H., Chagnon, F., Bernhagen, J., Lolis, E., Mor, G., Lesur, O., Bucala, R. (2011): The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proceedings of the National Academy of Sciences of the U S A, 108 (34), 577-585, [9.423]
• Meurer, S. K. , Tihaa, L., Borkham-Kamphorst, E., Weiskirchen, R. (2011): Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cellular Signalling, 23 (4), 683-699, [4.191]
• Moleda, L. , Trebicka, J., Dietrich, P., Gabele, E., Hellerbrand, C., Straub, R. H., Sauerbruch, T., Schoelmerich, J., Wiest, R. (2011): Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction. Gut, 60, 1122-1132, [14.921]
• Nattermann, J. , Vogel, M., Nischalke, H. D., Danta, M., Mauss, S., Stellbrink, H. J., Baumgarten, A., Mayr, C., Bruno, R., Tural, C., Klausen, G., Clotet, B., Naumann, U., Lutz, T., Rausch, M., Schewe, K., Bienek, B., Haerter, G., Sauerbruch, T., Rockstroh, J. K., Spengler, U. (2011): Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. Journal of Infectious Diseases, 203 (5), 595-601, [6.344]
• Nattermann, J. , Timm, J., Nischalke, H. D., Olbrich, A., Michalk, M., Tillmann, H. L., Berg, T., Wedemeyer, H., Tenckhoff, H., Wiese, M., Kullig, U., Gobel, U., Capka, E., Schiefke, I., Guthof, W., Grungreiff, K., Konig, I., Roggendorf, M., Sauerbruch, T., Spengler, U., East German, H. C. V. S. G. (2011): The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Delta32 mutation. Journal of Hepatology, 55 (6), 1201-1206, [10.590]
• Nattermann, J. (2011): NK cells in acute hepatitis C. Journal of Hepatology, 55 (2), 265-267, [10.590]
• Neukam, K. , Nattermann, J., Rallon, N., Rivero, A., Caruz, A., Macias, J., Vogel, M., Benito, J., Camacho, A., Mira, J., Schwarze-Zander, C., Barreiro, P., Martinez, A., Rockstroh, J., Soriano, V., Pineda, J. (2011): Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype. HIV Medicine, 12 (8), 487-493, [3.341]
• Nischalke, H. D. , Berger, C., Luda, C., Berg, T., Muller, T., Grunhage, F., Lammert, F., Coenen, M., Kramer, B., Korner, C., Vidovic, N., Oldenburg, J., Nattermann, J., Sauerbruch, T., Spengler, U. (2011): The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS One, 6, e27087, [3.057]
• Nischalke, H. D. , Berger, C., Aldenhoff, K., Thyssen, L., Gentemann, M., Grunhage, F., Lammert, F., Nattermann, J., Sauerbruch, T., Spengler, U., Appenrodt, B. (2011): Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. Journal of Hepatology, 55 (5), 1010-1016, [10.590]
• Ooi, J. D. , Snelgrove, S. L., Engel, D. R., Hochheiser, K., Ludwig-Portugall, I., Nozaki, Y., O'Sullivan, K. M., Hickey, M. J., Holdsworth, S. R., Kurts, C., Kitching, A. R. (2011): Endogenous foxp3(+) T-regulatory cells suppress anti-glomerular basement membrane nephritis. Kidney International, 79 (9), 977-986, [7.683]
• Pieper-Furst, U. , Hall, R., Huss, S., Hochrath, K., Fischer, H. P., Tacke, F., Weiskirchen, R., Lammert, F. (2011): Expression of the megalin C-terminal fragment by macrophages during liver fibrogenesis in mice. Biochimica et Biophysica Acta, 1812 (12), 1640-1648, [5.158]
• Raffetseder, U. , Rauen, T., Boor, P., Ostendorf, T., Hanssen, L., Floege, J., En-Nia, A., Djudjaj, S., Frye, B. C., Mertens, P. R. (2011): Extracellular YB-1 blockade in experimental nephritis upregulates notch-3 receptor expression and signaling. Nephron Experimental Nephrology, 118, 100-108, [1.531]
• Raskopf, E. , Sauerbruch, T., Schmitz, V. (2011): Apoptotic Potency of Angiostatic Compounds in the Treatment of Cancer. Current Pharmaceutical Biotechnology, 13 (11), 2289, [3.052]
• Rauen, T. , Weiskirchen, R., Floege, J. (2011): In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL. Nephrology Dialysis Transplantation, 26, 445-447, [4.085]
• Roderburg, C. , Urban, G. W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., Tacke, F., Trautwein, C., Luedde, T. (2011): Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.. Hepatology, 53, 209-218, [11.711]
• Roderburg, C. , Trautwein, C., Luedde, T. (2011): MicroRNA-199a/b-3p: a new star in the liver microcosmos. Hepatology, 54, 729-731,
• Ruhl, M. , Knuschke, T., Schewior, K., Glavinic, L., Neumann-Haefelin, C., Chang, D. I., Klein, M., Heinemann, F. M., Tenckhoff, H., Wiese, M., Horn, P. A., Viazov, S., Spengler, U., Roggendorf, M., Scherbaum, N., Nattermann, J., Hoffmann, D., Timm, J., East German, H. C. V. S. G. (2011): CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology, 140 (7), 2064-2073, [18.187]
• Schildberg, F. A. , Wojtalla, A., Siegmund, S. V., Endl, E., Diehl, L., Abdullah, Z., Kurts, C., Knolle, P. A. (2011): Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology, 54 (1), 262-272, [11.711]
• Schirin-Sokhan, R. , Winograd, R., Tischendorf, S., Wasmuth, H. E., Streetz, K., Tacke, F., Trautwein, C., Tischendorf, J. J. (2011): Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study. Digestion, 83, 263-268, [1.884]
• Scholten, D. , Weiskirchen, R. (2011): Questioning the challenging role of epithelial-to-mesenchymal transition in liver injury. Hepatology, 53 (3), 1048-1051, [11.711]
• Scholten, D. , Al-samman, M., Sahin, H., Trautwein, C., Wasmuth, H. (2011): CXCR3 Ligands induce Expression of CXCL1 (KC/murine IL8 homolog). Mouse Hepatic Stellate Cells. Journal of Cell Science & Therapy, 5, 4, [4.706]
• Sibbing, B. , Nattermann, J. (2011): Hepatitis C virus infection and genetic susceptibility to therapy. Journal of Gastrointestinal and Liver Diseases, 20 (4), 397-406, [1.891]
• Smeets, B. , Kuppe, C., Sicking, E. M., Fuss, A., Jirak, P., van Kuppevelt, T. H., Endlich, K., Wetzels, J. F., Grone, H. J., Floege, J., Moeller, M. J. (2011): Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. Journal of American Society of Nephrology, 11 (7), 1262-1274, [8.491]
• Stickel, F. , Buch, S., Lau, K., Meyer zu Schwabedissen, H., Berg, T., Ridinger, M., Rietschel, M., Schafmayer, C., Braun, F., Hinrichsen, H., Gunther, R., Arlt, A., Seeger, M., Muller, S., Seitz, H. K., Soyka, M., Lerch, M., Lammert, F., Sarrazin, C., Kubitz, R., Haussinger, D., Hellerbrand, C., Broring, D., Schreiber, S., Kiefer, F., Spanagel, R., Mann, K., Datz, C., Krawczak, M., Wodarz, N., Volzke, H., Hampe, J. (2011): Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.. Hepatology, 53 (1), 86-95, [11.711]
• Suppiah, V. , Gaudieri, S., Armstrong, N. J., O'Connor, K. S., Berg, T., Weltman, M., Abate, M. L., Spengler, U., Bassendine, M., Dore, G. J., Irving, W. L., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Muller, T., Hammond, E., Dunn, D., Negro, F., Bochud, P. Y., Mallal, S., Ahlenstiel, G., Stewart, G. J., George, J., Booth, D. R., International Hepatitis, C. G. C. (2011): IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS Med, 8 (9), e1001092, [13.585]
• Tacke, F. , Zimmermann, H. W., Trautwein, C., Schnabl, B. (2011): CXCL5 plasma levels decrease in patients with chronic liver disease. Journal of Gastroenterology & Hepatology, 26 (3), 523-529, [3.322]
• Tacke, F. , Zimmermann, H. W., Berres, M. L., Trautwein, C., Wasmuth, H. E. (2011): Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases. Liver International, 31 (6), 840-849, [4.470]
• Tacke, F. , Kurts, C. (2011): Infiltrating monocytes versus resident Kupffer cells: do alternatively activated macrophages need to be targeted alternatively?. Hepatology, 54 (6), 2267-2270, [11.711]
• Tacke, F. , Kanig, N., En-Nia, A., Kaehne, T., Eberhardt, C. S., Shpacovitch, V., Trautwein, C., Mertens, P. R. (2011): Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease. BMC Cancer, 11, 185, [3.265]
• Teteris, S. A. , Engel, D. R., Kurts, C. (2011): Homeostatic and pathogenic role of renal dendritic cells. Kidney International, 80 (2), 139-145, [7.683]
• Tittel, A. P. , Heuser, C., Ohliger, C., Knolle, P. A., Engel, D. R., Kurts, C. (2011): Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol, 22, 1435-1441,
• Trebicka, J. , Racz, I., Siegmund, S. V., Cara, E., Granzow, M., Schierwagen, R., Klein, S., Wojtalla, A., Hennenberg, M., Huss, S., Fischer, H. P., Heller, J., Zimmer, A., Sauerbruch, T. (2011): Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver International, 31 (6), 860-870, [4.470]
• Trebicka, J. , Krag, A., Gansweid, S., Appenrodt, B., Schiedermaier, P., Sauerbruch, T., Spengler, U. (2011): Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt. European Journal of Gastroenterology & Hepatology, 23 (12), 1218-1225, [2.093]
• van Roeyen, C. R. , Eitner, F., Boor, P., Moeller, M. J., Raffetseder, U., Hanssen, L., Bucher, E., Villa, L., Banas, M. C., Hudkins, K. L., Alpers, C. E., Ostendorf, T., Floege, J. (2011): Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D. Kidney International, 80 (12), 1292-1305, [7.683]
• Villa, L. , Boor, P., Konieczny, A., Kunter, U., van Roeyen, C. R., Denecke, B., Gan, L., Kupper, M. B., Hoffmann, K., Eitner, F., Ostendorf, T., Floege, J. (2011): Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis.. Nephrology Dialysis Transplantation, 26 (10), 3131-3143, [4.085]
• Vogel, M. , Friedrich, O., Luchters, G., Holleczek, B., Wasmuth, J. C., Anadol, E., Schwarze-Zander, C., Nattermann, J., Oldenburg, J., Sauerbruch, T., Rockstroh, J. K., Spengler, U. (2011): Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. European Journal of Medical Research, 16 (3), 101-107, [1.684]
• Weber, S. N. , Lammert, F. (2011): Genetics of liver injury and fibrosis. Alcoholism Clinical & Experimental Research, 35 (5), 800-803, [2.829]
• Weiskirchen, R. (2011): CCN proteins in normal and injured liver. Frontiers in Bioscience, 16, 1939-1961, [2.484]
• Zimmer, V. , Lammert, F. (2011): Genetics in liver disease: new concepts. Current Opinion in Gastroenterology, 27 (3), 231-239, [3.618]
• Zimmer, V. , Lammert, F. (2011): Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases. Best Practice & Research Clinical Gastroenterology, 25 (2), 269-280, [3.897]
• Zimmermann, H. W. , Tacke, F. (2011): Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflammation & Allergy - Drug Targets, 10 (6), 509-536, [1.560]
• Zimmermann, H. W. , Seidler, S., Gassler, N., Nattermann, J., Luedde, T., Trautwein, C., Tacke, F. (2011): Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One, 6 (6), e21381, [3.057]

2010

• Amann, T. , Bataille, F., Spruss, T., Dettmer, K., Wild, P., Liedtke, C., Muhlbauer, M., Kiefer, P., Oefner, P. J., Trautwein, C., Bosserhoff, A. K., Hellerbrand, C. (2010): Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. American Journal of Pathology, 176 (3), 1433-1442, [4.206]
• Amini-Bavil-Olyaee, S. , Vucur, M., Luedde, T., Trautwein, C., Tacke, F. (2010): Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains. Journal of Virology, 84 (29, 1026-1033, [4.606]
• Appenrodt, B. , Grunhage, F., Gentemann, M. G., Thyssen, L., Sauerbruch, T., Lammert, F. (2010): Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology, 51 (4), 1327-1333, [11.711]
• Becker, J. U. , Opazo Saez, A., Zerres, K., Witzke, O., Hoyer, P. F., Schmid, K. W., Kribben, A., Bergmann, C., Nurnberger, J. (2010): The mTOR pathway is activated in human autosomal-recessive polycystic kidney disease. Kidney Blood Pressure Research, 33, 129-138, [2.908]
• Berres, M. L. , Koenen, R. R., Rueland, A., Zaldivar, M. M., Heinrichs, D., Sahin, H., Schmitz, P., Streetz, K. L., Berg, T., Gassler, N., Weiskirchen, R., Proudfoot, A., Weber, C., Trautwein, C., Wasmuth, H. E. (2010): Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. Journal of Clinical Investigation, 120 (11), 4129-4140, [12.575]
• Bettermann, K. , Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., Muller, M., de Vos, R., Wolf, M. J., Boege, Y., Seleznik, G. M., Zeller, N., Erny, D., Fuchs, T., Zoller, S., Cairo, S., Buendia, M. A., Prinz, M., Akira, S., Tacke, F., Heikenwalder, M., Trautwein, C., Luedde, T. (2010): TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell, 17 (5), 481-496, [23.214]
• Bohr, W. , Kupper, M., Hoffmann, K., Weiskirchen, R. (2010): Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein. PLoS One, 5 (12), e16000, [3.057]
• Bomble, M. , Tacke, F., Rink, L., Kovalenko, E., Weiskirchen, R. (2010): Analysis of antigen-presenting functionality of cultured rat hepatic stellate cells and transdifferentiated myofibroblasts. Biochem Biophys Res Commun, 396, 342-347, [2.371]
• Boor, P. , van Roeyen, C. R., Kunter, U., Villa, L., Bucher, E., Hohenstein, B., Hugo, C. P., Eriksson, U., Satchell, S. C., Mathieson, P. W., Eitner, F., Floege, J., Ostendorf, T. (2010): PDGF-C mediates glomerular capillary repair. American Journal of Pathology, 177 (1), 58-69, [4.206]
• Boor, P. , Ostendorf, T., Floege, J. (2010): Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nature Reviews Nephrology, 6 (11), 643-565, [9.463]
• Burgdorf, S. , Schuette, V., Semmling, V., Hochheiser, K., Lukacs-Kornek, V., Knolle, P. A., Kurts, C. (2010): Steady-state cross-presentation of OVA is mannose receptor-dependent but inhibitable by collagen fragments. Proceedings of the National Acadedemy of Sciences in the U S A, 107 (13), 48-49, [9.423]
• Coenen, M. , Nattermann, J. (2010): The role of CCR5 in HCV infection. European Journal of Medical Research, 15, 97-101, [1.684]
• Drenth, J. P. , Chrispijn, M., Bergmann, C. (2010): Congenital fibrocystic liver diseases. Best Practice & Research Cliicaln Gastroenterology, 24 (5), 573-584, [3.897]
• Engel, D. R. , Koscielny, A., Wehner, S., Maurer, J., Schiwon, M., Franken, L., Schumak, B., Limmer, A., Sparwasser, T., Hirner, A., Knolle, P. A., Kalff, J. C., Kurts, C. (2010): T helper type 1 memory cells disseminate postoperative ileus over the entire intestinal tract. Nature Medicine, 16 (12), 1407-1413, [30.357]
• Grunhage, F. , Wasmuth, J. C., Herkenrath, S., Vidovic, N., Goldmann, G., Rockstroh, J., Lammert, F., Oldenburg, J., Sauerbruch, T., Spengler, U. (2010): Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART. European Journal of Medical Research, 15 (4), 139-144, [1.684]
• Grunhage, F. , Nattermann, J., Gressner, O. A., Wasmuth, H. E., Hellerbrand, C., Sauerbruch, T., Spengler, U., Lammert, F. (2010): Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. Journal of Hepatology, 52 (2), 153-159, [10.590]
• Grunhage, F. , Nattermann, J. (2010): Viral hepatitis: human genes that limit infection. Best Pract Res Clin Gastroenterol, 24 (5), 709-723, [3.897]
• Hausmann, R. , Kuppe, C., Egger, H., Schweda, F., Knecht, V., Elger, M., Menzel, S., Somers, D., Braun, G., Fuss, A., Uhlig, S., Kriz, W., Tanner, G., Floege, J., Moeller, M. J. (2010): Electrical forces determine glomerular permeability. Journal of American Society of Nephrology, 21 (12), 2053-2058, [8.491]
• Huss, S. , Schmitz, J., Goltz, D., Fischer, H. P., Buttner, R., Weiskirchen, R. (2010): Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis. Fibrogenesis Tissue Repair, 3, 10, [2.329]
• Karlmark, K. R. , Zimmermann, H. W., Roderburg, C., Gassler, N., Wasmuth, H. E., Luedde, T., Trautwein, C., Tacke, F. (2010): The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology, 52 (5), 1769-1782, [11.711]
• Kern, M. , Popov, A., Kurts, C., Schultze, J. L., Knolle, P. A. (2010): Taking off the brakes: T cell immunity in the liver. Trends in Immunology, 3 (8), 311-317, [11.433]
• Koch, A. , Weiskirchen, R., Zimmermann, H. W., Sanson, E., Trautwein, C., Tacke, F. (2010): Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators of Inflammation, [3.418]
• Koch, A. , Weiskirchen, R., Sanson, E., Zimmermann, H. W., Voigt, S., Duckers, H., Trautwein, C., Tacke, F. (2010): Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Crit Care, 14, R179, [4.950]
• Koch, A. , Sanson, E., Helm, A., Voigt, S., Trautwein, C., Tacke, F. (2010): ): Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis.. Crit Care, 14, R94, [4.950]
• Krawczyk, M. , Mullenbach, R., Weber, S. N., Zimmer, V., Lammert, F. (2010): Genome-wide association studies and genetic risk assessment of liver diseases. Nature Reviews, Gastroenterology & Hepatology, 7 (12), 669-681, [14.435]
• Kurts, C. , Robinson, B. W., Knolle, P. A. (2010): Cross-priming in health and disease. Nature Reviews Immunology, 10, 403-414, [39.416]
• Kurts, C. (2010): Dendritic cells erase bad memory. European Journal of Immunology, 40 (7), 1870-1872, [4.179]
• Lammert, F. (2010): Hereditary liver diseases. Preface. Best Practice & Research Clinical Gastroenterology, 24 (5), 529, [3.897]
• Lange, C. M. , Roomp, K., Dragan, A., Nattermann, J., Michalk, M., Spengler, U., Weich, V., Lengauer, T., Zeuzem, S., Berg, T., Sarrazin, C. (2010): HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection. Journal of Hepatology, 53 (6), 1022-1028, [10.590]
• Langhans, B. , Braunschweiger, I., Arndt, S., Schulte, W., Satoguina, J., Layland, L. E., Vidovic, N., Hoerauf, A., Oldenburg, J., Sauerbruch, T., Spengler, U. (2010): Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.. Clinical Science (London), 119, 97-109, [5.016]
• Liu, M. , Shi, S., Senthilnathan, S., Yu, J., Wu, E., Bergmann, C., Zerres, K., Bogdanova, N., Coto, E., Deltas, C., Pierides, A., Demetriou, K., Devuyst, O., Gitomer, B., Laakso, M., Lumiaho, A., Lamnissou, K., Magistroni, R., Parfrey, P., Breuning, M., Peters, D. J., Torra, R., Winearls, C. G., Torres, V. E., Harris, P. C., Paterson, A. D., Pei, Y. (2010): Genetic variation of DKK3 may modify renal disease severity in ADPKD.. Journal of the American Society of Nephrology, 21 (9), 1510-1520, [8.491]
• Luedde, T. (2010): MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma. Hepatology, 52 (3), 1164-1166, [11.711]
• Ma, H. , Wang, J., Thomas, D. P., Tong, C., Leng, L., Wang, W., Merk, M., Zierow, S., Bernhagen, J., Ren, J., Bucala, R., Li, J. (2010): Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation, 122 (3), 282-292, [17.202]
• Mertens, P. R. , Muller, R. (2010): Vitamin D and cardiovascular risk. International Urology and Nephrology, 42 (1), 165-171, [1.292]
• Moeller, M. J. (2010): Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?. Nephrology Dialysis Transplantation, 25, 2101-2103, [4.085]
• Moeller, M. J. (2010): Novel insights into the glomerular structure. Dtsch Med Wochenschr, 135 (24), 1232-1236, [0.503]
• Nischalke, H. D. , Vogel, M., Mauss, S., Baumgarten, A., Lutz, T., Danta, M., Naumann, U., Coenen, M., Sauerbruch, T., Rockstroh, J. K., Spengler, U., Nattermann, J. (2010): The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection.. AIDS, 24, 2001-2007, [4.407]
• Otto, E. A. , Hurd, T. W., Airik, R., Chaki, M., Zhou, W., Stoetzel, C., Patil, S. B., Levy, S., Ghosh, A. K., Murga-Zamalloa, C. A., van Reeuwijk, J., Letteboer, S. J., Sang, L., Giles, R. H., Liu, Q., Coene, K. L., Estrada-Cuzcano, A., Collin, R. W., McLaughlin, H. M., Held, S., Kasanuki, J. M., Ramaswami, G., Conte, J., Lopez, I., Washburn, J., Macdonald, J., Hu, J., Yamashita, Y., Maher, E. R., Guay-Woodford, L. M., Neumann, H. P., Obermuller, N., Koenekoop, R. K., Bergmann, C., Bei, X., Lewis, R. A., Katsanis, N., Lopes, V., Williams, D. S., Lyons, R. H., Dang, C. V., Brito, D. A., Dias, M. B., Zhang, X., Cavalcoli, J. D., Nurnberg, G., Nurnberg, P., Pierce, E. A., Jackson, P. K., Antignac, C., Saunier, S., Roepman, R., Dollfus, H., Khanna, H., Hildebrandt, F. (2010): Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nature Genetics, 42, 840-850, [31.616]
• Panzer, U. , Kurts, C. (2010): T cell cross-talk with kidney dendritic cells in glomerulonephritis. Journal of Molecular Medicine (Berl), 88 (1), 19-26, [4.855]
• Raskopf, E. , Vogt, A., Standop, J., Sauerbruch, T., Schmitz, V. (2010): Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma. Zeitschrift für Gastroenterologie, 48 (1), 21-27, [1.357]
• Roderfeld, M. , Rath, T., Lammert, F., Dierkes, C., Graf, J., Roeb, E. (2010): Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC. World Journal of Hepatology, 2 (5), 175-179, [3.660]
• Sahin, H. , Trautwein, C., Wasmuth, H. E. (2010): Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol, 7 (12), 682-690, [14.435]
• Schurich, A. , Berg, M., Stabenow, D., Bottcher, J., Kern, M., Schild, H. J., Kurts, C., Schuette, V., Burgdorf, S., Diehl, L., Limmer, A., Knolle, P. A. (2010): Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J Immunol, 184, 4107-4114,
• Seidler, S. , Zimmermann, H. W., Bartneck, M., Trautwein, C., Tacke, F. (2010): Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults.. BMC Immunol, 11, 30, [2.161]
• Semmling, V. , Lukacs-Kornek, V., Thaiss, C. A., Quast, T., Hochheiser, K., Panzer, U., Rossjohn, J., Perlmutter, P., Cao, J., Godfrey, D. I., Savage, P. B., Knolle, P. A., Kolanus, W., Forster, I., Kurts, C. (2010): Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nature Immunology, 11, 313-320, [19.381]
• Siegmund, S. V. (2010): Role of the endocannabinoid system in alcoholic liver disease. Digestive Disease, 28, 751-755, [1.777]
• Smeets, B. , Moeller, M. J. (2010): Models of FSGS and minimal change nephropathy. Drug Discovery Today: Disease Models, 7, 3-11, [5.625]
• Stabenow, D. , Frings, M., Truck, C., Gartner, K., Forster, I., Kurts, C., Tuting, T., Odenthal, M., Dienes, H. P., Cederbrant, K., Protzer, U., Knolle, P. A. (2010): Bioluminescence imaging allows measuring CD8 T cell function in the liver.. Hepatology, 51, 1430-1437, [11.711]
• Tacke F , Weiskirchen R. (2010): Liver fibrosis - pathogenesis and novel therapeutic approaches. Der Internist, 51 (1), 21-29, [0.336]
• Teixeira-Clerc, F. , Belot, M. P., Manin, S., Deveaux, V., Cadoudal, T., Chobert, M. N., Louvet, A., Zimmer, A., Tordjmann, T., Mallat, A., Lotersztajn, S. (2010): Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology, 52 (3), 1046-1059, [11.711]
• Thomson, A. W. , Knolle, P. A. (2010): Antigen-presenting cell function in the tolerogenic liver environment. Nature Reviews Immunology, 10, 753-766, [39.416]
• Tillmann, H. L. , Thompson, A. J., Patel, K., Wiese, M., Tenckhoff, H., Nischalke, H. D., Lokhnygina, Y., Kullig, U., Gobel, U., Capka, E., Wiegand, J., Schiefke, I., Guthoff, W., Grungreiff, K., Konig, I., Spengler, U., McCarthy, J., Shianna, K. V., Goldstein, D. B., McHutchison, J. G., Timm, J., Nattermann, J., German Anti, D. S. G. (2010): A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology, 139 (5), 1586-1592, [18.187]
• Trebicka, J. , Hennenberg, M., Odenthal, M., Shir, K., Klein, S., Granzow, M., Vogt, A., Dienes, H. P., Lammert, F., Reichen, J., Heller, J., Sauerbruch, T. (2010): Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. Journal of Hepatology, 53 (4), 702-712, [10.590]
• Vidovic, N. , Lochowsky, R. S., Goldmann, G., Rockstroh, J., Wasmuth, J. C., Spengler, U., Sauerbruch, T., Lammert, F., Oldenburg, J., Grunhage, F. (2010): Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection. Haemophilia, 16 (5), 778-785, [2.673]
• Vucur, M. , Roderburg, C., Bettermann, K., Tacke, F., Heikenwalder, M., Trautwein, C., Luedde, T. (2010): Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?. Oncotarget, 1 (5), 373-378, [5.008]
• Wasmuth, H. E. , Weiskirchen, R. (2010): Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines. Zeitschrift für Gastroenterologie, 48 (1), 38-45, [1.357]
• Wasmuth, H. E. , Weiskirchen, R. (2010): Personalized medicine in hepatitis C: from genome-wide association studies to clinical practice. Hepatology, 51 (6), 2223-2225, [11.711]
• Weber, S. , Grunhage, F., Hall, R., Lammert, F. (2010): Genome-wide association studies in hepatology. Zeitschift für Gastroenterologie, 48 (1), 56-64, [1.357]
• Zaldivar, M. M. , Pauels, K., von Hundelshausen, P., Berres, M. L., Schmitz, P., Bornemann, J., Kowalska, M. A., Gassler, N., Streetz, K. L., Weiskirchen, R., Trautwein, C., Weber, C., Wasmuth, H. E. (2010): CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology, 51 (4), 1345-1353, [11.711]
• Zimmermann, H. W. , Seidler, S., Nattermann, J., Gassler, N., Hellerbrand, C., Zernecke, A., Tischendorf, J. J., Luedde, T., Weiskirchen, R., Trautwein, C., Tacke, F. (2010): Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One, 5 (6), e11049, [3.057]

2009

• Ahlenstiel, G. , Woitas, R. P., Iwan, A., Nattermann, J., Feldmann, G., Rockstroh, J. K., Oldenburg, J., Kupfer, B., Sauerbruch, T., Spengler, U. (2009): Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia. Immunol Invest, 38, 284-296, [1.780]
• Amini-Bavil-Olyaee, S. , Herbers, U., Mohebbi, S. R., Sabahi, F., Zali, M. R., Luedde, T., Trautwein, C., Tacke, F. (2009): Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome. J Hepatol, 51, 647-654, [10.590]
• Appel, D. , Kershaw, D. B., Smeets, B., Yuan, G., Fuss, A., Frye, B., Elger, M., Kriz, W., Floege, J., Moeller, M. J. (2009): Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol, 20, 333-343, [8.491]
• Berres, M. L. , Trautwein, C., Zaldivar, M. M., Schmitz, P., Pauels, K., Lira, S. A., Tacke, F., Wasmuth, H. E. (2009): The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo. Biol Chem, 390, 1039-1045, [2.710]
• Deveaux, V. , Cadoudal, T., Ichigotani, Y., Teixeira-Clerc, F., Louvet, A., Manin, S., Nhieu, J. T., Belot, M. P., Zimmer, A., Even, P., Cani, P. D., Knauf, C., Burcelin, R., Bertola, A., Le Marchand-Brustel, Y., Gual, P., Mallat, A., Lotersztajn, S. (2009): Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One, 4, 5844, [3.057]
• Dooley, S. , Weng, H., Mertens, P. R. (2009): Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.. Dig Dis, 27, 93-101, [1.777]
• Fischer, D. C. , Jacoby, U., Pape, L., Ward, C. J., Kuwertz-Broeking, E., Renken, C., Nizze, H., Querfeld, U., Rudolph, B., Mueller-Wiefel, D. E., Bergmann, C., Haffner, D. (2009): Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol Dial Transplant, 24, 1819-1827, [4.085]
• Floege, J. , Smeets, B., Moeller, M. J. (2009): The SDF-1/CXCR4 axis is a novel driver of vascular development of the glomerulus. J Am Soc Nephrol, 20, 1659-1661, [8.491]
• Hakroush, S. , Moeller, M. J., Theilig, F., Kaissling, B., Sijmonsma, T. P., Jugold, M., Akeson, A. L., Traykova-Brauch, M., Hosser, H., Hahnel, B., Grone, H. J., Koesters, R., Kriz, W. (2009): Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am J Pathol, 175, 1883-1895, [4.206]
• Hennenberg, M. , Trebicka, J., Stark, C., Kohistani, A. Z., Heller, J., Sauerbruch, T. (2009): Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol, 157, 258-270, [5.259]
• Hennenberg, M. , Trebicka, J., Kohistani, A. Z., Heller, J., Sauerbruch, T. (2009): Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis. Eur J Clin Invest, 39, 906-913, [2.687]
• Heymann, F. , Trautwein, C., Tacke, F. (2009): Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy Drug Targets, 8, 307-318, [1.560]
• Heymann, F. , Meyer-Schwesinger, C., Hamilton-Williams, E. E., Hammerich, L., Panzer, U., Kaden, S., Quaggin, S. E., Floege, J., Grone, H. J., Kurts, C. (2009): Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest, 119, 1286-1297, [12.575]
• Karlmark, K. R. , Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., Tacke, F (2009): Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology, 50, 261-274, [11.711]
• Klotz, L. , Burgdorf, S., Dani, I., Saijo, K., Flossdorf, J., Hucke, S., Alferink, J., Nowak, N., Beyer, M., Mayer, G., Langhans, B., Klockgether, T., Waisman, A., Eberl, G., Schultze, J., Famulok, M., Kolanus, W., Glass, C., Kurts, C., Knolle, P. A. (2009): The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med, 206, 2079-2089, [1.287]
• Koch, A. , Gressner, O. A., Sanson, E., Tacke, F., Trautwein, C. (2009): Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.. Crit Care, 13, R95, [4.950]
• Kovalenko, E. , Tacke, F., Gressner, O. A., Zimmermann, H. W., Lahme, B., Janetzko, A., Wiederholt, T., Berg, T., Muller, T., Trautwein, C., Gressner, A. M., Weiskirchen, R. (2009): Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.. J Viral Hepat, 16, 612-620, [4.179]
• Kramer, B. , Schulte, D., Korner, C., Zwank, C., Hartmann, A., Michalk, M., Sohne, J., Langhans, B., Nischalke, H. D., Coenen, M., Mohl, C., Vogt, A., Hennenberg, M., Sauerbruch, T., Spengler, U., Nattermann, J. (2009): Regulation of NK cell trafficking by CD81.. Eur J Immunol, 39, 3447-3458, [4.179]
• Lutz, M. B. , Kurts, C. (2009): Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.. Eur J Immunol, 39, 2325-2330, [4.179]
• Nattermann, J. , Tacke, F. (2009): The structure behind diversity: covariance networks in hepatitis C virus sequences are associated with treatment response.. Hepatology, 49, 1767-1769, [11.711]
• Paust, H. J. , Turner, J. E., Steinmetz, O. M., Peters, A., Heymann, F., Holscher, C., Wolf, G., Kurts, C., Mittrucker, H. W., Stahl, R. A., Panzer, U. (2009): The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol, 20, 969-979, [4.657]
• Schulte, D. , Vogel, M., Langhans, B., Kramer, B., Korner, C., Nischalke, H. D., Steinberg, V., Michalk, M., Berg, T., Rockstroh, J. K., Sauerbruch, T., Spengler, U., Nattermann, J. (2009): The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells. J Infect Dis, 200, 1397-1401, [6.344]
• Smeets, B. , Uhlig, S., Fuss, A., Mooren, F., Wetzels, J. F., Floege, J., Moeller, M. J. (2009): Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells.. J Am Soc Nephrol, 20, 2604-2615, [8.491]
• Trebicka, J. , Hennenberg, M., Schulze Probsting, A., Laleman, W., Klein, S., Granzow, M., Nevens, F., Zaagsma, J., Heller, J., Sauerbruch, T. (2009): Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.. Hepatology, 50, 1924-1935, [11.711]
• Wasmuth, H. E , Tag, C. G., Van de Leur, E., Hellerbrand, C., Mueller, T., Berg, T., Puhl, G., Neuhaus, P., Samuel, D., Trautwein, C., Kanse, S. M., Weiskirchen, R. (2009): The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.. Hepatology, 49, 775-780, [11.711]
• Wasmuth, H. E. , Lammert, F., Zaldivar, M. M., Weiskirchen, R., Hellerbrand, C., Scholten, D., Berres, M. L., Zimmermann, H., Streetz, K. L., Tacke, F., Hillebrandt, S., Schmitz, P., Keppeler, H., Berg, T., Dahl, E., Gassler, N., Friedman, S. L., Trautwein, C. (2009): Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.. Gastroenterology, 137, 309-319, 301-303, [18.187]
• Weiskirchen, R. , Wasmuth, H. E. (2009): The genes that underlie fatty liver disease: the harvest has begun. Hepatology, 49, 692-694,
• Weiskirchen, R. , Liedtke, C., Trautwein, C. (2009): When sleeping beauty wakes up and jumps into a cancer-minded environment. Hepatology, 49, 2122-2124., [11.711]
• Weng, H. L. , Liu, Y., Chen, J. L., Huang, T., Xu, L. J., Godoy, P., Hu, J. H., Zhou, C., Stickel, F., Marx, A., Bohle, R. M., Zimmer, V., Lammert, F., Mueller, S., Gigou, M., Samuel, D., Mertens, P. R., Singer, M. V., Seitz, H. K., Dooley (2009): The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology, 50, 230-243, [11.711]